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ABSTRACT 
Microemulsion is a more sophisticated form of emulsion to improve the stability and 
appearance as compared to simple emulsions or macroemulsion. Microemulsion 
preparations of various cosmetic products are used as moisturizing, sunscreens and 
smoothing agents. The aim of this study was to develop thermodynamically stable 
microemulsions with plants extracts, their characterization and in vivo study on 
volunteers. Extracts of Lycopersicon esculentum (F1), Carica papaya (F2) and Punica 
granatum (F3) were successfully prepared. The antioxidant activities of the plant extracts 
were measured by DPPH radical scavenging assay. Standardization of extracts and 
construction of pseudo phase diagram was done by aqueous titration method. Stable MEs, 
of F1, F2 and F3 of o/w type were prepared using oily phase (IPM, Palm oil), Tween 80 
and propylene glycol as emulsifiers while distilled water was used as aqueous phase. 
Crude plant extract 10% and 4% was used in F1, F2 and F3, respectively while base (B1 
and B2) was utilized without extracts. All these MEs were kept at four different storage 
conditions, i.e. 8ºC, 25ºC, 40ºC and 50ºC for a period of three months to evaluate their 
stability characteristics. Human volunteers were used for in vivo evaluation of F1, F2 and 
F3 to estimate their effects on human skin. Different skin parameters like skin melanin, 
erythema, skin pH, moisture contents, elasticity, sebum contents and surface evaluation of 
living skin (SELS) were measured at different time intervals for three months. The results 
obtained were compared with zero hour readings. Statistical tools of ANOVA and paired 
sample t-test were used to evaluate the results. Three plants extracts showed significant 
antioxidant potential. Electrical conductivity results confirmed that an outer phase of MEs 
was water. Significant (P ˂ 0.05) differences in the level of melanin were produced by F3. 
In case of sebum contents, insignificant (P > 0.05) difference was observed for F1, F2 and 
F3. Significant decrease in erythema was observed in F1, F2 and F3, while F1, F2 and F3 
showed insignificant differences in skin pH. A significant (P ˂ 0.05) increase in elasticity 
was produced by F1, F2 but F3 showed insignificant differences whereas F1, F2 and F3 
showed significant differences on SELS parameters. As a conclusion F1 and F2 MEs with 
10% plant extract were found more effective with anti-aging properties. F3 MEs with 4% 
plant extracts was effective, safe with whitening effect as well as anti-aging properties.  
Key Words: Lycopersicon esculentum (F1), Carica papaya (F2), Punica granatum (F3), 
Microemulsions, DPPH, Extracts, Melanin, Sebum, Skin pH, SESL 
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1. INTRODUCTION 
 
The design and development of new drug delivery systems in order to enhance their 
efficacy is an on-going process in pharmaceutical research. Thus, new approaches of 
formulation are needed. Microemulsions are well known to improve absorption and 
bioavailability of many compounds. Microemulsions, liposomes, multivasicular system 
and multiple emulsions are now a day used in cosmetics industries with more better 
preparations are easy to apply, with better benefits and more safe products (Bolzinger et 
al., 1998). The droplets in a microemulsion are in the range of 0.1-1.0µm (Hoar and 
Schulman, 1943). 
Cosmetic formulations are made to satisfy and provide full benefits, e.g: aesthetic and 
functional. Many cosmetic formulations are designed to protect the skins from damaging 
effects of sunlight by making sun screens. In addition, the designs should give a satisfying 
odour make skin feel charming and appeal to the client on application. Nowadays, many 
beautifying formulations are based on oil-in-water (o/w) or water-in-oil (w/o) emulsions 
which are made to produce creams with the right constancy (Rheology) that attracts the 
customer.These systems are thermo-dynamically uneven. Microemulsions are isotropic 
systems, made up of oil, water and surfactant and the free energy of their preparation is 
zero or negative (Tadros, 1992).  
Microemulsion is defined as a distribution consisting of surfactant, oil, aqueous phase and 
co-surfactant, which is an only optically isotropic and thermodynamically constant liquid 
solution and it, has 10-140 nm diameters of droplets (Chen et al., 2006). Microemulsions 
have several benefits such as enhanced drug solubility, good thermodynamic stability, 
enhancing effects on transdermal ability over orthodox formulations. There are so many 
penetration increasing procedures of microemulsions like an increased concentration 
gradient and thermodynamic activity towards skin and the permeation enhancement 
activity of the components of microemulsions. Microemulsion offers a significant 
advantage of increasing solubility of active agents for delivering active agents through 
skin or mucous membrane and also can reduce their barrier due to its powerful 
permeation enhancing effect (Chen et al., 2007). Since microemulsions were discovered 
approximately six decades ago, their applications in several fields, including cosmetics, 
have been increased due to their good appearance, thermodynamic stability, high 
solubilization power, and ease of preparation. In addition, microemulsions can enhance 
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skin permeation of the loaded substances. They are classified into three types: oil-in-
water, bicontinuous and water-in-oil. All types of microemulsions can be formed 
spontaneously when the ratios of oil, water and amphiphile in the systems are appropriate 
(Boonme, 2007). 
 The largest organ of human body is the skin and it protects and separates the external and 
internal organs of the body. Building blocks of skin – DNA, collagen, and cell 
membranes are damaged by the environmental elements like exposure to solar radiation, 
air pollution and normal aging process. Our skin is affected by the cosmetic products 
having medicinal or drug – like benefits. These products go beyond adorning and coloring 
the skin. Such products improve the texture and functioning of the skin by combating 
harmful effects of free radicals and by enhancing collagen growth, eventually the 
structure of keratin is maintained properly and skin becomes healthier (Dureja et al., 
2005). Cosmetic product may be non-medicinal or medicinal affects are put on skin 
depending upon active ingredients in products. It may be used for treatment or for 
enhancements in beautification or attractiveness of skin by applying topically or locally 
(Pieroni et al., 2004). Among the various transdermal drug delivery systems, 
microemulsions appear to be an appropriate dosage form used for increasing cutaneous 
delivery, improving thermodynamic stability, products appearance, physicochemical 
characteristics and enhancement of bioavailability (Mortazavi et al., 2013). Drug 
permeation is improved by the droplets which settle down very close to the surface of the 
skin and increase the concentration gradient. Similarly a good contact to the skin is 
maintained by the presence of low surface tension. The surfactant and co-surfactant in the 
microemulsions can decrease the diffusion hurdles of the stratum corneum by acting as 
penetration enhancers and ultimately they facilitate cutaneous penetration (Azeem et al., 
2008). 
Crude extracts of three plants namely; Punica granatum, Lycopersicon esculentum and 
Carica papaya were used separately to study the antioxidant and anti-aging properties by 
formulating their extracts into formulations i.e. microemulsions. The 1st, 2nd and 3rd plant 
belongs to family Punicaceae, Solanaceae, and Caricaceae, respectively. The 
microemulsion systems consist of IPM, Tween 80, Propylene glycol and Palm oil, Tween 
80 and Propylene glycol. 
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The aims of this study were; 
1. Study of natural ingredients on human skin 
2. Antioxidant activity measurement of these extracts 
3. Formulation of different microemulsions from these plant extracts 
4. To characterize the microemulsion formulations on basis of viscosity, pH, and 
conductivity measurement 
5. In-vitro stability studies of these microemulsions for a period of three months 
6. In-vivo evaluation on human volunteers for a period of at least three months. 
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2. REVIEW of LITERATURE  
For thousands of years, nature had been the source of thousands of medicinal agents and 
from these agents; countless medicines have been isolated so far (Redo et al., 1989). 
Need of cheaper and effective plant based drugs having more effects and less side effects 
has become need of the hour. That’s why in the recent times attention to the development 
of such medicines has become question of all the questions (Essawi and Srour, 2000).  
2.1 Plants used in Current Study 
2.1.1 Lycopersicon esculentum (Solanaceae) 
Consumers perceive about the quality and flavour of any fruit by the first look at its 
colour. Similarly carotenoids in whatever form along with the chlorophyll and 
anthocyanins are considered as responsible for establishing the colour in the fruits. 
Tomato is the rich source of lycopene.  The scientific name of tomato is “Lycopersicon 
esculentum,” that’s why the antioxidant found in the tomato is called as lycopene (Nandi 
and Joshi, 2007). More the tomato is brighter more amount of lycopene is present in it 
(Toor et al., 2005). Reactive oxygen species produced under photoxidative conditions are 
effectively scavenged by the carotenoids. High doses of ß-carotene have bound found 
effective against damages caused by the UV induced erythema (Stahl et al., 2001). 
Antioxidant compounds like phenolics, ascorbic acid and lycopene are richly found in the 
tomatoes (Toor et al., 2008). Various diseases like cardiovascular diseases, cancer based 
on lycopene contents and UV light induced erythema can be effectively treated by the use 
of tomato products. Nutritional interest for finding out the health benefits of tomato 
products and tomato itself is therefore based on the quantification of lycopene contents of 
tomatoes (Periago et al., 2004). Antioxidants depleted by UV radiations from the skin are 
restorable by the topical application of lycopene (Lopes and Reed, 2010). 
Lycopene (an acylic carotenoid) has 13 bonds (double) and gives red colour to the 
tomatoes. Other sources of lycopene include, pink grapefruit, apricots, water melon and 
guava. Tomatoes nutritional analysis have shown that about 72-92% of lycopene is found 
in the skin of tomatoes and it is in the form of water insoluble fractions (Rozzi et al., 
2002). 
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2.1.2 Carica papaya (Caricaceae) 
Papaya (Carica papaya L.) is considered as one of the most famous fruits of tropical and 
sub-tropical climates.  A single genetic locus is responsible of controlling two fruit 
colours, yellow and red. However yellow is dominant over the red one.Carotenoid 
contents control the fruit flesh colours. Similarly the red- fleshed colour of papaya fruit is 
due to the high concentrations of lycopene and vice versa (Devitt et al., 2009). Red-
fleshed papaya fruit contain high levels of lycopene, whereas yellow-fleshed fruit do not. 
The colour of papaya fruit flesh is determined largely by the presence of carotenoid 
pigments. Red-fleshed papaya fruit contain lycopene, whilst this pigment is absent from 
yellow-fleshed fruit (Devitt et al., 2009). Lycopene present in the red- coloured papaya is 
a very good antioxidant against cardiovascular disease and cancer. It also has benefits in 
coping with several oxidative damages. This specific aspect of papaya has been used as 
the curing agent of skin diseases. Papaya has also been found useful in promoting the 
brightness of skin (Chandrika et al., 2004). In the various developing countries, Carica 
papaya is used as an extensively available fruit for medicinal purposes of skin disease 
particularly the skin burns (Gurung and Skalko-Basnet, 2009). Fungal infections of the 
skins can be easily treated by using the latex of un-ripened fruits known as pawpaw 
plants. This part of papaya fruit is rapidly making its place in the herbal markets. There is 
a proteolytic enzyme found in the latex which is helpful in the healing of wounds. It is 
just like of bromelain of pineapple which is recommended by various surgeons after 
liposuction (Draelos, 2001). Restoration of various antioxidants depleted from the skin by 
UV radiation can be achieved conveniently by the use of lycopene (Kasai et al., 2006). 
2.1.3 Punica granatum (Punicaceae) 
Pomegranate (Punica granatumL.) belongs to the family Punicaceae, which is considered 
as a holy fruit in the Quran (Kulkarni and Aradhya, 2005). Pomegranate contains richly 
colored grains which contain delicious juice (Maskan, 2006). Fruit can be divided into 
three parts: the juice (30% of fruit weight) and seeds (3% of fruit weight) and the peels 
with interior network of membranes (Syed et al., 2007). There is 80% juice along with 20 
% seeds is present in the edible portion of the pomegranate fruit (50% of total fresh 
weight). In the same way juice of pomegranate is comprised of water and total sugars at 
the rate of 85 and 10 percent respectively. Similarly a considerable portion of 1.5% of 
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polyphenolic, flavonides, ascorbic acid and pectin has also been reported in the fresh 
juice of pomegranate.Seeds of pomegranate have also been reported of having a rich 
amount of pectin, sugars and pectin. Similarly steroid estrogen, isoflavone 
phytoestrogens, daidzein and genistein are also found in the dried seeds of pomegranate. 
Similar quantities of glucose and fructose are found in the juice of pomegranate. 50% of 
ash contents of calcium and glutamic acid and aspartic acid have also been found in the 
pomegranate juice. Depending upon variety the soluble polyphenol content in PJ are 
found within the range of 0.2–1.0% and has  mainly anthocyanins (such as cyanidin-3-
glucoside,cyanidin-3, 5-diglucoside, and delphindin-3-glucoside), catechins, ellagic 
tannins, and gallic and ellagic acids (Aviram et al., 2000). Antioxidants are able to protect 
the skin against oxidative stress (Bickers and Athar, 2006). Polyphenols such as 
punicalagin, ellagitannin and ellagic acid (EA) are found responsible of having 
antioxidants and anti-atherosclerotic activities (Seeram et al., 2006). 
 It has also been reported that antiviral and antioxidant properties are found in the 
pomegranate juice. If the juice of pomegranate fruit is compared with the red wine and 
green tea then it is easily found that it has more antioxidant punch. Dermal regeneration 
has been found taking place by the use of pomegranate peel fractions and epidermal 
regeneration by the use of pomegranate juice. Photochemopreventive property of 
pomegranate juice has also been found in the recent studies (Baumann, 2007). Skin 
whitening effect of pomegranate extract (PE) having 90 % ellagic acid has also been 
reported in the various studies (Yoshimura et al., 2005) 
2.1.3.1 Natural Products and Skin Whitening  
Dermal pigmentation is either dependent on the number, size, composition and 
distribution of melanocytes or activity of melanogenic enzymes tyrosinase. Its inhibition 
is the most common approach to achieve skin whitening. Several hypopigmenting 
products have been developed from natural sources are still considered more desirable 
and will predominate in the cosmetic products. Natural whitening products inhibiting 
tyrosinase can be roughly divided into two categories, simple phenols and polyphenols 
(Zhu and Gao, 2008). 
Ellagic acid was a polyphenol found in berries, green tea and Punica granatum with 
strong antioxidative properties and tyrosinase inhibition. The skin lightening effects of 
ellagic acid may be due to chelating copper to reduce its activity. In addition, the ROS-
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scavenging and antioxidative behaviour of ellagic acid may contribute to its skin-
whitening effect (Zhu and Gao, 2008). Flavonoid had phenolic and pyrane rings. It had 
been reported that flavonoids inhibit enzymes due to their abilities to chelate copper at 
substrates, yielding yellow oxidation products (Zhu and Gao, 2008). Niacinamide 
(Nicotinamide; 3-pyridinecarboxamide) is the amide form of vitamin B3 and had been 
shown to down regulate melanogenesis via inhibiting the transfer of melanosomes from 
melanocytes to keratinocytes. In addition, niacinamide is also a tyrosinase inhibitor (Zhu 
and Gao, 2008).  
2.2 The Skin 
Skin is the connection between internal and external environment. It plays an important 
role in defence mechanism of body (Ross and Christiano, 2006). The cutis and its certain 
specialized appendages constitute integument system (Gray, 2000). Skin has large surface 
area: 15-20 sq ft (1.5-2 m2). It is also served as outer protective layer; the cutis barrel 
relates body’s physical functions to the harsh weather conditions cover the entire body 
(Ross and Christiano, 2006). The thickness of the skin varies between 1.5-4.0 mm in 
different parts of the body (Veena, 2005). And a largest organ of the body consider body 
weight 16% 1.8m2   surface area in youngs and 2500 cm2 in children (Gray, 2000). 
Human skin is of two types. The skin which has grooves on the surface of palms and 
soles is called as glabrous skin. This type of skin has thick epidermis and no hair follicles. 
Skin which has hair on the remaining part of the body is called as hairy skins because it 
has hair follicles (Hendriks, 2005). 
Both melanins and erythema usually determine the colour of skin. Facultative or 
inducible skin colours are affected by the environmental exposures of the skin and 
ethnicity is the term generally describes the whole phenomenon of changes in the skin 
colours (Chan et al., 2005). 
2.2.1 Functional Anatomy of Skin 
With clear structural parts skin has many layers (Silver et al., 2001). Various races have 
difference in anatomy and physical function of skin. Hereditary material is necessary for 
colour and to measure the response to physiologic insult (Chan et al., 2005). The general 
structure of skin is depicted in figure 2.1. 
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Figure 2.1 Structure of Skin 
2.2.1.1 Epidermis 
It is the outermost layer of skin which is composed of stratified squamous keratinized 
epithelium. Epidermis "epi" is Greek word it meaning over or upon, is the outer layer of 
cutis. It is the outermost layer of the skin. It provides water barrier, protect and covers all 
body parts (Grabe and Neuber, 2005). 
The superficial layer consists of layers of different cells. Amino acids or proteins known 
as desmosomes connect with cells. Thickness of epidermis in most areas of body is 35-50 
micrometres.the epidermis is translucent, it allows light to pass. It gets oxygen and 
nutrients from deeper layer of skin. A very thin membrane is present at bottom of 
epidermis called basement membrane (Gray, 2000). 
The epidermis which forms a single barrier its thickness ranges from 0.07-0.12 mm 
throughout the body surface (Silver et al., 2001). There are keratinocytes present in the 
epidermis, these keratinocytes vary in the cellular constituents when move from one place 
to another (Hendriks, 2005). The epidermis synthesizes all lipids for barrier functions by 
metabolical processs; it is specially used to synthesized large amount of glycosyl 
ceramide and ceramide (Maria et al., 1997). 
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Epidermis has following five layers or strata as given in figure 2.2: 
1. Stratum corneum  
2. Stratum lucidum 
3. Stratum granulosum 
4. Stratum spinosum 
5. Stratum germinativum or Stratum basale (Baumann, 2007). 
 
 
 
 
Figure 2.2 Layers of Epidermis 
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2.2.1.1.1 Stratum Corneum 
Stratum corneum acts as an outer covering to the skin. This layer also called horny layer 
or cornified layer, the stratum corneum consists of 15-20 layers of dead a-nucleate cells 
that are hexagonal thin at squames. At this stage the cells are called as corneocytes 
because these cells are terminally differentiated keratinocytes (Hendriks, 2005; Gray, 
2000). 
The existence of liquid or aquous crystalline material in the cornified layer extracellular 
fatty material would have barrier and protection ability to skin. Lipids composed 
ofcholesterol, long chain saturated ceramides and free fatty materials.  Further, liquid 
lipid crystals could responsible for formation of structures but not bilayers structure 
(Plasencia et al., 2007). The pH of cornified layer may used to determine the functional 
properties of lipid and fatty material by its structure and stability. The human stratum 
corneum lipid composition have been complicated by adding of sebaceous gland lipids ad 
other exogenous materials contaminants the stratum corneum fatty acids, which have 20 
carbons may be saturated and straight chained. These lipids provide 98% water retention 
ability of the cornified layer. More lipid content on skin provide good barrier for water 
retention in skin (Plasencia et al., 2007). 
2.2.1.1.2 Stratum Lucidum 
This layer of epidermis is found in the form of thin translucent band such as in the palms 
and soles otherwise it is absent in the whole body. It composed of 2-3 layers of packed 
and flattened, eosinophilic cells. There are no nuclei and organelles (Hendriks, 2005).  
2.2.1.1.3 Stratum Granulosum 
This stratum consists of 3-5 layers of flattened rhomboid cells with their long axes 
parallel to the surface of the skin. Keratohyalin contains proteins granules, which used to 
bind the keratin filaments together. This layer has nuclei. With increase in size and 
number of keratohyaline granules, the nuclei of cells show degenerative changes. 
Keratinosomes cells also exist in stratum granulosum (Piepkorn et al., 2003). 
2.2.1.1.4 Stratum Spinosum 
The spinosum layer consists several layers of irregular polyhedral keratinocytes has 
spherical nuclei cells becomes flattened on surface. The cells of stratum spinosum show 
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fine cytoplasmic processes or spines which link with similar processes of adjacent cells 
by means of desmosomes. The stratum basale and stratum is responsible for the 
proliferation of keratinocytes and initiation of keratinization process. The stratum 
Malpighi also lodges melanocytes, langerhan cells and merkel cells (Ross and Pawlina, 
2003). 
2.2.1.1.5 Stratum Germinativum (Stratum Basale) 
This layer consists of a single layer of basophilic columnar or cubiodal keratinocytes 
resting on basement membrane which lies on the dermis. Each cell contains an oval 
nucleus. Desmosomes occur frequently at the lateral and outer surfaces of cells and serve 
to bind the cells together. The stratum basale is characterized by the presence of 
numerous mitotic figures, indicating that this layer is responsible for the production of 
new keratinocytes. The newly produced cells are constantly displaced into the layer above 
(Hendriks, 2005; Ross and Pawlina, 2003). 
2.2.1.2 Dermis 
Dermis or deeper layer is second layer which composed thick collagens tissues. The 
dermis is a sheet of connective tissues which acts as a binder and supporter of epidermis 
and it binds subcutaneous tissues. The thickness of dermis varies from 0.5-3 mm. It is 
composed of two layers. The outer layer called Papillary Layer while deeper one is 
known as Reticular Layers. About 75% of the dermis is composed of fat free collagen. Its 
collagen fibrils are thin and its diameter is 20-40 nm (Silver et al., 2001). 
It is the dermis which has a due share of 15-20% of human body weight. It also has a 
sense of touch and heat and has nerve endings. Blood vessels also present and provide 
nutrients to cells and layers (Hendriks, 2005; Silver et al., 2001). 
The Papillary Layer this layer bears papaillae and ridges that protrude into the epidermis. 
This layer is thinner than reticular layer and is composed of loose connective tissue. It 
contains fibroblasts, mast cells, macrophages and an extensive network of fine 
collagenous, elastic and reticular fibres (Silver et al., 2001). The reticular fibres group to 
form fibrils which inter into the basal lamina of the epidermis and extend perpendicularly 
into the dermis. Fibrils called anchoring fibrils bind the epidermis to dermis. Those 
papillae that have capillary plexuses are termed vascular papillae (Gray, 2000).  
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The Reticular Layer this layer is thicker and consists of dense irregularly arranged 
connective tissue. It contains bundles of collagenous fibres; some elastic fibres are also 
present. Scattered smooth fibers are found within the deep parts of the reticular layer in 
the aerolae, penis, scrotum, and perineum. Such portions of the skin become wrinkled 
during contraction of these muscle fibers. Smooth muscle also occurs as erector muscles 
of the hair (Silver et al., 2001).  
2.2.1.3 Hypodermis   
Hypodermis contains delicate tissues and fatty tissues these support skin (Hendriks, 
2005). Hypodermis is composed of loose connective tissues and elastin with mainly 
adipose tissues i.e. subcutaneous fat. Infants and elderly have less of this than adults and 
are therefore more sensitive to cold. Anatomical site, nutritional status of individual, age, 
sex, race and endocrines are the factors which affect the thickness of hypodermis. It is 
10% of body weight (Hendriks, 2005). 
The general level of subcutaneous fat and several components are showing the influence 
of sex, age and physique on the regional distribution of this subcutaneous fat. The 
hypodermis provides insulation to conserve body heat, absorption, energy and working of 
joints (Shephard et al., 1969). 
2.2.2 Cells in the Epidermis of Skin 
Epidermis is composed of four types of cells (Ross and Pawlina, 2003) 
 Melanocytes 
 Langerhans cells 
 Keratinocytes 
 Merkel cells  
2.2.2.1 Melanocytes 
The melanocyte is stellate cells with oval bodies and long dendritic processes. These cells 
are found in to be scattered between the keratinocytes of the stratum basale and stratum 
spinosum of the epidermis. Melanocytes do not desmosomes with the adjacent 
keratinocytes. Major source of colour in human skin is organelles melanosomes (Young 
et al., 2000). During an inflammatory event or process the melanin is produced (Ortonne 
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and Bissett, 2008). Melanin has two types: phaeomelanin melanins which are irregular in 
shape and eumelanin granules which are round and smooth (Gray, 2000). 
The melanocytes synthesize a dark brown pigmet called melanin which is responsible for 
human skin color. Melanosome are formed by phygocytic process and shifted to 
keratinocytes (Quevedo et al., 1975). Difference in skin color occurs due to different 
number of melanin cells its arrangement and sizes. Black or dark skin has more number 
of melanin cells which are divided throughout the skin of body than in white or less dark 
skin (Gray, 2000). Exposure to ultraviolet light causes tanning of the human skin. 
 By lightchemical reaction melanin cells show dark color 
 Increase in melanin synthesis and un-reactive melanocytes become reactive 
  Keratinocytes raise uptake of melanin proteins from keratinocytes 
One melanocyte supplies about 36 keratinocytes (Gray, 2000). Dihydoxyphenyl alanine 
(DOPA) is produced by Tyrosine then it is transferred or by oxidation of DOPA into 
melanin then proteins bound with the melanin and melanin protien complex is formed. 
This melanin protein is then transferred to the cytoplasm by various processes taking 
place into the cells. However the highest concentrations of melanin are found in the basal 
cells. The amount of melanin present in skin of human varies from race to race (Ross and 
Pawlina, 2003). 
2.2.2.2 Langerhans Cells 
It is found in stratum spinosum and stratum granulosum these are macrophages which 
detect different pathogens, toxins and microbes and prevent them from getting entered 
into the skin by activating the immune system. These cells are also found around the 
blood vessels of papillary dermis. They have an oval, reniform or irregular pale nucleus 
surrounded by pale staining cytoplasm which extends as cytoplasmic processes between 
the keratinocytes (Ross and Pawlina, 2003). 
No melanosomes or filaments are present in the cytoplasm of a langerhans cells. Under 
electron microscope, langerhans cells show several distinctive structure, tennis racket 
shaped granules called Birbeck granules; these are rod like structure, whose function is 
not known. These resemble the rackets of tennis due to their particular structures. The 
function of the langerhans cell was obscure. These cells immunologically have 
importance and possess phagocytic properties (Ross and Pawlina, 2003). 
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2.2.2.3 Merkel Cells 
These cells are found in or near the stratum basale of the epidermis in association with 
intra-epithelial free nerve endings. The cytoplasm of these cells stains darkely due to the 
presence of numerous small, dense granules. Merkel cells and the associated free nerve 
endings serve as mechno-receptors. These are specialized touch receptors and scattered 
among the stratum basal. By light microscopy they are difficult to distinguish from 
melanocytes. Merkel cells and associated free nerve ending serve as mechano receptors 
(Ross and Pawlina, 2003; Gray, 2000). 
2.2.2.4 Keratinocytes 
Most cells in epidermis synthesize keratin. The epidermis is consists of many 
superimposed layers of keratinocytes. Keratin is skin protein hair made up similar, but 
harder material. It loose central nucleous, involving cellular proliferation and growth, 
outward displacement and differentiation, followed by death and desquamation of skin 
cells (Gray, 2000; Ross and Pawlina, 2003). 
2.2.3 Special Skin Structures 
2.2.3.1 Sebaceous Glands 
The sebaceous glands are spherical or ovoid structures enclosed in a thin connective 
tissue capsule. They lie in the dermis and their ducts open into necks of hair follicles. In 
certain locations, such as the glands penis, lips, labia minora and tarsal plates, the 
sebaceous glands are associated with hair follicles and open directly upon the free surface 
or the skin. Sebaceous glands completely are absent in palms and soles. They are 
prominent in upper body parts. Several alveoli open into the short wide duct. The oily 
material is sebum, is passed through the duct of gland onto the hair and upon the skin 
surface (Youn et al., 2005; Montagna, 1974; Robert et al., 2000). 
The sebaceous secreted fatty acid has 16-18 carbons in chain and has mono unsaturated 
branched chains. Our skin surface is covered with sebaceous lipids (Plasencia et al., 
2007). Secretions of sebaceous gland are under the control of androgens both in male and 
female. Sebaceous gland is richly supplied with blood vessels (Montagna, 1974). Sebum 
is secreted by sebaceous gland into hair follicle. It forms a mixture with water secretions 
of sweat gland, which covers the skin and spread along hair. This mixture forms a natural 
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oil-in-water emulsion, which have protective action on the hair and kills the fungi (Gray, 
2000; Stevens and Lowe, 1997). Most adult human beings normally have sebaceous 
glands on buccal, oral, gingival mucosa; they also develop on lower lip without hair 
follicle (Montagna, 1974). 
2.2.3.2 Sweat Glands 
On the basis of their structure and the nature of their secretion sweat glands are classified 
into two types (Michael, 2003). These two types of sweat glands are; 
2.2.3.2.1 Eccrine Sweat Glands 
These sweat glands are tubular type are present in the dermis expect lips and part of 
external genitalia it is not associated with hair follicles. Control of thermo-regularity 
sweating is through parasympathetic system, while imitational sweating may be 
controlled by adrenergic system. Eccrine sweat glands has two parts a secretory part and a 
duct part. Secretory part has convoluted tubule located in dermis (Michael, 2003). 
The Dark Cells contain an extensive rough endoplasmic reticulum and a large number of 
small basophilic secretory granules. These cells produced mucoid secretions. 
The Clear Cells are serous in nature and their height varies according to the activity of 
glands. Their cytoplasm contains fat droplets and pigment granules. The clear cells 
secrete a watery product containing solutes (Michael, 2003). 
The sweat is a clear liquid derived from a network of blood capillaries that intimately 
envelop the secretory portions of sweat glands. Its components are water, sodium 
chloride, urea, ammonia and uric acid. It plays an important role in temperature regulation 
of body by providing a film of moisture on the skin surface for evaporating cooling. All 
of the cells rest on the basal lamina; their arrangement is that of a pseudo stratified 
epithelium (Michael, 2003).  
2.2.3.2.2 Apocrine Sweat Glands 
Apocrine sweat glands are originated by the hair follicles and sebaceous glands. These 
produce a typical smell which dependent upon the sex hormones. Certain special sweat 
glands of apocrine variety are found in the axilla, areola of breast, labia majora and 
circum- anal region (Gray, 2000).  
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Apocrine sweat glands are coiled glands that are empty into hair follicles. They are 
sometimes branched.  The apocrine gland of eye lashes is also apocrine type glands 
(Michael et al., 2003). The secretory portion of gland is located deeply in the dermis or in 
the upper region of hypodermis. Unlike ecrine gland, apocrine glands stored their 
secretions in the lumen. The secretary portion of gland which is composed of simple 
epithelium (Michael et al., 2003). They start functions at puberty but its functions is 
unknown (Junqueira et al., 2004). 
2.2.4 Functions of Skin 
Skin acts as physical barrier our body and environment. Skin barrier capacity is due to 
lipid secretion from sebaceous glands and sweat glands. Stratum corneum is main part for 
barrier function of skin (Plasencia et al., 2007). Our skin is basically naked. Hair serves 
as regulator of temperature, resist environmental bad factors and injuries (Jablonski, 
2013). The skin has four major functions (Young et al., 2000). 
2.2.4.1 Protection 
Epidermis is outer layer of our skin which resists free radicals and different temperature 
conditions (Jablonski, 2013). Skin protects our internal organ and muscles from 
environmental condition i.e. injuries. Sun puts dangerous effect on the skin (Fisher et al., 
1997). Skin protects the human body from mechanical, chemical and radiations injuries 
(Young et al., 2000). 
2.2.4.2 Prevention of Water Loss 
Moisture loss from human body is affectively controlled by the stratum corneum. Basal 
layer has almost 70-75% of water while this proportion is just about 10-15% in the 
stratum corneum (Gray, 2000).  
These upper layers are responsible of losing or absorbing of water in the best interest of 
skin health. Water increases the plasticity of stratum corneum, when the hydration 
increases it causes more diffusibility (Larson, 1999). 
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2.2.4.3 Prevention of Infections 
First barrier for microrganims (e.g. bacteria, fungi and yeast) is the presence of oil-in-
water emulsion on the skin (Young et al., 2000). Skin has slightly acidic PH which acts as 
a good antibiotic agent (Larson, 1999).  
2.2.4.4 Thermoregulation 
Thermo regulation in the human body is mainly controlled by the skin. Insulation of heat 
from the human body is controlled by the hair and hypodermic fatty tissues. Sweat glands 
are responsible in skin for heat loss it is due to evaporation of sweat from surface of body 
and raise blood flowing in vascular system (Young et al., 2000). 
2.2.4.5 Depot and Formation 
Skin is depot for lipids and water contents and also occurs, formation of vitamin D in the 
presence of sun light (Gray, 2000). 
2.2.4.6 Elegances and Way of Conversation 
Our skin can explain our behaviour or mood, physical conditions and elegant 
beautifulness or attractiveness (Gray, 2000). 
2.2.4.7 Synthesis of Vitamin D by the skin 
Vitamin D is obtained from the diets as well as produced in the human body.Vitamin D 
obtained from the diet is of two types:  
 Vitamin D2 (Ergocalciferol) from plant sources and  
 Vitamin D3 (Cholecalciferol) from animal sources 
Vitamin D however, obtained from the dietary sources is in the very minute 
amount.Vitamin D in shape of vitamin D3 can be made from (7- DHC) in our skin by 
using UV light, mainly from light in the UVB spectrum .Vitamin D is a pro-hormone, 
converted ultimately to the reactive shape of 1, 25- dihydroxyvitamin D3 (1, 25(OH) 2 D3 
(Katie et al., 2006).  
In the base of epidermis the proliferating keratinocyte are present. Many elements can 
affect the proliferation and differentiation process. But we discuss calcium and 1, 
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25(OH)2 D3. Calcium is more potent agent which use for stimulating of epidermal 
differentiation and inhibition of proliferation process in vitro (Bikle, 2004). 
It is tempting to speculate that the UVB its wavelength is between 280-320 nm, induced 
vitamin D production conserved feed-back mechanism that protects the skin against the 
deleterious effects of sun rays (Reichrath, 2007). Pigmentation has been shown to affect 
cutaneous vitamin D production. Dark-skinned individuals living in northern latitudes 
might be at greater risk of vitamin D deficiency than their white-skinned neighbours, this 
is because the presence of high concentrations of melanin in the skin seems to limit 
vitamin D synthesis by competing with 7-DHC for ultraviolet photons (Malvy et al., 
2000). 
2.2.4.8 Specialized Functions of the Dermis 
The functions of dermis include: (Gray, 2000) 
 It protects the body mechanically from the bumps and the shocks 
 Human skin supplies nutrients to the hungry cells by the flow of oxygen and blood 
 It removes various toxins produced during the metabolism to prevent the body 
from their poisonous effects 
 It has a considerable contribution in providing the color to the skin 
 It controls the flow of blood and respiration and hence contributes in the 
thermoregulation 
 It provides skin sensation of touch, pain, heat and cold 
Providing shape and form to body by holding all structures together (Gray, 2000). 
2.3 Skin Aging 
Aging is the death and senescence ocuured by the progressive deterioration of cellular 
physiological mechanisms (Wlaschek, et al., 2001). It is a continuous process which 
depends upon time. Fine lines and wrinkles, alterations in skin pigmentation and the 
thinner skin are particular signs of aging (Chiu and Kimball, 2003). Skin cracks and fibers 
decreases and become disorganized with aging due to decreasing number of sebaceous 
glands. The collagenous fibers move apart because they become thicker. Wrinkles appear 
due to decrease in fibers, loose epidermis and decrease padding of epidermis with age and 
hair turn gray due to decrease in melanocytes (Mader, 2005). 
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2.3.1 Types of Aging 
 Thereare two categories of aging: extrinsic or premature aging and Intrinsic or 
chronological aging (Rabe et al., 2006). 
2.3.1.1 Intrinsic Aging 
In this type of aging some natural mechanisms take place. In this type of aging turn over  
of  new  skin  cells  may decrease  slightly and dead  skin  cells  do  not  shed  as  quickly. 
The  signs  of  intrinsic  aging  are  as  follows:  thin  and transparent skin, fine  wrinkles,  
bones shrink away from the skin due to bone loss resulting in sagging skin, loss of 
underlying fat leading to hollowed cheeks and eye sockets, graying hair that eventually 
turns white, inability to sweat sufficiently to cool the skin, unwanted hair, hair loss,  nail 
plate thins and ridges development are the specific signs of intrinsic aging (Holtkotter et 
al., 2005). Similarly, in the intrinsic aging collagen fibers become disoriented and 
biosynthetic capabilityof the fibroblasts is decreased. Intrinsic aging is a genetically 
controlled process which takes place in though a slow but inevitable manner (Jenkins, 
2002). 
2.3.1.2 Extrinsic Aging 
 Exogenous origins like smoking, exposure to sunlight and poor nutrition are the main 
cause of extrinsic aging. Premature aging of the skin is the outcome of these factors. 
Increased skin fragility and benign lesions along with the loss in tone and elasticity is 
observed in this type of aging. Epidermal atrophy, elastosis and distinct alteration 
inelastic fibres and collagen are the main properties in the Histopathology of photo aged 
skin. Extrinsic factors include exposure to sunlight, repetitive muscle movements like 
squinting or frowning, sleeping position, diet, nicotine, pollution and overall health and 
these are controllable to varying degrees (Farage et al., 2008).  
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Characteristics of extrinsic and intrinsic skin aging are summarized in table 2.1. 
Table 2.1 Characteristics of Extrinsic and Intrinsic Skin Aging 
Skin 
Characteristics 
Intrinsic Skin Aging Extrinsic Skin Aging 
Thickness Very thin skin 
Leather-like, thickened 
appearance 
Colour 
Transparent  appearing  skin  
with  visible underlying vascular 
structures 
Yellowish discoloration 
Appearance Fine lines and atrophic crinkling 
Deep wrinkles, folds  and 
furrows 
Elasticity 
Markedly reduced elasticity and 
firmness 
Reduced elasticity 
Pigmentation No pigment changes Various pigment irregularities 
Sebaceous fat tissue 
Reduced volume of subcutaneous 
fat tissue 
Reduced volume of 
subcutaneous fat tissue 
 
2.3.2 Features of Aging Skin 
Apparent thinning of skin, sagging, skin wrinkling and graying of hair are some of the 
changes that appear in aging skin. Epidermal cells are crowded at a very less rate due to 
inability of the epidermis to contract and it is resulted in the development of thinner skin 
because the elasticity of the skin occurred in the said phenomenon (Elias and Ghadially, 
2002). Skin deformation is resulted into the folding of skin which makes wrinkles. 
Wrinkles are of two types: shallow wrinkles and deep wrinkles. The warping of the 
epidermis caused by water loss produces shallow wrinkles. On the other hand, due to 
decreased elastin fibres and collagen elasticity of the dermis is decreased and deep 
wrinkles are resulted. Wrinkles can also be classified in another way and these are the 
wrinkles caused by the aging and expressive wrinkles. Wrinkles due to aging are formed 
bythe process mentioned above. During various expressions regardless of age some 
expressive wrinkles are produced while the wrinkles caused by the aging are resulted by 
the phenomenon explained above. Expressive wrinkles are formed by the movement of 
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skin muscles found in the dermis.  These wrinkles are also called as temporary wrinkles. 
Morphology of the wrinkles varies according to the regions of the skins and the age of 
person (Jaspers et al., 1999). 
 Along with the morphological changes in the skin some biochemical changes also take 
place. Changes in the dermal connective tissue Causes deterioration of the dermis. As the 
age increases the dermis becomes thinner due to decline in the organization and amount. 
Major contributing factor to the aging is said to be the degradation of collagen. It is 
responsible of major changes taking place in the dermis which finally leads to the 
appearance of the aged skin (Chung et al., 2001). Collagen bundles in the aged skin are 
separated while these are tightly packed in the young skin (Varani et al., 2000). As age 
increases the reduction of elastin fibres and collagen occurs which ultimately lead to 
sagging and reduced elasticity of skin (Ohnishi et al., 2000).The outward look of skin is 
conferred by, chondroitin 4-sulfate, hyaluronic acid and chondroitin 6-sulfate and 
decreased levels of hyaluronic acid and increased chondroitin sulfate is characteristic of 
photoaged skin (Waller and Maibach, 2006). In the elderly people, appearance of aged 
skin is due to the site specific alterations in the sub-cutaneous tissues. Issues of skin 
cancers in the elderly people are increased because the production of melanocytes in the 
body is reduced and hence the penetration of cancer causing radiations is not encountered 
well by the body. Aged skin is relatively more avascular due to reduced blood flow, 
depleted nutrient exchange and inhibited thermo regulation (Salavkar et al., 2011). 
2.3.3 Factors Causing Skin Aging 
There are many factors involved in the aging of human skin like hormonal changes, 
genetics, environmental exposures and metabolic processes. These factors cause 
alterations in the structures and functions of human skin (Leveque and Goubanova, 2004). 
Skin  aging  can  be  stimulated  by  sun  exposure before  intrinsic  aging  is started. 
Leathery appearance with wrinkle formation and fine lines; textural changes, impaired 
wound healing, appearance of lesions on the skin, pigmentary alterations as hyper 
pigmentation and skin cancer are specific symptoms of photo-aging of human skin 
(Rebecca et al., 2006). Smoking causes slowing down of production of new elastins and 
collagen due to release of several oxidants. Nutrients needed for healthy skin cannot reach 
their properly because flodd flow is restricted in the skins of smokers (Salavkar et al., 
2011). 
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Genetic factors are involved in the process of aging because it affects the rate and 
progress of aging. Healthy skin of both or one parent is genetically inherited into the 
children. Similarly, skin aging is also influenced by the life styles.  Stress, use of alcohols, 
lack of sleep, improper diet and less use of drinking water enhance the aging process. 
Hormonal changes during the years of menopause also affect the skin aging and wrinkles 
and loose skin are particular signs of these years (Leveque and Goubanova, 2004). 
Oxygen is a very reactive molecule and it produces some reactive radicals which 
ultimately cause the skin aging. Similarly some electrically charged atoms or molecules 
also play a vital role in promoting the aging by damaging the skin cells. Electrons  are  
captured  by  free  radicals  from  other  substances   to  neutralize  these charged 
molecules (Junqueira et al., 2005). By the activation of metalloproteinases breakdown of 
collagen takes place which ultimately promotes wrinkle formation. Oxidative stress is 
considered as the major factor for causing skin aging in the intrinsic and extrinsic aging. 
Bombardment of UV irradiation is one of the major factors influencing the production of 
oxidative species. Oxidative stress is the outcome of imbalance in the production and 
consumption of oxidative intermediates. The attack of free radicals on collagen and 
elastin results into the breakdown of structure of skiny (Leveque and Goubanova, 2004). 
Accumulation of free radicals causes the process of self repair to be slowed down. Age 
spots, skin sagging and wrinkles are the final outcome of the attack of free radicals. 
However the aging is not only caused by the free radicals. Body sometimes becomes 
unable to neutralize these free radicals and hence aging is not stopped by the self defence 
mechanism of the human body (Darvin et al., 2006). Free radicals are produced by 
naturally and can be induced by environmental insult (e.g. smoke, pollution and utravilet 
radiation etc). Reactive oxygen species are responsible for stimulation of skin degradation 
enzymes (Sharif et al., 2014). 
 Oxidation of lipids, proteins and change in the structures of protiens takes place by the 
action of free radicals (Dumay et al., 2001).  Continuation of these processes leads to the 
development of skin cancer (Moon and Oh, 2001). 
Hence, it is of very much importance to neutralize these oxidative molecules by the anti-
oxidative defence system of human body. Assimilation of various anti-oxidative 
molecules takes place to combat the oxidative stress on the human body (Sander et al., 
2004). Waste products are produced which are called as lipofuscins. These lipo fuscins 
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are responsible of destruction of cellular enzymes and causes inhibition of protein 
synthesis (Nishigori et al., 2004). 
2.3 Antioxidants 
 These are the molecules which prevent the human body from the negative effects of the 
oxidative species by neutralizing these molecules (Stone and Smith, 2004).With 
increasing age production of collagens and elastin is slowed down and wrinkles and skin 
sagging result. Free radicals are encountered by the antioxidants to maintain the skin 
elasticity. These molecules are produced naturally in the bodies of both plants and 
animals. Antioxidants are of three types Antioxidant enzymes (1), Chain breaking 
antioxidants (2) and Preventive antioxidants (3). Antioxidant enzymes include superoxide 
dismutase, glutathione peroxidase and catalase. 
These molecules produce oxygen and water by catalysing these free radicals. Chain 
breaking antioxidants include vitamin A, beta carotene, flavonoids, vitamin E, uric acid, 
thiol groups of plasma proteins such as albumin and bilirubin bound to albumin and 
vitamin C.  These molecules basically prevent the chain reactions. 
2.4.1 Role of Topical Antioxidants against Skin Aging 
Natural occurring phyto-antioxidants (e.g. polyphenols, flavonoids and phenolic 
compounds present in spices and herbs) are known to prevent harmful effects of oxidative 
stress by acting as free radical scavengers or promoting enzymatic-based oxidation 
(Sharif et al., 2014). 
A clear and important role is played by antioxidants in the prevention of aging. A large 
number  of  antioxidants  are  now  available  in  topical  and  oral  preparations.  
Synergistic effects  can  be  obtained  by  combinations  of  various  antioxidants  yielding  
formulations with  greater  efficacy,  instead  of  using  individual  antioxidant  
compounds.  All the antioxidants are distinguished from each other by various properties.  
A variety of antioxidant actives that are used in formulations for skin antiaging include 
polyphenols of tea extracted from green tea. Reduction in depletion of protective 
antioxidant enzymes in the skin occur after topical application of green tea extracts which 
helps in maintaining the levels of both glutathione and glutathione recycling enzymes in 
UV exposed skin (Vayalil et al., 2003). Silymarin has derived from the seeds of the milk 
24 
 
 
 
thistle plant silybummarianum which has a naturally occurring polyphenolic 
flaonolignans antioxidant. Strong  antioxidant  properties  are  exhibited  by  its  main  
component  silybin (silibinin)  which  is  considered  to  be  the  most  active  biologically.  
It has the properties of anti-inflammatory, antioxidant, and immune-modulatory that play 
important role to prevent photo aging and skin cancer (Meeran et al., 2006). 
A potent antioxidant containing polyphenols is extracted from the fruit of coffee plant C. 
arabica. The extract of grape seed is rich in proanthocyanidins flavonoids which are 
exhibited strong antioxidant activities by scavenging free radicals (Mantena and Katiyar, 
2006). The extracts from Pomegranate (Punica granatum) can be obtained from various 
fruit parts as seeds, juice and peel. Phenolic components are included in topical cosmetic 
formulations for anti-aging purposes as they have potent antioxidant activity. Particularly, 
skin damage is induced by UV that is shown to decrease in various studies by topical 
application of fruit extract (Aslam et al., 2006). 
Antioxidants deteriorate toxic effects of free radicals that would otherwise destroy skin 
cells  that  are  healthy  and  thus  they  help  in  protecting the  skin,  therefore  they 
areimportant  in  support  to  anti-aging  approaches.  The components of the skin anti 
oxidant system that neutralize free radicals become oxidized and inactive. The other 
components act  together  in  a  complex  manner  as  soon  as  one  component  becomes  
inactivated,  to restore the antioxidant capability and to recycle the inactive components 
back to an active state.  Flavonoids have been reported to exhibit strong antioxidant 
activities.  These are polyphenolic compounds which occur naturally and are universally 
found in vegetables and fruits of plant kingdom (Afaq and Mukhtar, 2002). In many 
disease conditions suchas neurodegenerative disorders, cancer and cardiovascular 
diseases, beneficial effects of flavonoids are reported.  These  compounds  possess  the  
iron  chelating  and  antioxidant  activities  and  are  capable  of  interacting  with  the  
proteins phosphorylation (Clark et al., 2005). 
In  human  skin,  both  fat  soluble  and  water-soluble  antioxidants  occur  naturally. 
Glutathione and Vitamin C are the most important water-soluble antioxidants. They 
protect  the  extra cellular  matrix  and  cytoplasm  of  the  cells  and  cytoplasm  (Lin et  
al., 2003).  The  use  of topical  cosmetics  containing  antioxidants  can  be  more  
effective  as compared to dietary supplementation (Nusgens et al., 2001). 
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2.5 Microemulsion 
Firstly Hoar and Schulman was introduced the concept of microemulsions in 1940s. It is 
optically clear, thermodynamically stable and low viscous solutions (Hoar and Schulman, 
1943). It is stated as system of water, oil and amphiphile which is an optically isotropic 
and thermodynamically stable liquid micro-dispersion (Danielsson and Lindman, 1981; 
Tenjarla, 1999; Lawrence and Rees, 2000).  
The micro-emulsions (droplets of 1-100 nm of diameter, usually between 10-50 nm) is an 
isotropic liquid system which, when compared to macro-emulsions are more transparent, 
more uniform/homogeneous in size, less viscous, display lower interfacial tension due to 
use of co-surfactant (short chain alcohol) as well as higher thermodynamic stability and 
higher bioavailability. In pharmaceutical care as well as in cosmetics, micro-emulsions 
give the best option (Menaa, 2014). 
Particle size and stability is the essential distinction between normal emulsion and 
microemulsion because normal emulsions are kinetically stable while microemulsions are 
thermodynamically stable. The stability of the microemulsion can be disturbed by 
addition of salt, other additives, pressure or temperature. Normal emulsions undergo 
aging by coalescence droplets and Ostwald ripening. As a result of these processes a 
decrease in the free energy of dispersion occurs. Ruckenstein and Chi (1975) has been 
proposed that thermodynamic stability of the microemulsions was due to interfacial free 
energy, reacting energy between droplets and entropy of dispersion. Microemulsions have 
several advantages some important are enhanced drug solubility, good thermodynamic 
stability and enhancing effect on transdermal delivery compared to conventional 
formulations (Lawrence and Rees, 2000). Water insoluble drugs may be taken through 
oil-in-water (o/w) microemulsions (Mizushima et al., 1982; Kronevi and Ljungberg, 
1983) although water soluble drugs may be taken through water-in-oil (w/o) 
microemulsions. These formulas may also be used for sustained release of drugs by 
formulating intramuscular preparations (Gasco et al., 1990). 
Microemulsions have thermodynamically stable, transparent isotropic solutions with 
particle sizes ranging from 5 to 100 nm and arise from the spontaneous self-assembly of 
the hydrophobic or hydrophilic parts of surfactant molecules. Several studies had been 
conducted on microemulsions, researching their use in a wide variety of systems, 
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including pharmaceuticals, cosmetics, food as models for biological membranes. There 
are many new applications which are being reported. 
Microemulsions have typically manufactured with exact concentrations of water, oil, 
surfactant and possibly co-surfactant and have deemed oil-in-water (o/w) or water-in-oil 
(w/o) depending on which has in the continuous phase. The concentrations at which 
microemulsions form have normally mapped out on ternary phase diagrams same as 
shown in Fig 2.3. 
 
Figure 2.3 Pseudo  ternary  phase  diagrams  for microemulsion  composed  of  oil  
(Isopropyl  Myristate), surfactant  (S,  Labrasol),  co-surfactant  (Co-S,  
PlurolOleique) and water (Shah et al., 2010). 
Basically, microemulsions differ from normal process; coarse emulsions in the micro 
emulsions simply form spontaneously, have very small particle sizes, are transparent and 
are thermodynamically stable. The hydrocarbon type of oil is used normally or short- and 
medium-chain triglyceride. The triglycerides are more difficult to make soluble as they 
are semi-polar compared to hydrocarbon oils and they are much bulky to penetrate the 
interfacial film to force in the formation of an optimal (Gaonkar and Bagwe, 2003). 
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2.5.1 Types of Microemulsion 
Winsor has gnarly identified four types of phase equilibria: Type I (O/W), II (W/O), III 
(B.C.) and IV (isotropic micellar solution) 1. Type 1 and 2 has two-phase systems, type 3 
three-phase systems, and type 4 a single-phase system. Depending on sample 
environment and surfactant type, phase types 1, 2, 3 or 4 form preferentially, the type 
which is dominant being related to the molecular arrangement at the interface. 
Conductivity measurement is so simple to determine the different microstructures of 
microemulsions for an ionic surfactant system, but cannot be implementing to a non-ionic 
surfactant system. 
2.5.2 Methods of Microemulsion Preparation 
Microemulsions are usually prepared by following methods; 
2.5.2.1 Phase of Titration Method  
In the titration method, microemulsions are formed by the spontaneous emulsification 
method it also stated phase titration method and can be predicted from phase diagrams. 
As quaternary phase diagram is difficult to interpret andtime consuming, pseudo ternary-
phase diagram is frequently formed to find the different zones including microemulsion 
zone, in which each and every corner of the diagram represents 100% of the particular 
component. Meta-stable systems should not be placed in observations (Shakeel et al., 
2007). The pseudoternary phase diagram showing microemulsion region is given in 
Figure 2.3.  
2.5.2.2 Phase Inversion Method  
When excess of the dispersed phase is added, phase inversion of microemulsions occurs. 
The physical changes occur including changes in particle size during phase inversion. 
Curvature of the surfactant is changed by these methods spontaneously. Despite this, for 
nonionic surfactants, it can be accomplish by changing the temperature of the system 
which forces a transition from an o/w microemulsion at low temperatures to a w/o 
microemulsion at higher temperatures. The system crosses a point of zero spontaneous 
curvature during cooling and minimal surface tension, increasing the formation of 
resultantly dispersed oil droplets. This is called as phase inversion temperature (PIT) 
method. The other parameters like salt concentration or pH value instead of the 
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temperature alone may be considered a similarly. Besides, a transition in the spontaneous 
radius of curvature can be obtained by changing the water volume fraction. By 
continuously addition of water into oil, initially water droplets are produced in a 
continuous oil phase. The increasing of the water volume fraction alter the spontaneous 
curvature of the surfactant from initially stabilizing a w/o microemulsion to an o/w 
microemulsion at the inversion locus. Surfactants which are short-chain prepared flexible 
monolayer at the o/w interface which ends in a bicontinuous microemulsion at the 
inversion point (Azeem et al., 2008). 
2.6 Microemulsions for Transdermal Delivery 
El Maghraby (2008) studied about the influence of co-surfactants on the skin penetration 
of hydrocortisone from microemulsion of eucalyptus oil thoroughly. Eucalyptus oil was 
used as the oil for the preparation of the steroidal drugs successfully. The surfactant 
(Tween 80) was used because it was readily soluble with eucalyptus oil. Isopropyl 
alcohol, ethanol and propylene glycol were used as cosurfactants due to their relative 
tolerability by the skin. The diagrams of Pseudoternary phase were developed with and 
without the use of cosurfactants. Microemulsion formulations comprising of oil (20%), 
water (20%) and of either Tween 80 or 1:1 surfactant/cosurfactant mixture (60%) were 
compared. The addition of cosurfactants enlarged the area of microemulsion. It was 
viscous without cosurfactant, despite the formulations containing cosurfactant were less 
viscous with. The release rate and drug loading were enhanced in the presence of co-
surfactants with the release rate depended upon the viscosity. The skin permeation of 
hydrocortisone from microemulsion was enhanced as compared to the saturated aqueous 
solution. In the presence of cosurfactants enhanced the percutaneous permeation in 
comparison to the cosurfactant free microemulsion. The greatest flux was obtained by 
ethanol followed by propylene glycol and isopropyl alcohol. Thus it was concluded that 
the presence of cosurfactant and its type can influence the percutaneous delivery ability of 
microemulsions. 
Zhu et al. (2008) checks the application of microemulsions as a dermal drug delivery 
vehicle for penciclovir. The pseudo-ternary phase diagrams were draw for various 
microemulsion formulations composed of oil phase (oleic acid), cosurfactant (ethanol) 
and surfactant (Cremorphor EL). It was necessary to optimize the composition of 
microemulsions by using simplex lattice mixture design including the concentrations of 
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surfactant, cosurfactant and water and the solubility and the cumulative amount of 
penciclovir permeated through excised mouse skins per unit area (dependant variables). 
The permeating capability of penciclovir by microemulsions was studied. The results 
seemed that the optimized microemulsion formulation was containing of 5% w/w oleic 
acid, 20% w/w Cremorphor EL, 30% w/w ethanol and 45% w/w water. The solubility 
rate of penciclovir in the microemulsion was 7.41mg/g. Its mean particle diameter was 
36.5 nm. The permeated cumulative amount of penciclovir from the microemulsion was 
about 3.5 times that of the commercial type of cream. It was proved that the permeation 
of penciclovir was highly increased from the microemulsion formulation as compared to 
commercial cream. 
Bolzinger et al. (2008) investigated the transport of caffeine to the hypodermis by an 
alcohol-free o/w microemulsion as compared to an aqueous gel and an o/w 
macroemulsion. The process of microemulsion was characterized and in vitro permeation 
experiments through pig skin having the hypodermis either kept or removed were 
performed using Franz diffusion cells. The microemulsion delivered a large amount of 
caffeine in the hypodermis, 22% of caffeine reached the hypodermis after 24 hrs, 1.3-
times greater as compared to that from the gel and emulsion. Half of this amount was 
observed in the hypodermis, the other half amount continuing its permeation to the 
receptor compartment. 
Hire et al. (2007) described a microemulsion based gel for topical delivery of lipophilic 
antifungal agent, itraconazole to increase its flux through the skin. The diagram of 
Pseudo-ternary phase was developed to identify microemulsion region using various 
combinations of surfactant and cosurfactant with oil and water. Solubility rate of drug in 
various oils was investigated to select the optimum oil having maximum loading potential 
for itraconazole. These formulations were characterized for phase separation, clarity, 
isotropic nature, and particle size analysis. Optimized formulations were selected to 
prepare microemulsion based gel by adding 0.75% w/w of carbopol 934P. These gels 
were investigated for rheological behaviour, in-vitro transdermal studies and in-vitro 
antifungal activity. The in-vitro transdermal studies were performed on human skin, 
mounted on Keshary-Chien diffusion cell using 10% v/v methanolic solution of 
phosphate buffer, pH 1.2 as receptor medium and Candida albicans as a model fungus to 
measure the antifungal activity of the drug. Significant enhancement in in-vitro 
transdermal flux was obtained from the microemulsion based gel compared with 
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marketed cream formulation. The in-vitro antifungal activity of Itraconazole was proved 
to be significant with microemulsion gel. Thus it was concluded that microemulsion 
based gel is a better vehicle for delivery of Itraconazole as topical drug delivery system. 
Sintov and Botner (2006) studied the in-vivo and in-vitro transdermal delivery potential of 
diclofenac sodium-containing microemulsion system. It contained 8-times higher drug 
plasma levels in rats were obtained after the transdermal administration of the 
microemulsion than those got after application of Voltaren Emulgel. The rates of 
permeation of diclofenac were measured by in-vitro using skin obtained from different 
type’s animals. For example in three different rodent species, transdermal fluxes of 
22.89±6.23 (hairless guinea pig), 31.66±4.45 (rat), 31.70±3.83 (hairless mouse), and 
53.35±8.19 µg/cm2/h (furry mouse), were taken after the application of the 
microemulsion. These fluxes were usefully greater than those achieved after the addition 
of the drug in aqueous solution. Frozen porcine skin was beneficially more permeable to 
drug aqueous solution than to the microemulsion formulation. It was concluded that the 
drug permeation from the microemulsion was showed no effects by the storage conditions 
of the skin. 
Chen et al. (2006) prepared microemulsion-based hydrogel formulation for topical 
delivery of ibuprofen. Of the oils tested, Ethyl oleate was selected as the oil phase of the 
microemulsion, as it showed a best solubilizing capacity and excellent skin permeation 
rate of the drug. The diagrams of Pseudoternary phase were constructed to obtain the 
concentration range of oil, surfactant and cosurfactant for microemulsion formation and 
the effect of these additives on skin permeation of ibuprofen was evaluated with remove 
porcine skins. The optimum and accurate formulation of the microemulsion contained 3% 
ibuprofen, 6% ethyl oleate, 30% Tween 80/PG (2:1) and water. The experimental data in 
vitro permeation showed that microemulsions enhanced the transdermal flux of ibuprofen 
5.73–30.00 times as compared to the saturate solution. The gum Xanthan was used to 
make the hydrogel which based on microemulsion for improving the viscosity of 
microemulsion for topical administration. The studied hydrogel based on microemulsion 
had a good stability, which showed that it might be a promising vehicle for topical 
delivery of ibuprofen. 
Ozguney et al. (2006) develop a comparison of the in vitro evolve rate of diclofenac 
sodium from microemulsions containing soybean oil, non-ionic surfactants (Span 80, 
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bajri 58) and different alcohols (alcohol, ethanol and propanol) as cosurfactant. The phase 
diagrams were develop to detect the optimum surfactant: cosurfactant (S: CoS) ratios of 
weight and microemulsion areas. So that three microemulsion formulations were choose 
and studied their physicochemical properties for the conductivity, PH and viscosity. 
According to the evolving rate of diclofenac sodium, microemulsion formed with 
propanol showed the importantely highest flux value (0.059 ± 0.018 mg/cm2/h) among all 
the formulations. The results relating to conductivity showed that drug-loaded 
microemulsions had greater conductivity values as compared to unloaded formulations, 
and loading the drug into the formulation had not any negative effects on stability of the 
system. The measurements of viscosity were made as a function of shear rate, and 
Newtonian fluid characterization was studied for each microemulsion system. They all 
formulations had appropriate pH values varying from 6.70 to 6.85 for topical application. 
A study of skin irritation was occurred with microemulsions on the body of human 
volunteers, and it had not showed any visible reaction with any type of the formulations. 
In the nutshell, microemulsions formed with propanol may be a more accurate 
formulation than the other two formulations discussed as drug carrier for topical 
application. 
Ozguney et al. (2006) investigated and compared with the in vitro and in vivo transdermal 
ability of microemulsion and gel bases for diclofenac sodium. The effects of dimethyl 
sulfoxide as a penetration increased in the microemulsion were also studied. To 
investigate the in vitro potential of these formulations through excised dorsal rat skin, 
permeation experiments were performed with Franz cells. To investigate the in vivo 
performance of the selected microemulsion formulations, a carrageenan-induced rat paw 
oedema model was used. The commercial type of formulation of diclofenac sodium was 
used as a reference formulation. The results of the in vitro permeation experiments and 
the rat paw oedema tests were analyzed by repeated-measures ANOVA. The in vitro 
permeation studies found that microemulsion was superior to gel and commercial 
formulation and that adding dimethyl sulfoxide to the microemulsion increased the 
transdermal flux. In the rat-paw oedema test, microemulsion produced the best 
permeation and effectiveness, and microemulsion with enhancer produced nearly the 
same effect as the microemulsion without enhancer. The results had proved that the 
studied of microemulsion could be a new, alternative dosage form for effective therapy. 
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Djordjevic et al. (2005) described the effects of vehicle structure and formulation 
parameters on the in-vitro evolverate of diclofenac diethylamine from microemulsions 
having a surfactant (PEG-8 caprylic glycerides), a co-surfactant (polyglyceryl-6 dioleate), 
an oil (isopropyl myristate) and water. It formed the pseudo-ternary phase diagram at 
surfactant–cosurfactant mass ratio 1:1, the appropriate oil-to-surfactant-co-surfactant 
mass ratio values (O/SC 0.67–1.64) for formulation of microemulsions were found. The 
characterization experiments results indicated that the selected microemulsion vehicles 
internal structure had non-spherial water-continuous. Low water myristate partition 
coefficient for diclofenac diethylamine and elevated electrical conductivity values for the 
selected microemulsions containing diclofenac diethylamine (1.17% w/w), indicated that 
the drug molecules were mostly partitioned in the water phase. Release of diclofenac 
diethylamine from the selected water-in-oil (W/O), oil-in-water (O/W) and proper 
microemulsions was studied by using rotating paddle dissolution fitted with an enhancer 
cell. The value of membrane flux was increased from 25.021µg/cm2/h (W/O 
microemulsion) to 117.941µg/cm2/h (O/W microemulsion) as the aqueous content 
increased.  
Parikh and Ghosh et al. (2005) determined the possibility of producing a transdermal drug 
delivery system of fluoxetine was investigated or searched. Transdermal experiments of 
fluoxetine were carried out using Franz diffusion cells maintained at 37 °C, fitted with 
human cadaver skin. The phosphate buffer pH 7.4 was used by receptor medium. There 
were various enhancers like SR-38, azone, and ethanol that added to enhance the 
permeation of fluoxetine, either in the salt or base form. Different o/w microemulsion 
systems of fluoxetine were formed to investigate their effect on the percutaneous 
absorption of fluoxetine. The results described that ethanol at 65% v/v increased the skin 
penetration of fluoxetine the high, while microemulsion systems produced decline in the 
skin penetration of fluoxetine. The transdermal flux of fluoxetine was taken by using a 
65% v/v ethanolic solution which indicated to be enough to deliver the required dose 
(20.0-80.0 mg) from a patch of feasible size.  
Chen et al. (2004) studied the microemulsions for transdermal delivery of triptolide. 
Triptolide has immunosuppressive, anti-cancer and anti-fertility activities. The controlled, 
sustained and prolonged delivery of triptolide via a transdermal route is demanded to 
reduce its brittle side effects due to its severe toxicity. The pseudo-ternary phase diagrams 
were constructed and different types of microemulsion formulations were formed by 
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using oil (oleic acid), surfactant (Tween 80) and cosurfactant (propylene glycol). The 
transdermal permeation of triptolide from microemulsions was evaluated in vitro by using 
Franz diffusion cells fitted with mouse skins. He was also investigated the effect of 
menthol (permeation enhancer), and the loading dose of triptolide in microemulsions on 
the permeation rate. The triptolide-loaded microemulsions had showed an increased in- 
vitro permeation compared with an aqueous solution of 20.0% and amount of triptolide in 
propylene glycol was 0.025%. There was no skin irritation was observed for the studied 
microemulsion ME6 which contained 40% isopropyl myristate, 50% Tween 80, 
propylene glycol (5:1) and water. The homogeneous solution of 20% propylene glycol 
containing 0.025% triptolide caused progressively skin irritation. The results showed that 
the research on microemulsion systems might be promising vehicles for the transdermal 
delivery of triptolide. 
Hua et al. (2004) prepared a novel on the microemulsion to enhance the solubility and the 
in vitro skin permeation of low water-soluble drug (vinpocetine). In which the correlation 
between the transdermal flux and structural characteristics of vinpocetine microemulsion 
was studied by field of pluses gradient nuclear magnetic resonance. For the sake of 
microemulsions, oleic acid was selected for oil phase, PEG-8 glyceryl caprylate/caprate 
(Labrasol) used as surfactant, purified diethylene glycol mono-ethyl ether (Transcutol P) 
used as cosurfactants, and the double-distilled water used as aqueous phase. The diagrams 
of Pseudo-ternary phase were obtained to describe the concentration range of each and 
every component for the microemulsion production. The effects of various oils and 
different weight ratios of surfactant to cosurfactant on vinpocetine for the solubility and 
permeation were studied. The procedure of Self-diffusion coefficients was described by 
PFG-NMR to investigate the influence of microemulsion composition on their 
transdermal delivery. At the end, the microemulsion having 20.5% Labrasol, 20.5% 
Transcutol P, 1% vinpocetine with 4% oleic acid and 55% water (w/w) was optimized, as 
compared to water  in which drug solubility was about 3160-times higher and the 
transdermal flux across the excised rate skin was 36.4±2.1 mg/cm2/h. The optimized 
microemulsion was following physicochemical properties were examined for the 
viscosity, refractive index, conductivity, pH and particle size distribution. The process of 
microemulsion was stable after storage for more than 12 months at 25ºC. The irritation of 
skin study showed that the optimized microemulsion was a non-irritant and non-
sensitizing to the skin. 
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Rhee et al. (2001) proposed the preparation of a transdermal which containing ketoprofen 
using system of microemulsion. In which Oleic acid was used as the oil phase due to a 
better solubilizing capacity and perfect skin permeation rate of ketoprofen. The diagrams 
of pseudo-ternary phase for microemulsion were prepared by using oil as the oleic acid, 
surfactant as the Labrasol, cosurfactant as the Cremophor RH 40. Different types of 
microemulsion formulations were formed and the abilities of various microemulsions to 
deliver ketoprofen through the skin were measured in vitro using Franz diffusion cells 
fitted with rat skins. The optimum formulation contained 3% ketoprofen, 6% oleic acid, 
30.0% Labrasol/Cremophor RH 40 (1:1) and water. Similarly 5% terpenes were added to 
the microemulsion and their effect on the skin permeation of ketoprofen was checked. 
There was only limonene resulted in a powerful increasing activity (3-fold increase over 
control) of the four terpenes used.  
Kreilgaard et al. (2000) investigated the effect of structure and composition of 
microemulsions (Labrasol / PlurolIsostearique / isostearylic isostearate / water) on their 
skin permeation ability of a hydrophilic (prilocaine hydrochloride) and a lipophilic model 
drug (lidocaine) and to compare the drug delivery potential of microemulsions to 
conventional dosage forms. Pulsed-gradient spin-echo NMR spectroscopy and T1 
relaxation times were used to determine the self-diffusion coefficients and to characterize 
the microemulsions. The rate of Permeation through rat skin of lidocaine and prilocaine 
hydrochloride was determined in vitro using Franz diffusion cells. The microemulsions 
enhanced the permeation rate of prilocaine hydrochloride almost 10 folds compared to a 
hydrogel and that of lidocaine up to four folds as compared to the conventional oil-in-
water macroemulsion. A correlation between the permeation rate and self-diffusion of the 
drugs in the vehicles was observed. The rising of percutaneous drug delivery from 
microemulsion formulations was mainly due to the increased solubility of drugs and is 
dependent on the drug mobility in the vehicle.  
2.7 Microemulsions meant for Other Routes 
Mehta et al. (2010) made an oral micro-emulsion which was composed of phosphate 
buffer, Tween 80, oleic acid, ethanol and they found its drug delivery system for anti-
tubercular drug rifampin. At a constant surfactant/cosurfactant ratio of Km 0.55 a pseudo-
ternary phase diagram was constructed. By the help of pH, conductivity and viscosity 
evaluations, solubility and partition studies were made. Changes in the microstructure of 
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micro-emulsion were determined after the injection of drug by using the same method. It 
was found that the micro-emulsion remained stable and no changes took place in its 
structure. It was also found that micro-emulsion was converted into the o/w emulsion at 
infinite dilution. Controlled release of rifampicin is expected from o/w emulsion droplet it 
was found during dissolution studies. 
For enhancing the bioavailability of acyclovir Ghosh et al. (2006) made an oral micro-
emulsion. A Labrafac-based microemulsion formulation with Labrasol as surfactant and 
PlurolOleique as cosurfactant was developed for oral delivery of acyclovir. In vivo oral 
absorption of acyclovir from the microemulsion was investigated in rats. Phase behaviour 
and solubilization capacity of the microemulsion system were characterized. In the 
pseudoternary phase diagrams, with the increase of Labrasol concentration, the 
microemulsion region area and the amount of water and Labrafac solubilized into the 
microemulsion system increased; however, the increase of PlurolOleique percentage 
produced opposite effects. The micro-emulsion system was also studied in terms of other 
characteristics, such as, viscosity, interfacial tension, refractive index, pH, bioavailability 
and diffusion. Acyclovir, a poorly soluble drug, displayed high solubility in a micro-
emulsion formulation using Labrasol (32%), Labrafac (10%), water (50%) and 
PlurolOleique (8%). The in vivo study and in vitro intra-duodenal diffusion and revealed 
an increase of bio-availability up to 12.78 times after the oraldirection of the micro-
emulsion preparation as compared with the commercially existing tablets. 
Araya et al. (2005) designed an innoative o/w micro-emulsion invention, which increased 
the oral bio-availability by enhancing the solubility of below par water soluble 
compounds. Using diglyceryl monooleate (DGMO-C), medium chain fatty acid 
triglyceride (MCT), ethanol and PBS (pH 6.8) as an oil phase (5%) polyoxyethylene 
hydrogenated castor oil 40 (HCO-40),  a lipophilic surfactant (1%), a solubilizer (5%), a 
hydrophilic surfactant (9%) and an aqueous phase (80%), respectively. The o/w micro-
emulsion with a middling particle diameter of 20 nm or less was formulated. For nine 
types of poorly water soluble compounds, such as Ketoprofen, Ibuprofen, Tamoxifen, 
Tolbutamide, Testosterone and other new compounds. The water solubility was increased 
from 60 to 20,000 times by this o/w micro-emulsion formulation. The AUCs in plasma 
concentration of Ibuprofen and a new compound, ER-1039, subsequent single oral 
direction of these compounds as the o/w micro-emulsion to fasted rats were equal  to that 
of solution administration or increased by 2-9 times compared to that of suspension 
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administration, respectively. Thus, it was concluded that this novel o/w microemulsion is 
a useful formulation, which increases the oral bio-availability by raising the solubility of 
less water soluble compounds. 
Yong et al. (2005) developed a parenteral o/w micro-emulsion system having less water-
soluble rutaecarpine, the solubility of rutaecarpine in ethanol, water, surfactants and 
various oils were investigated. Among the oils tested and surfactants PEG 400, Tween 20 
and castor oil were chosen as the co-surfactant, surfactant and oil phase of the micro-
emulsion, as rutaecarpine was most soluble in them, respectively. Pseudo-ternary phase 
diagrams were made to obtain the concentration range of surfactant, oil and cosurfactant 
for micro-emulsion formulation and the stability test of rutaecarpine transported by 
micro-emulsion formation was then assessed. The rutaecarpine (300 mg/g) loaded 
microemulsion composed of 7.2% Tween 80, 10.8% PEG 400, 72% water and 20% 
castor oil was chemically and physically stable for at least 6 months. Hence it can be said 
that this micro-emulsion system could be a firm dosage form for rutaecarpine. 
Zhang et al. (2004) conducted a study to increase the solubility and improve the brain 
uptake of nimodipine in an o/w micro-emulsion which was suitable for intranasal 
delivery. Three microemulsion systems stabilized by the non-ionic surfactants were either 
Labrasolor Cremophor RH 40, and having a variety of oils, namely Labrafil M 1944CS, 
Maisine 35-1 and isopropyl myristate, were established and characterized. The nasal 
absorption of nimodipine from micro-emulsion formulation was examined in rats. The 
optimum micro-emulsion formulation consisted of 30% Cremophor RH 40/ethanol (3:1), 
8% Labrafil M 1944CS and water, with a maximum solubility of nimodipine up to 6.4 
mg/ml, droplet size of 30.3 ± 5.3 nm, and no cilio-toxicity. After a single intranasal 
administration of this preparation at a dose of 2 mg/kg, the absolute bioavailability was 
about 32% and the plasma concentration peaked at 1 h. The uptake of nimodipine in the 
olfactory bulb from the nasal route was three higher times as compared to intravenous 
(i.v.) injection. The ratios of AUC in cerebrospinal fluid and brain tissues to that in 
plasma found after nasal administration were meaningfully higher than those after i.v. 
injecting. These results recommended that the micro-emulsion system is a hopeful 
approach for intranasal delivery of nimodipine for the cure and avoidance of neuro-
degenerative diseases. 
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Park and Kim (1999) made an o/w micro-emulsion of flurbiprofen that was appropriate 
for parenteral administration. Micro-emulsions with changing ratios of oil to surfactant 
were made with Tween 20, ethyl oleate, and isotonic solution. The effect of preparation 
variables on the particle size of micro-emulsion and solubility of flurbiprofen in micro-
emulsion system was examined. The pharmaco-kinetic parameters of flurbiprofen after 
intravenous administration of flurbiprofen-loaded micro-emulsion were compared with 
those of a solution of the drug. The mean droplet diameter of micro-emulsion containing 
less than 1% (w/w) of flurbiprofen was below 100 nm. The pharmacokinetic parameters 
of flurbiprofen after intravenous administration of flurbiprofen-loaded microemulsion to 
rats were not significantly different from those of flurbiprofen in phosphate buffered 
saline solution. It was concluded that micro-emulsions of flurbiprofen made with ethyl 
oleate and Tween 20 can be used as a parenteral drug carrier for this and other poor 
water-solubledrugs. 
Microemulsions represent an auspicious carrier system for beautifying active constituents 
due to their several advantages over the existing orthodox formulations. They are able of 
solubilizing both hydrophilic and lipophilic ingredients with comparatively higher 
encapsulation. There is an increasing recognition of their possible benefits in the field of 
cosmetic science adding to the drug delivery (Azeem et al., 2008). 
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3. MATERIALS AND METHODS 
All the plants material was purchased from local market of Pakistan. The following 
chemicals and apparatus were used during the research work. 
3.1 MATERIAL 
3.1.1 Chemicals 
Ethanol, Methanol                            Merck KGaA Darmstadt, Germany 
Acetone     BDH England 
n-Hexane    Merck KGaA Darmstadt, Germany 
Hydrochloric acid   Sigma-Aldrich Switzerland 
Sodium Sulfate Anhydride               Merck KGaA Darmstadt, Germany 
Ellagic acid     Sigma (St Louis, MO), USA 
Lycopene                                          Sigma (St Louis, MO), USA    
Tween® 80         Fisher Scientific, Germany 
 Propylene Glycol                               Merck, Germany 
Isopropyl Myristate                            Merck KGaA Darmstadt, Germany 
Palm kernal oil                                   R and M Chemicals. Sdn. Bhd (Malaysia) 
Punica granatum extract  Department of pharmacy, IUB, Pakistan 
Lycopersicon esculentum extract Department of pharmacy, IUB, Pakistan 
Carica papaya extracts  Department of pharmacy, IUB, Pakistan 
Distilled Water   Department of pharmacy, IUB, Pakistan   
3.1.2 Apparatus/Instruments 
Vacuum pump                               ILMVAC- Germany 
Separator Funnel                          Pyrex, England 
Test Tubes                                   Pyrex, England 
Beaker                                         Pyrex, England 
Cellulosic membrane                  Sarturios, Germany 
Filter paper                                   Whattman 42, England 
Vortex mixer                              MyLab (Scientific industries, USA) 
Sonicator                                      Elma, Germany 
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Centrifuge Machine                          Hettich EBA 20, Germany 
Cool Incubator                                 Sanyo MIR-153, Japan 
Conductivity-Meter                          WTW COND-197i, Germany 
Digital Humidity Meter                     TES Electronic Corp, Taiwan 
Electrical Balance                             Precisa BJ-210, Switzerland 
Hot Plate Magnetic Stirrer                Velp Scienifca, Germany  
Homogenizer                                     Euro-Star, IKA D 230, Germany 
Zeta Sizer Nano series                       Malvern instrument 1td. ZEN3600, UK 
Abbe Refractometer                          HEDAO, China 
Scanning Electron Microscope          19800 Hitachi S-3400N VP-SEM, Japan 
X-Ray Diffractometer                        Bruker D8, Discover. Germany 
Rheometer                                         RVDV-III Ultra (Brookfield, USA)                                   
Hot Incubator                                    Sanyo MIR-162, Japan 
pH-Meter                                          WTW pH-197i, Germany 
Refrigerator                                       Dawlance, Pakistan   
Rotary evaporator                             Eyela, Co. Ltd. Japan 
Water distillation apparatus           IRMECO GmbH, Germany 
UV-VIS spectrophotometer         Bio-Tek Instruments, Bad Friedrichshall, Germany 
Water Bath HH .S21 4, China 
Mexameter® MPA 580, MPA 5        Courage + Khazaka, Germany 
Corneometer® MPA 825, MPA 5     Courage + Khazaka, Germany 
Sebumeter® MPA 580, MPA 5         Courage + Khazaka, Germany 
Elastometer® EM 25             Courage + Khazaka, Germany 
Visioscan® VC98             Courage + Khazaka, Germany 
Skin pH meter®             Courage + Khazaka, Germany 
Rheocalc                                           Version 1 
Graphpad prism                                  Version 5 
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3.2 METHODS 
3.2.1           Plant Material 
Different plants i.e. Pomegranate, Tomato and Papaya were used. The identification of 
these plants was performed by Cholistan Institute of Desert studies at The Islamia 
University of Bahawalpur.  Carica Papaya, red and yellow were collected from Metro 
market Lahore, Pakistan. The identification of the plant (Carica Papaya, Punica 
granatum and Lycopersicon esculentum) was performed at the Institute of Horticultural 
Sciences, University of Agriculture, Faisalabad, Pakistan. The below voucher numbers 
were obtained from Herbarium, Department of Botany, University of Agriculture 
Faisalabad. Carica Papaya, Voucher No. 705-12-1907, Punica granatum, Voucher No. 
22007-9-1886 and Lycopersicon esculentum, Voucher No. 419-6-1934. 
Different parts of plants used were: 
 Shade-dried ground Punica granatum fruit rinds (Peels) were used as plant material. 
 Pulp of Lycopersicon esculentum was used as plant material. 
 Pulp of Carica papaya was used as plant material. 
3.2.2  Plant Material Treatment 
3.2.2.1  Extraction 
3.2.2.1.1 Lycopersicon esculentum Extract 
Lycopersicon esculentum 2kg pulp slurry was extracted with hexane-ethanol-acetone 
(100:50:50). After extraction 15 mL of water was added to separate the solution into 
polar and non-polar layers. Lycopene was concentrated in the upper non-polar phase 
while other components and polar pigments were retained in the lower polar phase 
(Souza et al., 2008). 
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3.2.2.1.2 Carica papaya Extract 
Carica papaya fruit 2 kg slurry was weighed and quantitatively transferred to test tube 
with 1litre of an ethanol:hexane (1:1) solvent mixture, and homogenized at 1200 rpm for 
5 minutes in a blender. All of the pulp residue retained in cellulosic membrane was 
filtered and transferred to test tube by repeating homogenization process, addition of 
about 1litre mL methanol:hexane 1:1 and filtration running until papaya pulp lost its 
typical color completely (three times on average). All filtered material was transferred to 
a separator funnel followed by addition of 1litre hexane and 500 ml distilled water and 
then shaken lightly for 30 to 60 seconds and left to rest for phase separation. Aqueous 
phase collected was transferred to a second separator funnel and subjected to two further 
extraction procedures by adding 1litre ethanol: hexane (1:1) mixture, collecting combined 
hexane phases containing all the carotenoid substances. Aqueous layer was removed from 
hexane phase by adding about 1.0 g of sodium sulfate anhydride (Na2SO4) and then 
shaken manually for 30 seconds. All hexane carotenoid extract content was removed to 
2litre bottles and concentrated by vacuum rotary evaporator at about 40ºC for 25 minutes. 
After concentrated, samples were recovered from hexane and transferred to brown color 
volumetric bottles, and the final volume made with hexane (Lopes and Reed, 2010). 
3.2.2.1.3 Punica granatum Extract 
Punica granatum fruit rinds 1kg slurry was subjected to extraction three times, with 50% 
aqueous ethyl alcohol at 60 to 70˚C for 2 hrs. The excess of ethyl alcohol was removed 
under vacuum at 44˚C. The resulting aqueous solution was acidiﬁed with hydrochloric 
acid and then reﬂuxed at 70˚C for 6 hrs. Liquid extract was collected in brown colored 
bottle and stored in refrigerator.  Futher upon dilution with water, ellagic acid was also 
precipitated. The precipitates were collected by ﬁltration and dried in vacuum tray driers 
at 40˚C for 12 days (Sadler et al., 2006). 
3.2.2.2  DPPH Scavenging Activity 
The stable DPPH radical was used for the determination of antioxidant activity. Different 
concentrations of extracts in respective solvents were added at an equal volume of 10μl to 
90μl of 100μm methanolic DPPH soln. in a total volume of 100μl in 96 well plates. The 
contents were mixed and incubated at 37°c for 30 minutes.  Ascorbic acid was used as 
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standard antioxidant. The reduction in absorbance was measured at 517 nm by using 
microplate reader; in comparison with the control solution (maximum absorption). The 
decrease in absorbance indicates increased scavenging activity.  The activity is mentioned 
in percentage form of DPPH radical scavenging according to the following formula: 
 %	ܫ݊ℎܾ݅݅ݐ݅݋݊ = Absorbance	of	control − Absorbance	of	tstAbsorbance	control 	× 100 
 
DPPH radical scavenging activity was measured in triplicate. 
 
Table 3.1 DPPH Scavenging Activity for Various Plants Extracts 
 
       n=3  
3.3 In-Vitro Evaluation of Plant Extracts 
3.3.1 Analysis of Lycopersicon esculentum and Carica papaya Extract by UV-
Visible Spectrophotometer  
A UV-Visible Spectrophotometer (Shimadzu, Japan) was used. The n-hexane was used as 
blank while UV detector wavelength was set at 470 nm (Bunghez et al., 2011).  
3.3.1.1 Preparation of Stock Solution 
The stock standard solution of lycopene was diluted to required concentration range of 
0.156 to 10µg/ml. The absorbance obtained from each concentration was plotted against 
concentration of lycopene to give the calibration curve. The calibration curve obtained for 
the determination of lycopene for the quantification of lycopene in Lycopersicon 
esculentum extract.  The amount of lycopene was calculated based on absorbance of 
sample and using the calibration curve. The correlation coefficient (R2) was used to 
determine the linearity of the calibration curve.  
Series Plant Extracts %age of DPPH Activity 
1 Lycopersicon esculentum(Lycopene) 79 
2 Carica papaya(Lycopene) 71 
3 Punica granatum(Ellagic Acid) 86 
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3.3.1.2 Determination of Lycopene in Lycopersicon esculentum Extract 
1 ml of extract was mixed with 10ml of n-hexane and then further diluted to10 µg/ml. 
The sample solution was mixed well by using Vortex (Scientific industries, USA) and 
filtered through 0.45µm cellulose acetate membrane before analysis. The amount of 
lycopene in extract was back-calculated from the calibration curve equation. 
3.3.1.3 Determination of Lycopene in Carica papaya Fruit Extract 
1 ml of extract was mixed with 10ml of n-hexane and then further diluted to10 µg/ml. 
The sample solution was mixed well by using Vortex (Scientific industries, USA) and 
filtered through 0.45µm cellulose acetate membrane before analysis. The amount of 
lycopene in extract was back-calculated from the calibration curve equation. 
3.3.2 Analysis of Punica granatum Extract by UV-Visible Spectrophotometer 
A UV-Visible Spectrophotometer (Shimadzu, Japan) was used for analysis of Punica 
granatum. Ethanol was used as blank. UV detector wavelength was set at 365 nm.  
3.3.2.1 Preparation of Stock Solution 
The stock standard solution of ellagic acid was diluted to required concentration range of 
0.156 to 10µg/ml. The absorbance of working standards of ellagic acid against each 
concentration was determined. The absorbance obtained from each concentration was 
plotted against concentration of ellagic acid to obtain a calibration curve. The calibration 
curve obtained for the quantification of ellagic acid in Punica granatum extract, the 
amount of ellagic acid was calculated based on absorbance of sample and using the 
calibration curve. The percentage of ellagic acid found in Punica granatum extract is 
given in results. The correlation coefficient (R2) was used to determine the linearity of the 
calibration curve. 
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3.3.2.2 Determination of Ellagic Acid in Punica granatum Extract 
Briefly, 1 ml of extract was dissolved in 10 ml of 80% ethanol and then further diluted 
to10 µg/ml. The sample solution was mixed well by using Vortex (Scientific industries, 
USA) and filtered through 0.45 µm cellulose acetate membrane filter before analysis. The 
absorbances of different concentrations of working standard of ellagic acid have given in 
results. The amount of ellagic acid in extract was back-calculated from the calibration 
curve equation. 
3.3.3 Pseudo-Ternary Phase Diagrams Studies 
Water titration method is most widely used to construct the pseudo-ternary phase diagram 
in which the homogenous liquid mixture of oil, surfactant, and cosurfactant is titrated by 
the dropwise addition of aqueous phase at ambient temperature (25oC) (Hua et al., 2004). 
Shakeel et al. (2007) and Shafiq-un-Nabi et al. (2007) provided the basis for calculating 
the percentage compositions of each component of microemulsion and construction of 
pseudo-ternary phase diagram by aqueous titration method and also provided an idea for 
the selection of microemulsion formulation from the phase diagram in least possible time. 
This method of calculation was followed in our study to construct the phase diagrams 
after some modifications. Phase diagrams were constructed in order to examine the 
formation of oil in water microemulsion using four components: oil, surfactant, 
cosurfactant and aqueous phase system by selecting the appropriate oil, surfactant, 
cosurfactant with suitable ratios (Ghosh et al., 2006) 
After each 5% addition of aqueous phase to the mixture of oil and Smix, the mixture was 
mixed properly under moderate stirring for 2-3 minutes, and then allowed to equilibrate at 
250C for 30 minutes. The mixture was sonicated for 1-2 minutes to remove the air 
bubbles which helped in better visual examination, if required, (Nandi and Joshi, 2003). 
The resulting equilibrated mixture was evaluated through visual observation to review its 
physical condition. On the basis of visual observation, the following categories were 
assigned:  
1. Microemulsion (oil in water): Clear, transparent, isotropic mixture and easily flowable.  
2. Microemulsion gel: Clear and highly viscous gel-like mixture that did not show a 
change in the meniscus after titled to an angle of 900.  
3. Macroemulsion: Milky or cloudy mixture.  
4. Emulgel: Milky and highly viscous gel.  
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Figure 3.1 Microemulsion at (right) and Macroemulsion at (left) respectively. 
 
Then the physical state which marked in the observation was plotted on a pseudo ternary 
phase diagram by using ProSim Ternary Diagram Software, where each corner of the 
diagram represented the 100% of that particular component. 
3.3.3.1 Pseudo-Ternary Phase Diagram Construction for B1and F1, F2 
All microemulsions were formulated with full pseudoternary phase diagram. In this study, 
Isopropyl Myristate (IPM) and  water  were  chosen  as  one  of  the  oil  and  aqueous  
phase respectively.  The  surfactant  (Tween® 80)  and  co-surfactant  (Propylene glycol)  
were  used  in  the  preparation  of  the microemulsion.  They were mixed in different 
ratios of surfactant and co-surfactant mixtures. For construction of the  phase  diagram,  
oil,  surfactant  mixture  and  water  were weighed  and  mixed together at room 
temperature. After each mixing, the sample was allowed to equilibrate for 30 minutes. 
The microemulsion regions in the pseudoternary phase diagram were determined and 
selected with 2:1 ratio. 
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Figure 3.2    Microemulsion F1 at right, F2 at (left) and B1 in mid respectively  
 
Formula of Base (B1) 2:1  Formula of Active Formulation (F1 and F2) 
IPM    25 %    IPM 15 % 
Smix   65 %    Smix 65 % 
Distilled Water 10 %                         Plant extract 10 % 
                          Distilled Water 10% 
3.3.3.2 Pseudoternary Phase Diagram Construction of B2 and F3 
All microemulsions were formulated with full pseudoternary phase diagram. In this study, 
Palm oil and  water  were  chosen  as  one  of  the  oil  and  aqueous  phase respectively.  
The  surfactant  (Tween 80)  and  cosurfactant  (Propylene glycol)  were  used  in  the  
preparation  of  the microemulsion. They were mixed in different ratios (2:1 and 5:1) of 
surfactant and cosurfactant mixtures. For construction of the  phase  diagram,  oil,  
surfactant  mixture  and  water  were  weighed  and  mixed together at room temperature. 
After each mixing, the sample was allowed to equilibrate for 24 hr. The microemulsion 
regions in the pseudoternary phase diagram were determined and selected ratio 5:1 for 
further study. The results showed the region of microemulsion on the phase diagram was 
obtained with increased ratio of Tween® 80. 
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Figure 3.3 Microemulsion B2 at right, F3 at (left) respectively 
Formula of Base (B2) 5:1   Formula of Active formulation (F3) 
Palm oil 5.6 %    Palm oil 1.6 % 
Smix   80 %     Smix 80 % 
Distilled water 14.4%    Plant extract 4 % 
                Distilled water 14.4 % 
3.3.4 In-Vitro Evaluation of Microemulsion Formulations Containing Plant 
Extracts of Punica granatum, Lycopersicon esculentum and Carica papaya 
3.3.4.1 Organoleptic and Physical Stability 
The  physical  stability  of  microemulsions  was  studied regarding  the  temperature  
stability  and  centrifugation. Microemulsions were kept at various temperatures (8ºC, 
25ºC, 40ºC and 50ºC) and observed for phase separation, flocculation or precipitation.  
Also Microemulsions were  centrifuged  by  Centrifuge Machine (Helttich, Germany) at 
6000  rpm  for 30  minute  at  25ºC  and  inspected  for  any  change  in their 
homogeneity.  
3.3.4.2 pH Determination  
The pH values of microemulsions (Bases and Formulations) kept at different storage 
conditions (i.e. 80C, 250C, 400C and 500C) were determined by a digital pH-Meter. 
Measurements were carried out at zero time and then repeated after 24 hrs, 48 hrs, 72 hrs, 
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1week, 2week, 3week, 4week, 6week, 8week, 12week of preparation. All the 
measurements were carried out in triplicate.  
3.3.4.3 Conductivity Measurements 
Electrical conductivity of microemulsions of base and formulations containing 
Pomegranate, Tomato and Papaya extracts were measured with a conductivity meter 
(Conductometer WTW, Cond 197i, Germany). 
3.3.4.4 Particle Size and Refractive Index Measurements  
The average droplet size of microemulsions of base and formulations containing 
Pomegranate, Tomato and Papaya extracts were measured at 25ºC by Zeta sizer (Malvern 
instrument Ltd. ZEN3600, UK) and their refractory indices (RI) were also calculated by 
Abbe refractometer (HEDAO, China). 
3.3.4.5 Viscosity Measurements 
Viscosity of microemulsions of base and formulations containing Pomegranate, Tomato 
and Papaya extracts were measured at 25ºC with a Brookfield viscometer (DV-III + Pro 
Brookfield., USA) using spindle no. 41.  
3.3.4.6 Zeta Potential Determination 
Zeta potential of microemulsions of base and formulations containing Pomegranate, 
Tomato and Papaya extracts were measured by Zeta sizer Nano series (Malvern 
instrument Ltd. ZEN3600, UK). Samples were placed in clear disposable zeta cells.  
3.3.4.7 Spreadability 
The spreadability of microemulsions of base and formulations containing Pomegranate, 
Tomato and Papaya extracts was determined by using an apparatus consisting of two 
glass slides (20 X 4 cm), one of them being fixed on to the wooden board and the other 
was moveable. About 1.0 gm of sample of base or formulation was placed in between two 
glass slides. A heavy weight was allowed to rest on the upper slide for few minutes to 
expel the entrapped air between the slides and to provide a uniform film of the applied 
sample. The weight was removed and the distance was measured by scale (Dhamankar et 
al., 2009) 
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3.3.4.8 Rheological Studies 
Rheological properties of microemulsions of base and formulations containing 
Pomegranate, Tomato and Papaya extracts were determined, using a Brookfield 
programmable Rheometer (Model DV.III; Brookfield Inc.). Rheocalc V 2.6 (Microsoft 
Corporation) was used as a support program during the measurements. 0.5 gm of each 
sample was applied in sample holder. The viscosities of the samples were determined at 
25°C with the spindle (CP41) speeds ranging from 100 to 200 rpm. The measurements 
were performed in triplicate.  
For evaluation, the results of viscosity measurements were fitted to the Power Law, 
known as:  
                 τ = K γ n 
Where τ is the shear stress, γ is the shear rate, K is the consistency index and n is the flow 
behaviour index. Consistency index K is a measure of the system consistency and it is 
related to apparent viscosity. Flow behaviour index n determines the degree of non-
newtonian behaviour and varies in the range between 0 and 1. The non–newtonian 
character of the investigated system is more pronounced for smaller values of constant 
“n”. High shear rates were applied for the quality assurance of emulsions by applying 
high shear stresses. 
3.3.4.9 X- Ray Diffraction 
Presence of crystallinity and amorphous nature of all the formulations containing extracts 
were evaluated by X-Ray Diffractometer (Bruker D8, Discover. Germany) using Ni –
filtered CuK alpha radiation source. The tube voltage of 35kv, current of 35 Ma and 
scaning rate 50 min-1, over a range of 80 -600   diffraction angle (2Ɵ) range. 
3.3.4.10 Thermo Gravimetric Analysis (TGA) and Differential Scanning 
Calorimetry (DSC) 
2-4 ml of the samples of all the formulations containing extracts individually were placed 
in aluminium pans and sealed prior to test. Measurements were performed at a rate 10°C 
per minute, under nitrogen flow of 25 ml per minute, over a temperature range of 0°C to 
500°C. Indium was used for the equipment calibration. 
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3.3.4.11 Scanning Electron Microscopy (SEM) 
Scanning electron microscopy was used to characterize microstructure of 
microemulsions. SEM of microemulsions of formulations containing Pomegranate, 
Tomato and Papaya extracts was measured by Scanning Electron Microscope (19800 
Hitachi S-3400N VP-SEM, Japan). 
3.5 Product Evaluation on Skin 
3.5.1 Ethical Considerations  
This study was approved by the Board of Advance Studies and Research and Ethical 
Review Committee, The Islamia University of Bahawalpur (Reference No 3715/Acad). 
The study was conducted in accordance with the ethics principles of the Declaration of 
Helsinki and was consistent with Good Clinical Practice guidelines. All participants were 
included in this study after written informed consents. They were informed about possible 
adverse reactions, procedures, protocols and objectives of this study. They reserved the 
rights to quit study without informing about such reasons. 
3.5.2 Study Design 
This monocentric study was carried out in Cosmetics Laboratory, The Islamia University 
of Bahawalpur, Pakistan. The single expert investigator ensured the proper conduct of the 
study and performed all experimentation as described in the protocols, to minimize 
person to person variations.  
11 volunteers were selected for the evaluation of each microemulsion having with ages 
between 20 and 30 years. Male volunteers were included in this work. Prior to the tests, a 
cosmetic expert, for any serious skin disease or damage especially on cheeks and 
forearms, examined the volunteers. Before the study, every volunteer filled a volunteer 
protocol. Every volunteer signed the terms and conditions of the testing individually. 
Information regarding the contents of base and formulation was not provided to the 
volunteers. All the skin tests were carried out at 250C and 40% relative humidity 
conditions. On the first day, patch test (Burchard test) was performed for 48 hrs on the 
forearms of each volunteer to determine any possible reactions to the ingredients of 
microemulsions. On the third day, each volunteer was given two formulations. One 
formulation was control formulation (base) without any active ingredient and the other 
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one was active formulation containing the active ingredients. Each formulation was 
marked with “right” or “left” indicating application of that formulation to the respective 
cheek. The volunteers themselves as instructed applied the formulations twice in a day for 
12 weeks. Every individual was instructed to come on week 2, 4, 6, 8, 10 and 12 for the 
skin measurements in the same time as well same day. 
Type of Preparation Microemulsion 
Duration of Study 12 weeks 
Daily use At night and morning 
Region of Application Cheeks  
3.5.3 Tests Performed 
1. Patch test (Burchard test)  
2. Melanin and Erythema contents 
3. Moisture contents  
4. Sebum contents  
5. Elasticity   
6. Skin pH    
7. SELS (Surface Evaluation of Living skin)  
8. Panel test 
3.5.4 Essential Criteria for Inclusion  
Individuals should be healthy male. 
1. No person should be with hypersensitive history 
2. There should be no lesions, diseases or any abnormality on the skin of face and 
forearm 
3. Nobody should use any other cream or any other product on the face, at least 15 
days before the study 
4. Every individual should read and sign the volunteer protocol 
5. During the study, every individual should come to the laboratory for 
measurements 
6. Age should be 20-30 year of each individual 
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3.5.5 Criteria for Exclusion  
Any individual under treatment for skin disorders during the study. 
1. Any individual hypersensitive to any ingredient of the cream or with history of 
sensitivity 
2. Any individual who does not obey the application rules of the creams 
3. Any individual with extraordinary hair on the cheeks 
4. Age  (>30 years) and gender (female) 
3.6 In-Vivo Evaluation of Microemulsion Formulations Containing 
Plant Extracts 
For in-vivo evaluation of microemulsions of plant extract following instruments were 
used in the study. 
3.6.1 Mexameter® MX18 
The  Mexameter MX18 (Courage + Khazaka, Germany) is  a  skin  color-measuring  
device,  and  has been  reported  to  provide  a reproducible and sensitive means of 
quantifying small skin color differences. To meet the requirements  for  a  precise  
determination  of  the  skin  color,  the  Mexameter  specifically measures the content of 
melanin and erythema in the skin. These two components are mainly responsible for the 
skin colour.  The measurement is based on the absorption principle. The special probe of 
the Mexameter emits light of three defined wavelengths. A receiver measures the light 
reflected by the skin. The positions of emitter and receiver guarantee that only diffused 
and scattered light is measured. As the quantity of emitted light is defined, the quantity of 
light absorbed by the skin can be calculated. The melanin is measured by two 
wavelengths. These wavelengths have been chosen in order to achieve different 
absorption rates by the melanin pigments.   For the erythema measurement, two different 
wavelengths are used to measure the absorption capacity of the skin.  One of these 
wavelengths corresponds with the spectral absorption peak of haemoglobin.  The  other  
wavelength  has  been  chosen  to  avoid  other  colour  influences (e.g.  Bilirubin).  The  
results  for  both  parameters  are  shown  within  1  second  as  index numbers between 0 
to 999. The same measuring probe is used to quantify both the skin redness (Erythema) 
and determine the degree of skin tanning (Melanin).  Also irritating effects of cosmetics 
53 
 
 
 
as well as smoothing effects of active agents can be calculated (Courage and Khazaka, 
2004). 
 
 
 
           Figure 3.4 Mexameter with Probe 
3.6.2 Skin pH Meter® PH 905 
Skin pH meter was used to measure skin pH content of the skin before application of any 
Formulation and Base at week 2nd, 4th, 6th, 8th, 10th and 12th 
 
 
   
                Figure 3.5 Probe Skin-pH-Meter 
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3.7.3 Elastometer® E25 
Skin elastometer was used to measure elasticity of the skin before application of any 
formulation and then on week 2nd, 4th, 6th, 8th, 10th and 12th. 
 
 
 
 
Figure 3.6 Elastometer with Probe 
3.7.4 Corneometer® CM825  
The total amount of water within the Stratum corneum is of significance both for barrier 
characteristics and for the clinical manifestation of the skin. This water content can be 
measured with a new instrument, the CM 825, which takes advantage of the high 
dielectric constant of water (Werner, 1985). The  measurement  of  the  skin  moisture  is  
based  on  the  internationally  recognized Corneometer  method, a capacitance  method.  
This measurement is based on the completely different di electric constant of water (81) 
and other substances (mostly < 7). It  is  an  indirect technique  of  determining  skin’s  
barrier  function  and  access  a  10-20 micrometer thickness of Stratum corneum (Hester 
et al., 2004). The measuring capacitor shows changes of capacitance according to the 
moisture content of the samples. A glass lamina separates the metallic tracks (gold) in the 
probe head from the  skin  in  order  to  prevent  current  conduction  in  the  sample.  An  
electric  scatter  field penetrates  the  skin  during  the  measurement  and   the  di-
electricity  is  determined.  One track builds up a surplus of electrons (minus charge), the 
other a lack of electrons (plus 45charge). An electric field between the tracks with 
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alternating attraction develops. During the measurement the scatter field penetrates the 
very first layer of the skin and determines the di-electricity.  Unlike the impedance 
measurement no galvanic relation between the device and the measuring object or 
polarization effects exist (Courage and Khazaka, 2004). 
 
 
          Figure 3.7 Corneometer CM825 
With the help of a Corneometer, moisture of the skin was measured before the application 
of any formulation and then on week 2nd, 4th, 6th, 8th, 10th and 12th. 
3.7.5 Sebumeter® MS 815 
It is a device by which sebum can be quantified from any area of skin in an objective 
manner. The sebum measurement on the skin as well as on the hair and scalp is based on 
the internationally recognized Sebumeter® method.  It is a direct measurement of the 
sebum secretion on skin, hair and scalp. The measurement principle is the photometric 
method, the grease spot photometer (Pande and Misri, 2005).  This method is not 
sensitive to moisture. The supplied sebumeter-cassette contains a mat synthetic tape 
which is 0.1 mm thick. The  measuring  head  of  the  cassette  exposes  a  64  mm 2  
measuring  section  of  the tape. For the next measurement the tape has to be transported 
forward by a trigger at the side of the cassette so that a new measuring section is exposed. 
One cassette can be used for approx. 450 measurements (if the trigger is only pulled down 
slowly for the next free measuring section). When completely consumed, the cassette is 
exchanged for hygienic reasons.  A  mirror  under  the  measuring  section  of  the  tape  is  
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protruding  approx. 1 mm from the measuring head. This mirror is linked with the 
cassette by a 0.3 N spring. This makes sure that the tape is pressed onto the measuring 
area with constant pressure by the mirror. The measuring time of 30 seconds is controlled 
by a clock in the software. For the determination  of  the  sebum,  the measuring  head  of  
the  cassette  is  inserted  into  the aperture  of  the  device,  where  a  photocell  measures  
the  transparency.  The  light transmission  represents  the  sebum  content  on  the  
surface  of  the  measuring  area.  A microprocessor calculates the result, which is shown 
on the display in values from 0-350 (Courage and Khazaka, 2004). 
 
 
Figure 3.8 Sebumeter (Device and cassette) 
Sebumeter was used to measure sebum content of the skin before application of any 
formulation and then on week 2nd, 4th, 6th, 8th, 10th and 12th. 
3.7.6 Visioscan VC® 98 
The state  and  function  of  human  skin  can  be quantified  by  numerous  non-invasive  
test  methods.   Profilometry was the only method which used skin replica for its 
calculations to determine the condition of the skin surface, other than subjective 
evaluations (Tronnier, 2003). A measurement where the skin can be monitored optically 
using an image-digitalization process without using replica is a great progress in the 
scientific research. This new method is called SELS (Surface Evaluation of the Living 
Skin) which is used in Visioscan. Surface evaluation of living skin (SELS) is a new 
optical-photo analytical process.  Four important parameters, determining the surface 
structure of the skin can be recorded simultaneously. Constitutional, topical and age  
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dependant  skin  surface  structures  can  also  be  recorded  by  means  of  this  method 
(Tronnier,  1997).  It  is  based  on  a  graphic  depiction  of  the  living  skin  under  
special illumination and the electronic processing and evaluation of this image according 
to four clinical  parameters. The  parameters  correspond  quantitatively  and  qualitatively  
to  the physiological  condition  of  the  skin  surface.  Those parameters are the skin 
smoothness (SEsm), skin roughness (SEr), skin scaliness (SEsc), skin wrinkles (SEw). 
These parameters were developed in various clinical studies and rechecked and modified 
over and over until they were perfectly suitable to characterize the skin surface (Courage 
and Khazaka, 2000). In contrary to the conventional color video cameras, the Visioscan® 
VC 98 consists of a special  video  sensor  chip  with  very  high  resolution,  an  objective  
and  an  UVA-light source  in  a small,  easy-to-handle,  ergonomically  designed  plastic  
casing.  Two special halogenide lights, arranged on opposite sides, illuminate the skin 
uniformly. 
The spectrum of the light, its intensity and the way it is arranged is chosen so that only 
the stratum corneum without reflections from deeper layers is monitored.  This special 
light excludes almost all undesired light reflections on the skin, thus bringing out a very 
sharp, non-glossy image of the skin & hair (Courage and Khazaka, 2000). 
 
 
                              Figure 3.9 Visioscan with Camera 
Numerous  studies  are  present  in  literature  on  the  use  of  Visioscan  to  determine  
the efficacy of products for skin surface parameters related to aging. In one study 
comparison was shown between coarse and smooth skin surface using Visioscan® VC 98 
(Pena Ferreira et al., 2010). In various studies the effects of topically applied Rooibos 
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extract, Hyaluronic acid, Tamarindus  indica seed  extract, Saccharina longicruris extract   
and  other  anti-wrinkle  products  were  evaluated  for  skin  surface,  hydration  and  
elasticity  (Schweikert, 2005; Beguin, 2005; Ferreira, 2010). 
Visioscan® 98 was used to measure SESL parameters of the skin before application of 
any formulation and then on month 1st, 2nd and 3rd. 
3.7.7 Panel Test 
Forms were given to every individual prepared previously to test the sensory values of 
base and formulations. This form consisted of seven parameters to be evaluated and every 
parameter was assigned 11 values from –5 to +5 indicating very bad to very good, with 0 
as base line respectively. This form was completed independently by each individual on 
week 12. The following was the questions; 
1. Ease of application  
2. Spreadability    
3. Sense just after application  
4. Sense in long-term   
5.  Irritation  
6. Shine on skin    
7. Sense of softness 
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3.8 Mathematical and Statistical Analyses 
The percentage changes for the individual values of different parameters, taken every 
Week, of volunteers were calculated by the following formula; 
   Percentage	Change = ୅ି୆
୆
 × 100   ............ (1) 
Where; A = Individual value of any parameter at 2nd, 4th, 6th, 8th, 10th or 12th week 
B = Baseline value of that parameter 
The measured values obtained for different parameters (skin moisture, sebum, melanin, 
erythema and elasticity) for base and for active formulations were analyzed using 
Graphpad prism version 5 on the PC computer (paired samples t-test for variation 
between effects of each two formulations; one-way ANOVA for variation between 
individuals). 
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4. RESULTS AND DISCUSSION 
The results and discussion of physical analysis, in-vitro and in-vivo evaluation of 
microemulsions containing Lycopersicon esculentum, Carica papaya and Punica 
granatum extracts are given below: 
4.1  Percentage Composition of Lycopersicon esculentum and Carica 
papaya Extract 
The calibration curves were obtained for the determination of lycopene and for the 
quantification of lycopene in Lycopersicon esculentum extract.  The amount of lycopene 
was calculated based on absorbance of sample and using the calibration curve (Bunghez, 
et al., 2011). 
 
 Table 4.1 %age Contents of Lycopene in Crude Extracts 
Sr. No. Plant Extract %age 
1 Lycopersicon esculentum extract 78.07 
2 Carica papaya extract 70.07 
    n=3 
 
 Table 4.2 Absorbance of Working Standards of Lycopene 
 
Concentration (µg/ml) Absorbance 
10 4498 
5 2022 
2.5 1019 
1.25 599 
0.625 267 
0.312 114 
0.156 53 
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  Figure 4.1 The Calibration Curve of Lycopene 
4.1.1 Phase Diagrams of Base Microemulsion Containing Lycopersicon 
esculentum and Carica papaya Extract 
For construction of the  phase  diagram selected oil,  surfactant  mixture  and  water  were  
weighed  and  mixed together at room temperature. Resultant figure has been shown in 
Figure 4.2. 
 
 
Figure 4.2 The Pseudo Ternary Phase Diagram of Surfactant Mixture, Oil and Water 
Smix2:1. 
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4.2 Percentage Composition of Punica Granatum Extract 
UV-Visible Spectrophotometer method was used for analysis of Punica granatum. UV 
detector wavelength was set at 365 nm. The amount of ellagic acid was calculated based 
on absorbance of sample and using the calibration curve. 
 
Table 4.3 Percentage Contents of Ellagic Acid in Punica granatum Extract 
 
Sr. No. Plant Extract %age 
1 Punica granatum extract 84.48 
 
 
Table 4.4 Absorbance of Working Standards of Ellagic Acid 
 
Concentration(µg/ml) Absorbance 
10 0.492 
5 0.261 
2.5 0.141 
1.25 0.680 
0.625 0.340 
0.312 0.160 
0.156 0.900 
 
63 
 
 
 
 
Figure 4.3 The Calibration Curve of Ellagic Acid 
 
4.2.1 Phase Diagrams of Microemulsion 
The  surfactant  (Tween 80)  and  cosurfactant  (Propylene glycol)  were  used  in  the  
preparation  of  the microemulsion with palm oil. They were mixed in different ratios of 
surfactant and cosurfactant mixtures. Result has been shown in Figure 4.4. 
 
 
 
Figure 4.4 The Pseudo Ternary Phase Diagram of Surfactant Mixture, Oil and 
Water Smix 5:1 
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4.3 In-Vitro Evaluation of Microemulsions 
4.3.1 Organoleptic/Physical Stability  
Microemulsion Formulations and Bases (F1, F2, F3, B1 and B2) each were divided into 
four samples which were kept at 80C in refrigerator, 250C, 400C and 500C in incubators. 
The samples were observed organoleptically to note changes in colour, turbidity and loss 
of clarity and phase separation for a period of 3 months at definite time intervals. The 
results have been presented in Table 4.5, 4.6 and 4.7. 
 
Table 4.5 Pysical Characterization of (B1) and (F1) at 8oC, 25 oC, 40 oC and 50 oC  
Observed 
Parameters 
Temp. 
(oC) 
Fresh After 
24 hrs 
After 
72 
hrs 
After 
7 days 
After30 
days 
After 
60 
days 
After 
90 
days 
B F B F B F B F B F B F B F 
Color 
8 W R W R W R W R W R W R W R 
25 W R W R W R W R W R W R W R 
40 W R W R W R W R W R W R W R 
50 W R W R W R W R W R W R W R 
Tubidity and Loss 
of Clarity 
8 - - - - - - - - - - - - - - 
25 - - - - - - - - - - - - - - 
40 - - - - - - - - - - - - - - 
50 - - - - - - - - - - - - - - 
Phase separation 
8 - - - - - - - - - - - - - - 
25 - - - - - - - - - - - - - - 
40 - - - - - - - - - - - - - - 
50 - - - - - - - - - - - - - - 
Centrifugation 
Stability 
(6000 rpm, 30 
min) 
8 S S S S S S S S S S S S S S 
25 S S S S S S S S S S S S S S 
40 S S S S S S S S S S S S S S 
50 S S S S S S S S S S S S S S 
* S = Stable, W = Whitish; R= Reddish 
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Table 4.6 Physical Characterizatin of (B1) and (F2) at 8oC, 25oC, 40oC and 50oC 
Observed 
Parameters 
Temp. 
(oC) 
Fresh 
After 
24 hrs 
After 
72 
hrs 
After 
7 days 
After30 
days 
After 
60 
days 
After 
90 
days 
B F B F B F B F B F B F B F 
Color 
8 W R W R W R W R W R W R W R 
25 W R W R W R W R W R W R W R 
40 W R W R W R W R W R W R W R 
50 W R W R W R W R W R W R W R 
Tubidity and Loss 
of Clarity 
8 - - - - - - - - - - - - - - 
25 - - - - - - - - - - - - - - 
40 - - - - - - - - - - - - - - 
50 - - - - - - - - - - - - - - 
Phase Separation 
8 - - - - - - - - - - - - - - 
25 - - - - - - - - - - - - - - 
40 - - - - - - - - - - - - - - 
50 - - - - - - - - - - - - - - 
Centrifugation 
Stability 
(6000 rpm, 30 
min) 
8 S S S S S S S S S S S S S S 
25 S S S S S S S S S S S S S S 
40 S S S S S S S S S S S S S S 
50 S S S S S S S S S S S S S S 
* S = Stable, W = Whitish; R= Reddish 
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Table 4.7Physical Characterization of (B2) and (F3) at 8oC, 25oC, 40oC and 50oC  
Observed 
Parameters 
Temp. 
(oC) 
Fresh 
After 
24 hrs 
After 
72 
hrs 
After 
7 days 
After 
30 
days 
After 
60 
days 
After 
90 
days 
B F B F B F B F B F B F B F 
Color 
8 W Y W Y W Y W Y W Y W Y W Y 
25 W Y W Y W Y W Y W Y W Y W Y 
40 W Y W Y W Y W Y W Y W Y W Y 
50 W Y W Y W Y W Y W Y W Y W Y 
Tubidity and Loss 
of Clarity 
8 - - - - - - - - - - - - - - 
25 - - - - - - - - - - - - - - 
40 - - - - - - - - - - - - - - 
50 - - - - - - - - - - - - - - 
Phase Separation 
8 - - - - - - - - - - - - - - 
25 - - - - - - - - - - - - - - 
40 - - - - - - - - - - - - - - 
50 - - - - - - - - - - - - - - 
Centrifugation 
Stability 
(6000 rpm, 30 
min) 
8 S S S S S S S S S S S S S S 
25 S S S S S S S S S S S S S S 
40 S S S S S S S S S S S S S S 
50 S S S S S S S S S S S S S S 
*W= Whitish, *Y=Yellowish 
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4.3.2 pH Measurement 
Averages of pH values of the Formulations and Bases kept at different storage conditions 
for 3 months have been presented in Figures 4.5, 4.6and 4.7.  
 
 
Figure 4.5 AveragespH value of B1 and F1 kept at Different Temperatures for 90 
Days 
 
 
 
 
Figure 4.6 Averages of pH Value of B1 and F2 Kept at Different Temperatures for 90 
Days 
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Figure 4.7 Averages of pH Values of B2 and F3 Kept at Different Temperatures for 90 
Days 
 
4.3.3 Electrical Conductivity Measurement 
Conductivity of the prepared formulations and bases were measured by digital 
Conductivity-Meter for all the samples (F1, F2, F3, B1 and B2) kept at 8oC, 25oC, 40oC 
and 50oC. All the measurements were carried out in triplicate. Results were represented in 
Figures 4.8, 4.9 and 4.10. 
 
Figure 4.8 Averages Conductivity Value of B1 and F1 Kept at Different Temperatures 
for 90 Days 
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Figure 4.9 Averages of Conductivity Value of B1 and F2 Kept at Different 
Temperatures for 90 Days 
 
 
 
Figure 4.10 Averages of Conductivity Value of B2 and F3 Kept at Different 
Temperatures for 90 Days 
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4.3.4 Characteriation of Fresly Prepared Microemulsions 
The droplet size, zeta potential, viscosity, conductivity, pH, refractive indices, 
polydispersity index and spreadiability  of  Bases and Formulations (F1, F2, F3, B1 and 
B2) containing Pomegranate, Tomato and Papaya extracts were measured and results 
have been given in Table 4.8, 4.9 and 4.10. 
Table 4.8 Physical Characteristics of B1 and F1 (n=3) 
* Refractive Index,   #Polydispersity Index 
Table 4.9 Characteristics of B1 and F2 Microemulsions (n=3) 
 
* Refractive Index,   #Polydispersity Index 
Table 4.10 Characteristics of B2 and F3 microemulsion (n=3) 
* Refractive Index,   #Polydispersity Index 
 
Formul
ations 
Zeta 
potentia
l (mv) 
Viscosit
y (cP) 
Particle 
size  (m) 
Conduct
ivity 
(µS/cm) 
pH RI* PI# 
Spreada
bility 
(cm) 
B1 -0.134 
4.51 
± 
0.12 
24.36 
± 
0.4 
6.62 5.73 1.443 1.00 5.5 
F1 -0.185 
4.69 
± 
0.05 
32.67 
± 
0.2 
5.08 5.66 1.437 0.94 5.40 
Formul
ations 
Zeta 
potentia
l (mv) 
Viscosit
y (cP) 
Particle 
size  
(nm) 
Conduct
ivity 
(µS/cm) 
pH RI* PI# 
Spreada
bility 
(cm) 
B1 -0.134 
4.51 
± 
0.12 
24.36 
± 
0.4 
6.62 5.73 1.443 1.000 5.5 
F2 -0.213 
5.59 
± 
0.05 
37.82 
± 
0.2 
5.3 5.68 1.45 0.724 5.25 
Formul
ations 
Zeta 
potentia
l (mv) 
Viscosit
y (cP) 
Particle 
size     
(nm) 
Conduct
ivity 
(µS/cm) 
pH RI* PI# 
Spreada
bility 
(cm) 
B2 -03 
5.23 
± 
1.88 
18.16 
± 
0.4 
18.4 5.81 1.41 0.22 5.2 
F3 -5.2 
5.93 
± 
1.66 
24.36 
± 
0.22 
19.7 5.673 1.45 0.36 5.3 
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4.3.5  Rheological Studies 
Rheological parameters (flow index and % confidence of fit) of Bases and Formulations 
(F1, F2, F3, B1 and B2) kept at various storage conditions up to 90 days were observed 
and have been given in Tables 4.11, 4.12, 4.13, 4.14, 4.15, 4.16, 4.17, 4.18, 4.19 and 4.20 
While Rheograms of the Bases and Formulations have been given in Figures 4.11, 4.12, 
4.13, 4.14, 4.15, 4.16, 4.17, 4.18, 4.19 and 4.20. 
 
Table 4.11 Results of Rheological Analysis of B1 Fresh Sample and Samples 
Stored at Different Conditions for 45 Days 
 
Parameter Fresh After 45 Days 
Temperature (ºC) - 8 25 40 50 
Consistency Index(CP)  4.35 4.05 3.64 4.40 3.16 
Flow Index 1.23 1.25 1.08 1.02 1.22 
Confidence of Fit % 99.7 99.4 97.1 98.9 99.4 
 
 
Table 4.12 Results of Rheological Analysis of B1 Fresh Sample and Samples 
Stored at Different Conditions for 90 Days 
 
Parameter Fresh After 90 Days 
Temperature (ºC) - 8 25 40 50 
Consistency Index(CP)  4.35 2.29 6.43 14.27 16.26 
Flow Index 1.23 1.17 1.13 1.08 1.02 
Confidence of Fit % 99.7 98.9 99.3 98.3 97.5 
 
 
72 
 
 
 
 
Table 4.13 Results of Rheological Analysis of F1 Fresh Sample and Samples 
Stored at Different Conditions for 45 Days 
 
Parameter Fresh After 45 Days 
Temperature (ºC) - 8 25 40 50 
Consistency Index(CP)  3.99 5.51 20.3 13.65 21.75 
Flow Index 1.12 1.07 1.01 1.02 1.01 
Confidence of Fit % 99.7 97.9 99.5 98.9 99.2 
 
 
 
 
 
Table 4.14 Results of Rheological Analysis of F1 Fresh Sample and Samples 
Stored at Different Conditions for 90 Days 
 
Parameter Fresh After 90 Days 
Temperature (ºC) - 8 25 40 50 
Consistency Index(CP) 3.99 14.26 13.1 15.72 26.75 
Flow Index 1.12 1.03 1.02 1.13 1.14 
Confidence of Fit % 99.7 99.8 97.7 98.3 96.8 
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n=10 
 
 
Figure 4.11 Viscosities of B1 Fresh and Samples Kept at Different Conditions for 45 
Days  
 
 
 
 n=10 
Figure 4.12 Viscosities of B1 Fresh and Samples Kept at Different Conditions for 90 
Days 
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  n=10 
Figure 4.13 Viscosities of F1 Fresh and Samples Kept at Different Conditions for 45 
Day  
 
 
 
n=10 
Figure 4.14 Viscosities of F1 Fresh and Samples Kept at Different Conditions for 
   90Days 
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Table 4.15 Results of Rheological Analysis of F2 Fresh Sample and Samples 
Stored at different conditions for 45 days 
 
Parameter Fresh After 45 Days 
Temperature (ºC) - 8 25 40 50 
Consistency Index(cP) 1.63 3.80 5.32 8.17 6.91 
Flow Index 1.01 1.09 1.03 1.16 1.11 
Confidence of Fit % 99.4 98.9 97.6 99.7 95.2 
 
 
Table 4.16 Results of Rheological Analysis of F2 Fresh Sample and Samples 
Stored at different conditions for 90 days 
 
Parameter Fresh After 90 Days 
Temperature (ºC) - 8 25 40 50 
Consistency Index(cP) 1.63 7.31 6.38 13.07 15.70 
Flow Index 1.01 1.07 1.05 1.11 1.13 
Confidence of Fit % 99.4 99.2 96.8 99.3 97.8 
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n=10 
Figure 4.15 Viscosities of F2 Fresh and Samples Kept at Different Conditions for 45   
Days 
 
 
n=10 
Figure 4.16 Viscosities of F2 Fresh and Samples Kept at Different Conditions for 90 
Days 
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Table 4.17 Results of Rheological Analysis of B2 Fresh and Samples Stored at 
Different Conditions for 45 Days 
 
Parameter Fresh After 45 Days 
Temperature (ºC) - 8 25 40 50 
Consistency Index(CP)  5.70 7.53 6.47 8.95 15.66 
Flow Index 1.01 1.08 1.06 1.07 1.00 
Confidence of Fit % 99.7 98.5 99.6 99.3 98.2 
 
 
 
Table 4.18 Results of Rheological Analysis of B2 Fresh and Samples Stored at 
Different Conditions for 90 Days 
 
Parameter Fresh After 90 Days 
Temperature (ºC) - 8 25 40 50 
Consistency Index(CP)  5.70 63.03 53.28 54.44 27.16 
Flow Index 1.01 1.08 1.06 1.00 1.14 
Confidence of Fit % 99.7 95.5 97.6 97.3 99.9 
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Table 4.19 Results of Rheological Analysis of F3 Fresh and Samples Stored at 
Different Conditions for 45 Days 
 
Parameter Fresh After 45 Days 
Temperature (ºC) - 8 25 40 50 
Consistency Index(CP)  4.24 2.12 4.75 21.98 27.71 
Flow Index 1.06 1.21 1.23 1.01 1.02 
Confidence of Fit % 97.7 98.5 99.6 99.3 97.2 
 
 
 
Table 4.20 Results of Rheological Analysis of F3 Fresh and Samples Stored at 
Different Conditions for 90 Days 
 
Parameter Fresh After 90 Days 
Temperature (ºC) - 8 25 40 50 
Consistency Index(CP)  4.24 21.89 34.51 24.41 20.19 
Flow Index 1.06 1.02 1.01 1.13 1.08 
Confidence of Fit % 97.7 98.9 97.6 99.3 99.8 
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n=10 
Figure 4.17 Viscosities of B2 Fresh and Samples Kept at Different Conditions for 45 
Days 
 
 
n=10 
Figure 4.18 Viscosities of B2 Fresh and Samples Kept at Different Conditions for 90 
Days 
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n=10 
Figure 4.19 Viscosities of F3 Fresh and Samples Kept at Different Conditions for 45 
Days 
 
n=10 
Figure 4.20 Viscosities of F3 Fresh and Samples Kept at Different Conditions for 90 
Days 
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4.3.6  Globule Size 
The average globule or droplet size of microemulsions of Formulations (F1, F2 and F3) 
containing Pomegranate, Tomato and Papaya extracts were measured. Results have been 
shown in Figure 4.21, 4.22, 4.23 and globule size values given in Table 4.8, 4.9, 4.10. 
 
 
 
Figure 4.21 Size Distributions of Globules in F1 Formulation  
 
 
Figure 4.22 Size Distributions of Globules in F2 Formulation 
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Figure 4.23 Size Distributions of Globules in F3 Formulation 
 
4.3.7  Scanning Electron Microscopy (SEM) 
Scanning electron microscope is also used to characterize microstructure of 
microemulsions as well as globule of microemulsion by preparing a thin layer smear on 
glass slide after drying. SEM of microemulsions (F1, F2 and F3) of formulations 
containing Pomegranate, Tomato and Papaya extracts was measured given in Figure 4.24, 
4.25 and 4.26. 
 
Figure 4.24 SEM of F1 Formulation 
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Figure 4.25 SEM of F2 Formulation 
 
 
 
 
Figure 4.26 SEM of F3 Formulation 
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4.3.8  XRD (X-Ray Diffraction) 
Presence of crystalline and amorphous nature of all the Formulations (F1, F2 and F3) 
containing extracts were evaluated by X-Ray Diffractometer. Results have been given in 
Figure 4.27, 4.28 and 4.29. 
 
 
 
 Figure 4.27 XRD of F1 Formulation 
 
 
   
  Figure 4.28 XRD of F2 Formulation 
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Figure 4.29 XRD of F3 Formulation 
 
4.3.9 Thermal Analysis (TGA) and Differential Scanning Calorimetry 
(DSC) 
Thermograms of all the Formulations (F1, F2 and F3) containing extracts are given in 
Figure 4.30, 4.31 and 4.33. 
 
Figure 4.30 TGA and DSC of F1 Formulation 
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Figure 4.31 TGA and DSC of F2 Formulation 
 
 
 
 
Figure 4.32 TGA and DSC of F3 Formulation 
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4.4  In-Vivo Evaluation of Microemulsion Bases and Formulations 
Containing Plant Extracts 
4.4.1  Patch Test for Malanin and Erythema 
In this study patch tests were performed on forearms of volunteers for 48 hours for both 
the Bases and Formulations, to check the cosmetic safety of the Formulations and the 
Bases on human skin by Mexameter. Results have been given in Figure 4.33, 4.34, 4.35, 
4.36, 4.37 and 4.38.  
 
 
 
Figure 4.33 %age Change in Melanin and Erythema after Application of Patch B1  
 
   Figure 4.34 %age Change in Melanin and Erythema after Application of Patch F1 
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Figure 4.35 %age Change in Melanin and Erythema after Application of Patch B1 
 
 
 
   Figure 4.36 %age Change in Melanin and Erythema after Application of Patch F2 
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Figure 4.37 %age Change in Melanin and Erythema after Application of Patch B2 
 
 
 
 Figure 4.38 %age Change in Melanin and Erythema after Application of Patch F3 
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4.4.2  Melanin 
In this study, the effect of the Bases and the Formulations (F1, F2, F3 and B1and B2) on 
the production of skin melanin was examined. The amount of melanin was measured by 
Mexameter for 12 weeks at different time intervals in each individual after application of 
base and formulation. Results have been given in Figures 4.39, 4.40, 4.41, 4.42, 4.43 and 
4.44 
 
 
 
Figure 4.39 %age Change in Skin Melanin after Application of B1 
 
 
 
Figure 4.40 %age Change in Skin Melanin after Application of F1 
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Figure 4.41 %age Change in Melanin after Application of B1 
 
 
 
Figure 4.42 %age Change in Melanin after Application of F2 
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Figure 4.43 %age Change in Melanin after Application of B2 
 
 
 
Figure 4.44 %age Change in Melanin after Application of F3  
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4.4.3  Erythema 
In this study, irritation was constantly monitored by Mexameter every 2nd week for the 
Bases and for the Formulations (F1, F2, F3 and B1 and B2) throughout the period of 
application for 3months. Results have been given in Figures 4.45, 4.46, 4.47, 4.48, 4.49 
and 4.50. 
 
 
 
Figure 4.45 %age of Change in Erythma after Application of B1 
 
 
 
Figure 4.46 %age Change in Erythma after Application of F1 
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Figure 4.47 %age Change in Erythma after Application of B1 
 
 
 
Figure 4.48 %age Change in Erythema after Application of F2 
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Figure 4.49 %age Change in Erythema after Application of B2 
 
 
 
 
Figure 4.50 %age Change in Erythema after Application of F3 
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4.4.4  Skin pH  
pH-value may fall anywhere on a scale from 0 (strongly acidic) to 14 (strongly alkaline), 
with a value of 7 representing neutrality. The measurement of the pH-value of skin was 
done with a glass electrode for 3 months. Results have been given in Figures 4.51, 4.52, 
4.53, 4.54, 4.55 and 4.56. 
 
 
 
Figure 4.51 %age Change in Skin pH after Application of B1 
 
 
Figure 4.52 %age Change in Skin pH after Application of F1 
0.00
1.00
2.00
3.00
2 4 6 8 10 12
%
 a
ge
 C
ha
ng
e
Time (Weeks) 
Skin pH B1
-4.00
-3.00
-2.00
-1.00
0.00
2 4 6 8 10 12
%
 a
ge
 C
ha
ng
e
Time (Weeks)
Skin pH F1
97 
 
 
 
 
 
 
Figure 4.53 %age Change in Skin pH after Application of B1 
 
 
 
 
Figure 4.54 %age Change in Skin pH after Application of F2 
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Figure 4.55 %age Change in Skin pH after Application of B2 
 
 
 
Figure 4.56 %age Change in Skin pH after Application of F3 
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4.4.5  Elasticity 
In this study, elasticity was constantly monitored by Elastometer every 2nd week for the 
Bases and the Formulations (F1, F2, F3 and B1and B2) throughout the period of 
application for 3 months. Percentage changes in the values have been given in Figures 
4.57, 4.58, 4.59, 4.60, 4.61 and 4.62. 
 
 
Figure 4.57 %age Change in Skin Elasticity after Application of B1 
 
 
Figure 4.58 %age Change in Skin Elasticity after Application of F1 
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Figure 4.59 %age Change in Skin Elasticity after Application of B1 
 
 
 
Figure 4.60 %age Change in Skin Elasticity after Application of F2 
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Figure 4.61 %age Change in Skin Elasticity after Application of B2 
 
 
 
Figure 4.62 %age Change in Skin Elasticity after Application of F3 
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4.4.6 Moisture Contents 
In this study, Moisture Contents were constantly monitored by Corneometer every 2nd 
week for the Bases and the Formulations (F1, F2, F3 and B1and B2) throughout the 
period of application for 3 months. Results have been given in Figures 4.63, 4.64, 4.65, 
4.66, 4.67 and 4.68. 
 
 
Figure 4.63 %age Change in Moisture Contents after Application of B1 
 
 
 
Figure 4.64 %age Change in Moisture Contents after Application of F1 
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Figure 4.65 %age Change in Moisture Contents after Application of B1 
 
 
 
 
Figure 4.66 %age Change in Moisture Contents after Application of F2 
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Figure 4.67 %age Change in Moisture Contents after Application of B2 
 
 
 
Figure 4.68 %age Change in Moisture Contents after Application of F3 
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4.4.7 Sebum Contents 
The percentage changes were observed in the sebum contents of the human volunteers 
after the application of the F1, F2, F3 and B1 and B2 during the study period of 12 weeks 
has been presented in Figures 4.69, 4.70, 4.71, 4.72, 4.73 and 4.74. 
 
 
 
Figure 4.69 %age Change in Sebum Contents after Application of B1 
 
 
 
Figure 4.70 %age Change in Sebum Contents after Application of F1 
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 Figure 4.71 %age Change in Sebum Contents after Application of B1 
 
 
 
 
 
Figure 4.72 %age Change in Sebum Contents after Application of F2 
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Figure 4.73 %age Change in Sebum Contents after Application of B2 
 
 
 
Figure 4.74 %age Change in Sebum Contents after Application of F3 
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4.4.8  SELS (Surface Evaluation of Living Skin)  
Four major SELS (SEr, SEsc, SEsm and SEw) parameters were measured at baseline (0 
time values) and then at 1st, 2nd and 3rd month of study period by Visioscan® VC 98. The 
percent changes in the values for all volunteers were calculated and presented in Figure 
4.75, 4.76, 4.77, 4.78, 4.79 and 4.80. 
 
 
Figure 4.75 %age Change in SELS Parameters after Application of B1 
 
 
Figure 4.76 %age Change in SELS Parameters after Application of F1  
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Figure 4.77 %age Change in SELS Parameters after Application of B1  
 
 
 
 
 
Figure 4.78 %age Change in SELS Parameters after Application of F2 
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Figure 4.79 %age Change in SELS Parameters after Application of B2  
 
 
 
 
Figure 4.80 %age Change in SELS Parameters after Application of F3 
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4.4.9  Panel Test 
A questionnaire performa containing seven questions was circulated in a duplicate to each 
volunteer for sensory assessment of F1, F2, F3, B1 and B2. Average points were 
calculated from the points assigned by each volunteer for each question for all of the 
Bases and Formulations for 12 weeks. Results have been given in Tables 4.21, 4.22 and 
4.23. 
Table4.21 Average Points of Panel Test by Volunteers for B1 and F1 
Parameters 
Average points for  
Base ± SEM 
B1 
Average points for 
Formulation ± SEM 
F1 
Ease of application 4.50 ± 0.07 4.48 ± 0.03 
Spreadability 4.38 ± 0.09 4.40 ± 0.08 
Sense just after  application 3.71 ± 0.08 3.90 ± 0.09 
Sense in Long Term 3.65 ± 0.04 3.70 ± 0.06 
Irritation 0.00 ± 0.00 0.00 ± 0.00 
Shine on Skin 3.50 ± 0.13 3.41 ± 0.07 
Sense of Softness 4.52 ± 0.06 4.40 ± 0.08 
 
Table 4.22 Average Points of Panel Test by Volunteers for B1 and F2 
Parameters 
Average points for 
 Base ± SEM 
B1 
Average points for 
Formulation ± SEM 
F2 
Ease of application 4.30 ± 0.09 4.40 ± 0.08 
Spreadability 4.25 ± 0.12 4.33 ± 0.10 
Sense just after  application 3.68 ± 0.12 3.74 ± 0.15 
Sense in long term 3.87 ± 0.09 3.90 ± 0.09 
Irritation 0.00 ± 0.00 0.00 ± 0.000 
Shine on skin 4.58 ± 0.07 4.48 ± 0.07 
Sense of softness 4.70 ± 0.06 4.58 ± 0.07 
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Table 4.23 Average Points of Panel Test by Volunteers for B2 and F3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameters 
Average points for  
Base ± SEM 
B2 
Average points for 
Formulation ± SEM 
F3 
Ease of application 4.02 ± 0.05 4.18 ± 0.12 
Spreadability 4.36 ± 0.08 4.37 ± 0.10 
Sense just after  application 3.64 ± 0.16 3.78 ± 0.18 
Sense in long term 4.00 ± 0.10 4.07 ± 0.12 
Irritation 0.00 ± 0.00 0.00 ± 0.000 
Shine on skin 4.37 ± 0.10 4.34 ± 0.13 
Sense of softness 4.43 ± 0.10 4.41 ± 0.11 
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4.4.10  Statistical Evaluation 
Results of statistical evaluation have been shown in Tables 4.24, 4.25, 4.26, 4.27, 4.28. 
 
Table 4.24 Statistical Evaluations of Values of Melanin after Application 
of Formulations F1, F2 and F3 
 
 
 
p>0.05=No Variance; p<0.05=Significant Variance; SEM=Standard Error Mean 
 
 
 
 
 
 
 
 
 
Formulations ANOVA 
Paired Sample t-test 
0 
week 
2nd 
Week 
4th 
week 
6th 
week 
8th 
week 
10th 
week 
12th 
Week 
F1 
 
p>0.05 
  
 
 
     
F2 
 
p>0.05 
  
 
 
   
p˂0.05 
 
p˂0.05 
 
F3 
 
p˂0.05 
  
 
 
  
p˂0.05 
 
p˂0.05 
 
p˂0.05 
 
p˂0.05 
 
F1 
Mean 
± 
SEM 
 1.43 
± 
0.52 
1.84 
± 
0.45 
1.92 
± 
0.79 
2.12 
± 
0.69 
2.31 
± 
0.59 
2.73 
± 
0.79 
 
F2 
Mean 
± 
SEM 
 1.07 
± 
0.52 
-0.95 
± 
0.84 
-1.58 
± 
0.71 
-2.10 
± 
0.75 
-2.53 
± 
0.45 
-3.07 
± 
0.54 
 
F3 
Mean 
± 
SEM 
 -4.77 
± 
0.32 
-7.27 
± 
0.32 
-11.39 
± 
0.97 
-12.96 
± 
1.30 
-13.88 
± 
1.24 
-14.70 
± 
1.42 
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Table 4.25 Statistical Evaluation of Values of Erythema after Application  
of Formulations F1, F2, F3 
 
 
p>0.05=No Variance; p<0.05=Significant Variance; SEM=Standard Error Mean 
 
 
 
 
 
 
 
 
 
 
 
 
 
Formulations ANOVA 
Paired Sample t-test 
0 
week 
2nd 
Week 
4th 
week 
6th 
week 
8th 
week 
10th 
week 
12th 
Week 
 
F1 
 
p˂0.05 
  
 
 
  
p˂0.05 
 
p˂0.05 
 
p˂0.05 
 
p˂0.05 
 
F2 
 
p>0.05 
  
 
 
 
p˂0.05 
 
p˂0.05 
 
p˂0.05 
 
p˂0.05 
 
p˂0.05 
 
F3 
 
 
p˂0.05 
  
 
  
p˂0.05 
 
p˂0.05 
 
p˂0.05 
 
p˂0.05 
F1 
Mean 
± 
SEM 
 -0.89 
± 
0.52 
-2.36 
± 
0.80 
-4.97 
± 
1.25 
-7.76 
± 
0.34 
-8.39 
± 
1.43 
-10.63 
± 
0.79 
F2 
Mean 
± 
SEM 
 -0.61 
± 
0.06 
-1.08 
± 
0.13 
-1.87 
± 
0.08 
-2.44 
± 
0.25 
-2.62 
± 
0.32 
-3.12 
± 
0.47 
F3 
Mean 
± 
SEM 
 -3.65 
± 
0.23 
-4.90 
± 
0.32 
-6.06 
± 
0.31 
-7.10 
± 
0.58 
-8.45 
± 
0.60 
-10.54 
± 
0.81 
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Table 4.26 Statistical Evaluation of Values of Skin pH after Application  
of Formulations F1, F2, F3 
 
 
p>0.05=No Variance; p<0.05=Significant Variance; SEM=Standard Error Mean 
 
 
 
 
 
 
 
 
 
 
Formulations ANOVA 
Paired Sample t-test 
0 
week 
2nd 
Week 
4th 
week 
6th 
week 
8th 
week 
10th 
week 
12th 
Week 
 
F1 
 
p>0.05 
 
 
 
      
 
F2 
 
p>0.05 
 
 
 
 
 
 
     
p˂0.05 
 
F3 
 
p˂0.05 
 
 
 
    
p˂0.05 
 
p˂0.05 
 
p˂0.05 
F1 
Mean 
± 
SEM 
 -0.98 
± 
0.29 
-1.88 
± 
0.36 
-2.13 
± 
0.52 
-2.45 
± 
0.62 
-2.51 
± 
0.68 
-3.13 
± 
0.72 
         F2 
Mean 
± 
SEM 
 -0.73 
± 
0.65 
-0.94 
± 
0.65 
-1.24 
± 
0.57 
-1.80 
± 
0.55 
-2.23 
± 
0.30 
-2.37 
± 
0.60 
F3 
Mean 
± 
SEM 
 -2.17 
± 
0.14 
-3.07 
± 
0.18 
-3.83 
± 
0.26 
-4.04 
± 
0.67 
-4.52 
± 
0.71 
-5.92 
± 
0.65 
116 
 
 
 
 
Table 4.27 Statistical Evaluation of Values of Elasticity after Application of 
Formulations F1, F2, F3 
 
 
 
p>0.05=No Variance; p<0.05=Significant Variance; SEM=Standard Error Mean 
 
 
 
 
 
 
 
 
Formulations ANOVA 
Paired Sample t-test 
0 
week 
2nd 
Week 
4th 
week 
6th 
week 
8th 
week 
10th 
week 
12th 
Week 
F1 
 
p˂0.05 
 
 
 
 
 
   p˂0.05 p˂0.05 p˂0.05 
F2 
 
p˂0.05 
 
 
 
 
 
p˂0.05 p˂0.05 p˂0.05 p˂0.05 p˂0.05 p˂0.05 
F3 
 
p>0.05 
 
   
 
 
 
 
p˂0.05 p˂0.05 p˂0.05 
F1 
Mean 
± 
SEM 
 
3.91 
± 
0.46 
4.69 
± 
0.64 
5.49 
± 
0.86 
5.96 
± 
0.83 
6.03 
± 
0.72 
6.91 
± 
1.02 
F2 
Mean 
± 
SEM 
 
3.06 
± 
0.41 
4.01 
± 
0.50 
4.32 
± 
0.90 
5.76 
± 
1.14 
5.78
± 
0.51 
6.32
± 
1.21 
F3 
Mean 
± 
SEM 
 
3.13 
± 
0.37 
3.28
± 
0.64 
4.54
± 
0.73 
4.83
± 
0.55 
5.09
± 
0.73 
5.55 
± 
0.67 
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Table 4.28 Statistical Evaluation of Values of Skin Moisture after    
Application of   Formulations F1, F2, F3 
 
 
p>0.05=No Variance; p<0.05=Significant Variance; SEM=Standard Error Mean 
 
 
 
 
 
 
 
 
 
 
 
 
Formulations 
 
ANOVA 
Paired Sample t-test 
0 
week 
2nd 
Week 
4th 
week 
6th 
week 
8th 
week 
10th 
week 
12th 
Week 
F1 p>0.05 
 
 
 
   p˂0.05 p˂0.05 p˂0.05 
F2 p>0.05 
 
 
 
 p˂0.05 p˂0.05 p˂0.05 p˂0.05 p˂0.05 
F3 p>0.05 
 
 
 
   p˂0.05 p˂0.05 p˂0.05 
F1 
Mean 
± 
SEM 
 
2.34 
± 
0.52 
2.75
± 
0.69 
3.17 
± 
0.52 
4.33 
± 
0.49 
4.75 
± 
0.84 
6.27 
± 
0.89 
F2 
Mean 
± 
SEM 
 
2.71 
± 
0.80 
3.40
± 
0.77 
4.32 
± 
0.82 
4.47 
± 
0.88 
5.24 
± 
0.39 
5.79 
± 
0.42 
F3 
Mean 
± 
SEM 
 
3.19 
± 
0.55 
3.50
± 
0.55 
4.96
± 
0.62 
5.81
± 
0.82 
6.33
± 
0.97 
7.21
± 
0.96 
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Table 4.29 Statistical Evaluation of Values of Sebum after Application  
of Formulations F1, F2, F3 
 
 
 
p>0.05=No Variance; p<0.05=Significant Variance; SEM=Standard Error Mean 
 
 
 
 
 
 
 
 
 
 
 
 
Formulations 
 
ANOVA 
Paired Sample t-test 
0 
week 
2nd 
Week 
4th 
week 
6th 
week 
8th 
week 
10th 
week 
12th 
Week 
F1 
 
p>0.05 
 
      p˂0.05 
F2 p>0.05   
 
 
 
 p˂0.05 
 
p˂0.05 
 
p˂0.05 
F3 p>0.05  
 
p˂0.05 
 
p˂0.05 p˂0.05 p˂0.05 p˂0.05 p˂0.05 
F1 
Mean 
± 
SEM 
 
-1.38 
± 
0.66 
-1.48 
± 
0.98 
-2.96 
± 
0.75 
-3.81 
± 
0.97 
-4.02 
± 
1.08 
-4.91 
± 
0.81 
F2 
Mean 
± 
SEM 
 
-2.11 
± 
0.74 
-2.38 
± 
1.27 
-2.66 
± 
1.38 
-3.87 
± 
1.22 
-4.62 
± 
0.81 
-5.49 
± 
0.95 
F3 
Mean 
± 
SEM 
 
-0.87 
± 
0.90 
-1.60 
± 
0.81 
-2.19 
± 
0.90 
-2.95 
± 
0.81 
-3.49 
± 
0.80 
-4.66 
± 
0.61 
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Table 4.30 Statistical Evaluation of Values of SELS Parameters  
after Application of F1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
p>0.05=No Variance; p<0.05=Significant Variance; SEM=Standard Error Mean 
 
 
 
 
 
 
 
 
 
 
 
Parameters ANOVA 
Paired Sample t-test 
0 
week 
1st 
Month 
2nd 
Month 
3rd 
Month 
SEr p>0.05   p˂0.05 p˂0.05 
SEsc p>0.05  p˂0.05 p˂0.05 p˂0.05 
SEsm p>0.05   p˂0.05 p˂0.05 
SEw p˂0.05  p˂0.05 p˂0.05 p˂0.05 
SEr 
Mean 
± 
SEM 
 
-0.83 
± 
0.14 
-2.14 
± 
0.57 
-2.93 
± 
0.25 
SEsc 
Mean 
± 
SEM 
 
-1.10 
± 
0.82 
-2.65 
± 
0.75 
-3.62 
± 
1.18 
SEsm 
Mean 
± 
SEM 
 
1.38 
± 
0.41 
2.44 
± 
0.55 
3.85 
± 
0.50 
SEw 
Mean 
± 
SEM 
 
-1.18 
± 
0.19 
-2.30 
± 
0.33 
-3.86 
± 
0.51 
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Table 4.31 Statistical Evaluation of Values of SELS Parameters 
 after Application of F2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
p>0.05=No Variance; p<0.05=Significant Variance; SEM=Standard Error Mean 
 
 
 
 
 
 
 
 
 
Parameters ANOVA 
Paired Sample t-test 
0 
week 
1st 
Month 
2nd 
Month 
3rd 
Month 
SEr p>0.05  p˂0.05 p˂0.05 p˂0.05 
SEsc p˂0.05   p˂0.05 p˂0.05 
SEsm p>0.05  p˂0.05 p˂0.05 p˂0.05 
SEw p˂0.05    p˂0.05 
SEr 
Mean 
± 
SEM 
 -0.75 
± 
0.11 
-1.43 
± 
0.22 
-2.26 
± 
0.19 
SEsc 
Mean 
± 
SEM 
 -1.57 
± 
0.39 
-3.11 
± 
0.57 
-4.91 
± 
0.53 
SEsm 
Mean 
± 
SEM 
 0.43 
± 
0.16 
0.63 
± 
0.24 
0.65 
± 
0.14 
 
SEw 
 
Mean 
± 
SEM 
 -7.44 
± 
1.37 
-13.28 
± 
1.24 
-16.89 
± 
1.56 
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Table 4.32 Statistical Evaluation of Values of SELS Parameters  
after Application of F3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
p>0.05=No Variance; p<0.05=Significant Variance; SEM=Standard Error Mean 
 
 
 
 
 
 
 
 
Parameters  ANOVA 
Paired Sample t-test 
0 
week 
1st 
Month 
2nd 
Month 
3rd 
Month 
SEr p>0.05      
SEsc p>0.05      
SEsm p˂0.05    p˂0.05 p˂0.05 
SEw p˂0.05     p˂0.05 
SEr 
Mean 
± 
SEM 
 
-2.13 
± 
0.29 
-3.24 
± 
0.42 
-3.95 
± 
0.54 
SEsc 
Mean 
± 
SEM 
 
-1.57 
± 
0.66 
-2.64 
± 
0.86 
-3.72 
± 
0.51 
SEsm 
Mean 
± 
SEM 
 
2.82 
± 
0.90 
5.26 
± 
1.24 
6.14 
± 
1.23 
SEw 
 
 
Mean 
± 
SEM 
 
-2.38 
± 
0.36 
-3.99 
± 
0.51 
-6.99 
± 
1.15 
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4.5 DISCUSSION 
4.5.1 Assay of Plants Extracts 
The quantification and standardization of extracts of lycopene, carotenoids and ellagic 
acid in the samples of different crude extract of Lycopersicon esculentum, Carica papaya 
and Punica granatum was determined by using calibration curve (Bunghez, et al., 2011) 
The calibration curve obtained for the determination of lycopene was (y = 444.99x - 
36.846), (R2 = 0.997) for the quantification of lycopene in Lycopersicon esculentum 
extract. The % age amount of lycopene was calculated on the basis of absorbance of 
samples which were 78.07% and 70.07%. The determination of ellagic acid was (y = 
49.29x + 6.25), (R2 = 0.998) for the quantification of ellagic acid in Punica granatum 
extract. The amount of ellagic acid was calculated based on absorbance of sample and 
using the calibration curve. The percentage of ellagic acid found in Punica granatum 
extract was 84.48. 
4.5.2 Pseudo-Ternary Phase Diagrams 
The microemulsion existence region was determined by constructing phase diagrams. 
Figure 4.2 describes the pseudoternary phase diagrams with various weight ratios of 
tween® 80 to propylene glycol. The translucent region presented in phase diagram reveals 
the microemulsion existence region. No distinct conversion from water-in-oil (w/o) to oil-
in-water (o/w) microemulsion was observed. The rest of region on the phase diagram 
represents the turbid and conventional emulsions basedon visual inspection. The phase 
diagrams clearly indicated that microemulsion existence region increased with increasing 
in the weight ratio of surfactant/co-surfactant (Smix =2:1).  
Microemulsion region was determined for F3 microemulsion by using water/ Palm oil, 
Tween 80/ Propylene glycol. The phase diagrams clearly indicated that shaded 
microemulsion existence region and rest of the region was indicated turbid or 
macroemulsion region.The region of microemulsion increased with increase in the weight 
ratio of surfactant/co surfactant (Smix =5:1). This ratio was used for further preparation 
of formulation. Construction of pseudoternary phase diagrams is the best way to study all 
types of formulations that can originate from mixing of surfactants, water and oil and 
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these diagrams can cover the whole probabilities of mixing ratios (Abdulkarim, et al., 
2011).  
4.5.3 Organoleptic/ Physical Stability 
The freshly prepared bases were transparent in color and formulations (F1and F2) were 
reddish but F3 was yellowish in color. There was no change in color upto observation 
period of three months. This showed that all samples were stable at different storage 
conditions i.e. 80C, 250C, 400C and 500C throughout study period. No change in the color 
may be attributed to different factors contributing the microemulsion stability. As plant 
extracts contain anti-bacterial components which protect the formulations components 
from microbial growth and thus might inhibit the production of such substances which are 
able to change the color of the formulation during the storage time.  Visually no phase 
separation was observed in any sample kept at different temperatures i.e. 80C, 250C, 400C 
and 500C. There was no phase separation observed in any of the samples kept at 80C, 
250C, 400C and 500C up to observation period of three months with naked eye. It showed 
that all samples were stable at all storage conditions considering no phase separation as a 
parameter of stability. Previously described that microemulsions are thermodynamically 
stable system composed of fixed proportion of oil, surfactant/cosurfactant and water 
which tends to show no phase separation, phase inversion, aggregation, creaming and 
cracking of microemulsion formulations. All formulation were seen free from physical 
instabilities (Bajpai et al., 2011). 
Microemulsions were stored at different temperature i.e. 80C, 250C, 400C and 500C, 
visually observed all samples at definite intervals for clarity, tubidity and phase 
behaviour. All samples except the sample at 80C were shown with no change in clarity, 
tubidity and phase. According to previous report (Cui et al., 2011), the coagulation of the 
internal phase at low temperature might lead to turbidity and these microemulsions are 
recovered by heating. 
4.5.4  Centrifugation Test 
All the samples of bases and formulations kept at different storage conditions were 
centrifuged at 6000 rmp for 30 minutes at definite time intervals. No phase separation on 
centrifugation was seen in any of the samples during whole observation period of 90 
days. Centrifugation (phase separation test) is usually used to evaluate the physical 
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stability of heterogeneous systems in terms of phase separation. Although MEs presented 
a low viscosity level, the macroscopic observation showed no evidence of phase 
separation or any precipitation or flocculation phenomena even under stress conditions 
(Jadhav et al., 2010). Therefore, the centrifugation testing indicated good physical 
stability of both preparations stored at different temperatures.  
4.5.5  pH Measurements 
Regarding stability studies pH values of the freshly prepared bases (B1 and B2) was 5.73 
and 5.81 respectively which is near to the pH range of the skin. pH value of the bases at 
different conditions gradually decreased  with time and increasing temperature 40°C and 
50°C. 
pH of the freshly prepared formulations F1, F2 and F3 was found to be 5.66, 5.68 and 
5.71 respectively. pH value of the formulations also decreased with time and temperature 
increment for samples stored at different  conditions. More prominent reduction occurred 
at 40°C and 50°C. 
Incorporation of extract did not significantly affect the observed pH value of the 
microemulsions but slight reduction in pH value occurred. Bases and formulations 
showed no significant variations in pH by applying ANOVA test.  
The slight reduction in pH of the formulations at different storage conditions with the 
passage of time might be due to the oxidation of oils or degradation due to microbial 
growth with passage of time (Dawkins et al., 2003), (Omodamiro and Amechi, 2013) 
while at 40°C and 50°C but decrease in pH values of bases might be due to oils because 
bases were without extract. This degradation may be due to production of acidic by 
products from extracts as reported in the previous work (Akhtar et al., 2008). Skin pH 
values are variable as reported in literature with a broad range of pH 4.0 to 7.0 (Lambers 
et al., 2006).  
4.5.6  Electrical Conductivity Measurement  
In this study, conductivity test was performed for all samples of microemulsions i.e, B1, 
B2 and F1, F2, F3 kept at different storage conditions. Conductivity values of freshly 
prepared B1, F1 and F2 were 6.62, 5.08 and 5.3 respectively and the conductivity values 
of B2 and F3 were 18.4 to 19.7 respectively. Slight gradual increment was observed in 
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conductivity values with increasing temperature but conductivity values were low at 8°C 
and 25°C than 40°C and 50°C. These differences in conductivity values might be 
attributed to slow movements of ions. 
It was seen that no dramatically increase or decrease during 90 days occurred in 
conductivity values. Thus, this study revealed that MEs were stable and no percolation of 
water occurred. Percolation is considered as sign of ME instability. 
Applying one way ANOVA, insignificant differences were shown during study period 
which indicated that the samples were stable.  
Previously revealed interpretation of the increasing conductivity is related to clustering of 
the microemulsion droplets and migration of charges within the aggregates and 
percolation phenomenon observed in ME system (Mehta et al., 2010). The increase in 
conductivity values during storage time is ascribed due to i) diffusion of an electrolyte, ii) 
the coalescence of internal and aqueous phases iii) destruction of oil film because of 
osmotic pressure and the leakage of internal aqueous phase (Pays et al., 2002; Wen and 
Papadopoulos, 2001). Khalil et al. (2012) have already reported this increase in 
conductivity values. In this work no such sudden and sharp increase in conductivity was 
observed, consequently it might be assumed that MEs studied in this work were stable 
within the studied conditions. 
4.5.7 Rheological study 
Rheological parameters i.e. flow index and consistency index were calculated by applying 
power law in Rheocalc software of fresh and stored samples.  Rheological studies were 
performed at 25ºC for F1, F2, F3 and B1, B2. Changes in viscosity were noted when 
shear stresses were applied. Rheogram of viscosity versus shear rate were obtained for all 
the formulations F1, F2, F3 and bases B1, B2. These samples have shown that viscosities 
were increased with increasing shear stresses at different temperatures for 45 days but at 
90 days, more increment in viscosities values observed at higher temperature conditions. 
All bases and formulations have shown non-Newtonian flow at different storage 
temperature conditions and at different time intervals for 90 days.  Flow index values of 
all samples were found to be greater than 1 (n > 1) which showed non-Newtonian flow 
i.e., dilatants behaviour. 
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The mean viscosity values of freshly prepared bases and formulations were 4.51 ± 0.12 
cps and 4.69 ± 0.05 cps respectively. By applying one way ANOVA, no significant 
difference was found between the viscosities of bases and formulations containing 
different plants extracts (p>0.05).  
Korac and Khambholja, 2011 described ME systems exhibited a non-linear relationship 
between the viscosity and shear rate showing non-Newtonian flow characteristic. 
Previously explained in literature, this increase in the viscosity with temperature has been 
reported.The increase in temperature may increase viscosity by way of clusters of the 
droplets which lead to network structure (Moulik and Pakshit, 2006). It is well known that 
increase in volume of dispersed phase in microemulsion increases the viscosity of the 
system. The viscosity change with water content is further correlated to the compositional 
and structural effects derived from interfacial packing. The increase in viscosity 
measurement is sharper in the case of Tween 40®, 60®, and 80® as compared to Tween 
20. In general, Tween surfactants have different hydrophobic groups. However, Tween 
40, 60, and 80 have bulkier side chains which are responsible for different interfacial 
packing and thus, these systems show a sharper change in the viscosity values as 
compared to Tween 20 (Mehta et al., 2010). Mortazavi et al. (2013) has reported that, the 
Tweens based on their hydrophilic nature and large number of polyoxyethylene groups 
available in their structure tends to absorb the aqueous phase and increase the viscosity by 
reducing the free-water of the formulations. Tween and propylene glycol were the best 
surfactants and co-surfactant used respectively, which resulted in the formation of 
transparent stable microemulsions. Tween80 showed suitable apparent viscosities as well 
as good physical appearances. 
Eshuis and Mellema (1984) already revealed that viscosity of the systems was 
independent of evaporation and noted the absence of crystal formation or flocculation 
(Dhamankar et al., 2003). It is already reported from the rheological measurements that 
the length scale of structure increases with rising temperature. These effects are often 
attributed to a transition from spherical micelles to rods or cylinders. By increasing the 
temperature viscosity attains higher value.  
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4.5.8  Globule Size, Zeta Potential and Polydispersity Index 
Globule size, Zeta potential and polydisperisty index (PI) of freshly prepared 
formulations and bases i.e. F1, F2, F3, B1 and B2 were determined. The zeta poetential 
and average globule size of F1 was -0.185mV and 32.67 ± 0.2 nm with PI 0.941, for  F2 -
0.213mV and 37.82 ± 0.2nm with PI 0.724 and F3 -03 mV and 24.36 ± 0. nm with PI 
0.36, B1 -0.134mV and 24.36 ± 0.4nm with PI 1.00 and B2 -5.2mV and 18.16  ± 0.4nm 
with PI 0.22. 
Zeta potential is an important parameter used for assessing emulsion stability since 
electric charges on the particles affect the rate of flocculation (Ahmad et al., 2011). The 
large value of zeta potential indicates good stability of microemulsion. Presence of zeta 
potential prevents the aggregation and coalescence of globules (Kalr et al., 2010). 
The ratio of standard deviation to mean droplet size is called Polydispersity. It indicates 
the uniformity of droplet size within the formulation (Kalr, et al., 2010). In literature, the 
mean particle size of formulations was reported from 7 to 79 nm.  In literature particle 
size of drug free MEs and drug loaded MEs were determined and there was no significant 
difference observed in average particle size after loading the drug. The formulation had 
the lowest average particle size 7.03 ± 0.2nm with PI of 0.362 ± 0.032. PI is a measure of 
particle homogeneity and it varies from 0.0 to 1.0. The closer to zero the PI value the 
more homogenous are the particles (Moghimipour et al., 2013; Nagariya et al., 2010). 
The results of this study are also in consistence to the values reported in literature. 
4.5.9  Scanning Electron Microscopy (SEM) 
SEM is a powerful method for visualizing the structure of microemulsions. The structures 
of micro globules of (F1, F2 and F3) were also confirmed with SEM image. Increased 
size and irregular shaped of globules due to agglomeration of micro globules. The images 
showed the residual of extract as well as excipients. This work already performed and 
explained shape of microemulsion micelles and hexagonal structures by Moghimipour et 
al., 2013. Patel et al. (2012) also performed SEM analysis of their gel formulation and 
explained the same phenomenon which supports our findings. 
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4.5.10  X-Ray Diffraction (XRD) 
XRD is used to determine the presence of any crystal in formulations, XRD graph of 
microemulsion containing extracts (F1, F2 and F3) showed that there were no crystalline 
structure in the microemulsions and it was found that microemulsions containing extracts 
showed amorphous in nature.  It is already reported in literature that XRD is used to 
differentiate crystalline and amorphous nature of any subsatance (Lonsdale, 1968). 
4.5.11 Thermal Analysis (TGA) and Differential Scanning Calorimetry 
(DSC) 
The melting point range of Lycopene and ellagic acid is 172º-175ºC and 360ºC, 
respectively. From thermogram it was clear that melting points of both Lycopene and 
ellagic acid were below the reported values might be due to presence of both compounds 
in liquid form which showed the loss of crystalline structure and became amorphous in 
nature. The amorphous nature of the extract was further confirmed with DSC and TGA 
thermo grams of (F1, F2 and F3) and it showed that there was no sharp peak indicating 
melting point of any crystalline substance as shown in results. 
4.5.12 Refractive Index (RI) 
The refractive index (RI) of the B1, B2, and F1, F2 and F3 was found in range of 1.4 to 
1.45 respectively which showed that the microemulsions were transparent. This work 
supported that most transparent media when viewed under visible light have refractive 
indices between 1 and 2 (Hashem et al., 2011; Katakam and Narendra, 2011). 
4.5.13  Spreadability Test 
Spreadability is defined as the quality of being easy to spread or apply on a surface. 
Spreadability of B1, B2, F1, F2 and F3 was found in range of 5cm to 5.5cm respectively. 
Easy spreadability is one of important parameter for characterization of microemulsion 
and gels (Waghmare et al., 2011). 
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4.5.14 Dermatological Study 
4.5.14.1 Patch Test 
In this study patch tests were performed on forearms of volunteers for 48 hours for base 
B1, B2 and formulation F1, F2 and F3 to check the cosmetic safety of the formulation and 
the base on human skin. It was found that erythematic level was decreased after the 
application of F1, F2 and F3 by the end of 48 hours as compared to B1 and B2. But with 
paired sample t-test it was evident that the effects of F1 and F2 were significant with 
respect to B1. There were no significant results of F1 and F2 with respect to B1 of 
melanin as the p values were greater than 0.05. 
 After 48 hours of application of F3 and B2, it was found that erythema and melanin 
contents decreased by comparison to B2. With paired sample t-test, for melanin and 
erythema contents, P values were less than 0.05 which indicated significant results of 
melanin and erythema.  
 It was concluded that the formulations (F1, F2, and F3) and the bases (B1, B2) produced 
no skin irritation after performing patch test of 48 hours, so both bases and formulations 
can be used safely on human cheeks for in-vivo dermatological evaluation. 
4.5.14.2 Melanin 
 Melanocytes are present in the basal layer of the epidermis. These melanocytes 
synthesize a special pigment called melanin which is responsible for skin colour. 
Different chemical synthetized agents used for skin whitening effects but these agents 
have many side effects. A change is being observed recently to use plant extracts as skin 
whitening agents in different types of formulations (Parvez et al., 2006). 
In this study, the effects of bases and formulations on the production of skin melanin were 
examined. The effects on melanin were measured for 12 weeks at different time intervals 
in each individual after application of the B1, B2 and F1, F2 and F3. It was found that 
bases B1 and B2 have increasing effects on melanin throughout the study period of 
twelve weeks of human volunteers as well as formulations F1 and F2 have also increasing 
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effects on human melanin while formulation F3 has decreasing effects throughout the 
study period. 
With the help of one way ANOVA test it was found that B1 and F1 and F2 produced no 
significant effects on skin melanin content with respect to time for twelve weeks. With 
the help of paired sample t-test, insignificant differences were observed on the effects of 
B1 and F1 on melanin but F2 showed significant differences on melanin with respect to 
base B1 only in 8th and 10th weeks of study period.  
After application of F3, a gradual reduction in melanin contents was observed. With the 
help of ANOVA test, it was found that F3 produced significant differences (P< 0.05) on 
skin melanin contents with respect to time. With the help of paired sample t-test, 
significant differences were observed between the melanin effects of base and the 
formulation at 6th, 8th, 10th and 12th weeks in the study period. It can be concluded that F3 
showed whitening effect on skin. 
It can be assumed that the decrease in skin melanin content after application of F3 may be 
attributed to the antioxidant activity of Punica granatum extract which is rich in ellagic 
acid, punicagalin and vitamins C (Lansky and Newman, 2007). 
Ellagic acid causes inhibition of tyrosinase and melanin synthesis thus inhibiting 
melanogenesis in human skin (Kasai et al, 2006). A pomegranate extract (PE) from the 
rind containing 90% ellagic acid was tested for its skin-whitening effect. PE showed 
inhibitory activity against mushroom tyrosinase in- vitro and the inhibition by the extract 
was comparable to that of arbutin, which is a known whitening agent (Yoshimura et al., 
2005).  
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4.5.14.3 Erythema 
Inflammation may result in hyperpigmentation through several mechanisms. Among them 
is direct stimulation of melanocytes by inflammatory mediators such as Interleukin- 1-
alpha, endothelin-1, and stem cell factor. Reactive oxygen species, such as superoxide 
and nitric oxide, generated in damaged skin (for example from UV exposure) or released 
as by-products from inflammatory cells are also known stimulators of Melanocytes 
(Ortonne and Bissett, 2008). 
In this study, irritation was constantly monitored every 2nd week for bases and 
formulations during the period of application. It was found that bases B1 and B2 have 
increasing effects on erythema throughout the study period of twelve weeks of human 
volunteers while formulations F1, F2 and F3 has decreasing effects on melanin during the 
study period. 
When one way ANOVA was applied, it was found that there were significant (P< 0.05) 
differences with respect to time between F1, F2 as compared to B1 which showed 
insignificant results. With the help of paired sample t-test it was evident that after 
application of  F1 and F2 there was significant reduction in irritation with respect to base 
in 8th, 10th and 12th week of the study period. 
With the help of ANOVA test it was found that the B2 produced insignificant effects on 
skin erythema, whereas application of F3 produced significant effects on skin erythema 
with respect to B1. With the help of sample paired t-test, it was evident that there was 
insignificant variation in irritation with respect to base and formulation during 0, 2nd, 4th 
weeks but significant changes occured during 6th, 8th, 10th and 12th week during the study 
period. 
Lycopene is a C40 carotenoid commonly found in red-colored fruits, which is up to 10-
fold more efficient at quenching singlet oxygen than b-carotene or a-tocopherol. A 
preventive role of lycopene against photo damage due to inhibition of UVB-induced 
ornithine decarboxylase and myeloperoxidase, reducing inflammatory responses and skin 
thickness among other effects (Lopes et al., 2010). Several epidemiological studies report 
that lycopene-rich diets have beneficial effects on human health. A possible role has been 
suggested for tomatoes and tomato products in preventing cardiovascular disease and 
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protecting against some types of cancer (based on lycopene content) as well as against 
ultraviolet light-induced erythema (Periago et al., 2004). A high dietary intake of 
carotenoids (usually in supplement form) has been shown to significantly increase the 
skin’s endogenous level of UV photoprotection by reducing its sensitivity to UV-induced 
erythema (Alaluf et al., 2002). The protective effect observed in the present study for 
lycopene-rich tomato paste is consistent with data from other studies that reported 
protection against erythema formation upon supplementationwith ß-carotene (Stahl et al., 
2001). 
As reported in literature that pomegranate extract is rich in ellagic acid, vitamin C and 
contain potent antioxidant which have anti-inflammatory effects on skin and therefore 
reduced erythema (Lansky and Newmann, 2007; Kasai et al, 2006). Pomegranate has 
antioxidant, anti-inflammatory and anti-carcinogenic potential (Aslam et al., 2006). 
4.5.14.4 Skin pH   
pH of Stratum corneum is believed to be of central importance for skin barrier capacity. 
Skin diseases characterized by a perturbed skin barrier function, such as atopic dermatitis, 
irritant contact dermatitis, and ichthyosis vulgaris, express an elevated skin surface pH. 
Elevation of stratum corneum pH by topically applied formulations has been claimed to 
decrease skin barrier capacity as measured by an increased transepidermal water loss 
(Plasencia et al., 2007). The pH of human skin ranges from 4.5 to 6.0 and 5.5 is 
considered to be average pH of the skin (Matousek et al., 2003). 
In this study, it was found that bases B1 and B2 have increasing effects on skin pH 
throughout the study period of twelve weeks of human volunteers while formulation F1, 
F2 and F3 has decreasing effects on skin pH throughout the study period. 
With the help of one way ANOVA test it was found that all the samples of bases as well 
as formulations showed insignificant differences in skin pH values throughout the study 
period of 90 days with respect to time. With the help of paired sample t-test it was evident 
that F1 showed insignificant differences in all weeks while F2 showed significant 
differences in only 12th weeks with respect to B1. Non-significant differences in the skin 
pH values were observed in 0, 2nd, 4th and 6th weeks with respect to B2 and F3 showed 
significant results in 8th, 10th and 12th weeks in 90days study period. 
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It can be concluded that significant differences of F3 with respect to B2 in skin pH might 
be attributed to the presence of ellagic acid rich extract. In literature it has been reported 
that the antioxidant activities of Punica granatum extract is due to the presence of ellagic 
acid, punicagalin and vitamins C (Lansky and Newman, 2007). 
4.5.14.5 Elasticity  
Collagens account for up to 75% of the weight of the dermis, and are responsible for the 
elasticity of the skin. The collagen bundles are held together by elastic fibers. These are 
made of a protein called elastin. The younger a person is and the healthier the life style is 
(healthy food, good skin care, sufficient sleep, no drugs etc.) the higher elasticity will be 
(Courage and Khazaka, 2005). 
In this study, it was found that bases B1 and B2 as well as formulations F1, F2 and F3 all 
have increasing effects on human skin elasticity throughout the study period of twelve 
weeks.  
With the help of one way ANOVA test it was found that B1 has insignificant changes in 
elasticity values with respect to the time, whereas F1 and F2 showed significant variation 
throughout the study period of 90 days with respect to time. With the help of paired 
sample t-test it was evident that significant differences in the elasticity values were 
observed in8th, 10th and 12th weeks after application of F1 with respect to B1.  
With the help of one way ANOVA test it was found that B2 and F3 showed non-
significant changes in elasticity values with respect to the time throughout the study 
period of 90 days. With the help of paired sample t-test it was evident that F3 showed 
significant differences in 8th, 10th and 12th weeks with respect to B2 in 90 days study 
period. 
Priyanka et al. (2012) reported that the use of carotenoids, particularly lycopene in the 
cosmetic composition is intended for the effects of epidermal renewal and to support the 
regeneration of skin and thickness of epidermis layer. Lycopene is an agent which has 
properties which are effective against UV rays.  
Aslam et al. (2006) described that extract of pomegranate peel has a potent dermal effect 
stimulating dermal fibroblast proliferation and collagen synthesis while inhibiting the 
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major collagen-degrading enzyme in skin but does not stimulate keratinocyte 
proliferation. 
4.5.14.6 Moisture Contents 
The moisturizing treatment involves repairing the skin barrier, retaining/increasing water 
content, reducing TEWL, restoring the lipid barriers' ability to attract, hold and 
redistribute water, and maintaining skin integrity and appearance. 
Kulkarni et al. (2005) has already mentioned that microemulsions are well suitedfor the 
preparation of various cosmetic products for use as moisturizing and smoothing agents, as 
sunscreens as antiperspirants and as body cleaning agents. 
In this study, after application of the bases B1, B2 and formulations F1, F2 and F3, it was 
found that bases as well as formulations have increasing effects on skin moisture content 
throughout the study period of twelve weeks in human volunteers.  
After applying the statistical ANOVA tests, it was found that the formulations as well as 
bases showed insignificant differences in moisture contents values with respect to time 
throughout the study period of 90 days. With the help of paired sample t-test, it was 
evident that F1showed significant differences on the moisture values with respect to 
B1only in 6th, 8th, 10th and 12th weeks and F2 also showed significant values in 4th, 8th, 
10th and 12th week with respect to B1. F3 also showed significant differences in 8th, 10th, 
and 12th weeks with respect to B2. 
Lycopersicon esculentum is an important source of lycopene and beta-carotenes which act 
as sunscreens and high antioxidants. These agents are used to reduce risk of damage of 
collagens by combating with the production of free radical molecules. It is necessary to 
support the antioxidants level in the skin (Priyanka et al., 2013; Schwarz et al., 2001).  
Skin moisturizing, sun protection and anti-wrinkle, stain and frekless effects are mainly 
attributed to ellagic acid (Yoshimura et al., 2005).  
4.5.14.7 Sebum Contents 
Face is covered by lipid film derived from sebum and epidermal lipid. Of the two, sebum, 
which is secreted by the sebaceous glands, is the major component of the lipid film. 
Sebum secretions vary individually according to age, sex, inherited traits, and 
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topographical variations of the skin (Youn et al., 2005). Sebum, the product of sebaceous 
glands, is a complex of various lipids that are thought to act as an epidermal and/or 
follicular lubricant (Robert et al., 2000). 
In this study, it was found that bases as well as formulations have decreasing effects on 
skin sebum contents throughout the study period of twelve weeks in human volunteers. 
With the help of one way ANOVA test it was found that B1 and B2 showed insignificant 
differences in sebum content values with respect to time. Also F1, F2 and F3 showed 
non-significant differences throughout the study period of 90 days with respect to time. 
With the help of paired sample t-test it was evident that F1 showed significant differences 
on sebum contents values only in12th weeks as compared to B1while F2 showed 
significant difference on sebum contents in 10th and 12th weeks with respect to B1 and F3 
showed significant differences with respect to B2 in all weeks throughout the study 
period of 3 months. 
4.5.14.8 Surface Evaluation of Living Skin (SELS) 
Skin surface is explained mainly by four different parameters like roughness (SEr), 
scaliness (SEsc), smoothness (SEsm) and wrinkling (SEw).  SELS are used to evaluate 
quantitatively and qualitatively of the skin surface (Song et al., 2013). 
SELS parameters SEr, SEsc, SEsm and SEw were measured before application of bases 
as well as formulations at 0 hour and then at 1st, 2nd and 3rd months for 3months study by 
Visioscan VC 98 (Courage and Khazaka, 2000). 
In this study all four parameters of SELS are improved by the application of F1, F2 and 
F3. The F1, F2 and F3 showed decrease in mean values of skin roughness (SEr) which 
indicated that the formulation possess anti aging properties.With the help of ANOVA test, 
it was found that B1, B2 and F1, F2 and F3 showed non-significant differences in SEr 
with respect to time. With the help of sample paired t-test, it was evident that FI showed 
significant differences with respect to B1 in 2nd and 3rd month and F2 also showed 
significant differences in 1st, 2nd and 3rd month in comparison to B1. But F3 showed 
insignificant difference in SEr with respect to B2. 
136 
 
 
 
SEsc (scaliness) evaluates Stratum corneum hydration level, the smaller SEsc; the more is 
the hydration level with less scaliness.  Decrease in skin scaliness values was observed 
after application of F1, F2 and F3. With the help of ANOVA test, it was found that F2 
and F3 showed significant differences with respect to time and F1showed insignificant 
differences with respect to time in SEsc. With the sample t-test, it was found that F1 and 
F2 showed significant differences in 2nd and 3rd month when compared to B1 while F3 
showed insignificant differences with respect to B2 in SEsc values. 
SEsm (smoothness) is the measurement of the depth of wrinkles in the skin. More is the 
smoothness of skin less will be the depth of wrinkles. In this study, after the application 
of F1, F2 and F3 increase in values of skin smoothness was observed.  
Statistically after applying the ANOVA, it was found that F1, F2 and F3 showed 
significant differences and bases B1 and B2 showed insignificant differences with respect 
to time. With the help of sample t-test, it was found that F1 and F3 showed significant 
differences in 2nd and 3rd months and F2 showed significant differences in only 3rd week 
with respect to B1 and B2. 
SEw (skin wrinkle) is the marker of the number and width of skin wrinkles. Greater the 
value of SEw less will be the smoothness of skin and vice versa (Korać and Khambholja, 
2011). After applying F1, F2 and F3, decrease in SEw values was observed throughout 
study period. After applying ANOVA, it was found that F1, F2 and F3 showed significant 
effects with respect to time while bases B1 and B2 showed insignificant differences with 
respect to time. By applying paired sample t-test, F1 showed significant differences in 1st, 
2nd and 3rd month and F2 showed significant differences only in 3rd month in comparison 
to B1. F3 showed significant differences only in 3rd month in respect to B2.  
A prolonged exposure to ultraviolet (UV) radiations lead to several deleterious effects to 
the human skin, including damage to the DNA, premature skin aging, and skin cancer. 
Because naturally occurring cutaneous compounds that counteract these effects are 
continuously depleted by UV radiation and other harmful environmental factors, topical 
application of antioxidants can replenish cutaneous stores and reduce/prevent UV-
induced skin damage. Among many available antioxidants, lycopene has aroused great 
interest because of its strong in-vitro antioxidant activity. Lycopene against photodamage 
due to inhibition of UVB-induced ODC and myeloperoxidase, reducing inflammatory 
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responses and skin thickness among other effects. In addition, it was recently 
demonstrated that lycopene content of Lycopersicon esculentum in the skin was inversely 
proportional to skin roughness; supporting the hypothesis that lycopene may be able to 
reduce skin aging and formation of furrows and wrinkles (Lopes et al., 2010).  
Rubbing the pulp of raw Carica papaya improves pimples as well as wrinkles. Papaya 
works as a good bleaching agent also. Experts suggest that Carica papaya can help in 
removing dead worn-out skin cells and replace it with healthy new cells (Aravind et al., 
2013). 
 Plant botanicals have been used in preserving and enhancing human skin as plant 
botanicals have many useful properties, such as sunscreen, anti-aging, moisturizing, anti-
oxidant and anti-cellulite property. Topical formulations developed for facial use, 
typically claim to encourage more even skin tone, improve skin texture, increase skin 
glow, decrease skin wrinkling and provide anti-aging benefits. Plant botanicals are 
usually incorporated into moisturizing formulations designed to achieve the above 
mentioned claims (Waqas et al., 2010). The role of Punica granatum extract is mainly 
attributed to its antioxidant activity, particularly its potential antioxidant ellagic acid, 
punicalagin, and vitamin C (Lansky and Newman, 2007). Skin whitening, moisturizing, 
sun protection and anti wrinkle, stain and freckles effects are mainly attributed to ellagic 
acid (Yoshimura et al., 2005). 
4.5.14.9 Panel Test 
A questionnaire containing seven questions was prepared and two copies of this form 
were given to each volunteer for sensory evaluation of base and each formulation. 
Average points were calculated from the points assigned by each volunteer for each 
question for formulations F1, F2 and F3 and base B1 and B2. The results were shown in 
Table 4.21, 4.22 and 4.23. 
Average points for the first question, i.e. ease of application of formulations (F1, F2 and 
F3) and bases (B1, B1, B2) were found to be 4.48, 4.30, 4.18 and 4.50, 4.40, 4.02 
respectively. This indicated that formulations and bases can be easily applied on the skin. 
Average points regarding spreadability were 4.40, 4.33, 4.37 for formulations and 4.38, 
4.25, 4.36 for bases which means that the formulations spreaded on skin better than the 
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bases. Average points for sense of feel just after application were 3.90, 3.74, 3.78 for the 
formulations and 3.71, 3.68, 3.64 for the bases. This indicated that formulations were felt 
well on the skin than bases. Average points for the sense in long-term application were 
3.70, 3.90, 4.07 and 3.65, 3.87, 4.00 for the formulations and bases respectively. This 
showed that formulations produced more pleasant feeling on application to skin than the 
bases. There was no irritation on the skin as both of formulations and bases were assigned 
0 points for irritation by all the volunteers. Shine on skin was 3.41, 4.48, 4.34 for the 
formulations and 3.50, 4.58, 4.37 for the bases. This was expected since the bases 
contained higher quantity of oil than the formulations. Similarly, the bases lead to more 
softness of the skin than formulations. The average points for the bases were 4.52, 4.70, 
and 4.43 while it was 4.40, 4.58, and 4.41 for the formulations.  
It was found from paired sample t-test that there was an insignificant difference between 
the average points of sensitivity for bases and formulations. It was concluded that there 
was no big variation between bases and formulations regarding the sensory evaluation. 
Both behaved same for sensitivity. Base and formulation showed that p>0.05. 
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5 CONCLUSION 
It can be concluded that; 
 It is possible to formulate topical MEs containing 50% hydro-alcoholic extract of Punica 
granatum and n-hexan extracts of Lycopersicon esculentum and Carica papaya having 
thermodynamically stability with 3 months storage. 
 The further studies such as irritability to skin, skin rejuvenation efficiency, and 
acceptance from the volunteers/consumers have evaluated the value of our prepared MEs. 
None of the MEs was found irritant to the skin. 
   The observed results lead us to conclude that the selected plants extracts have good 
effects when applied topically to human skin to improve aging effect, inflammation 
elasticity and whitening effects. 
 In-vivo effects of the prepared MEs produced good effects on other parameters of skin 
surface parameters SELS (SEr, SEsc, SEsm and SEw).   
5.1 Future Perspectives 
Though sufficient data has been generated in this study regarding development of plant 
extract loaded topical MEs with good stability but still some other below studies could be 
performed in future; 
 In vitro permeability study of MEs 
 HPLC chromatographic analysis of active ingredients from plant extrats 
 MEs based gels and creams formulations 
 
 
 
 
 
140 
 
 
 
6  REFERENCES  
Abdulkarim, M. F.,   Abdullah, G.  Z., Sakeena, M. H. F., Chitneni, M., Yam, M. F., 
Mahdi, E. S., Salman, I.  M., Ameer, O. Z., Sattar, M. A., Basri, M. and Noor, A. M. 
(2011). Study of Pseudoternary Phase Diagram Behaviour and the Effect of Several 
Tweens and Spans on Palm Oil Esters Characteristics. International Journal of Drug 
Delivery, 3: 95-100. 
Afaq, F. and Mukhtar, H. (2002). Photo-chemoprevention by botanical anti-oxidants. 
Skin Pharmacology and Applied Skin Physiology, 15: 297-306. 
Ahmad, J., Kohli, K., Mir, S. R. and Amin, S. (2011). Formulation of Self-
Nanoemulsifying Drug Delivery System for Telmisartan with improved dissolution 
and oral bioavailability. Journal of Dispersion Science and Technology, 32(7): 958-
968. 
Akhtar, N., Ahmad, M., Gulfishan, Masood, M. I. and Aleem, M. (2008). Formulation 
and in-vitro evaluation of a cosmetic emulsion from almond oil. Pakistan Journal of 
Pharmaceutical Sciences, 21: 430-437. 
Alaluf, S., Heinrich, U., Stahl, W., Tronnier, H. and Wiseman, S. (2002). Dietary 
carotenoids contribute to normal human skin color and UV photosensitivity. The 
Journal of nutrition, 132(3): 399-403. 
Aravind, G., Bhowmik, D., Duraivel, S. and Harish, G. (2013). Health Benefits and 
Medicinal Properties of Carica papaya. Annals of Plant Sciences, 2(02). 
Araya, H., Tomita, M. and Hayashi, M. (2005). The novel formulation design of O/W 
microemulsion for improving the gastrointestinal absorption of poorly water soluble 
compounds. International journal of pharmaceutics, 305(1): 61-74. 
Aslam, M. N., Lansky, E. P. and Varani, J. (2006). Pomegranate as a cosmeceutical 
source: pomegranate fractions promote proliferation and procollagen synthesis and 
inhibit matrix metalloproteinase-1 production in human skin cells. Journal of 
ethnopharmacology, 103(3): 311-318. 
141 
 
 
 
Aslam, M. N., Lansky, E. P. and Varani, J. (2006). Pomegranate as a cosmeceutical 
source: pomegranate fractions promote proliferation and procollagen synthesis and 
inhibit matrix metalloproteinase-1 production in human skin cells. Journal of 
Ethnopharmacology, 103(3): 311-318. 
Aslam, M. N., Lansky, E. P. and Varani, J. (2006). Pomegranate as a Cosmeceutical 
Source: Pomegranate Fractions Promote Proliferation and Procollagen Synthesis and 
Inhibit Matrix Metalloproteinase-1 Production in Human Skin Cells. Journal of 
ethnopharmacology, 103(3): 311-318. 
Aviram, M., Dornfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., Coleman, R., 
Tony, H., Dita, P. and Fuhrman, B. (2000). Pomegranate juice consumption reduces 
oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies 
in humans and in atherosclerotic apolipoprotein E–deficient mice. The American 
Journal of Clinical Nutrition, 71(5): 1062-1076. 
Azeem, A., Rizwan, M., Ahmad, F. J., Khan, Z. I., Khar, R. K., Aqil, M. and 
Talegaonkar, S. (2008). Emerging role of microemulsions in cosmetics. Recent 
patents on drug delivery and formulation, 2(3): 275-289. 
Bajpai, S. K., Bajpai, M. and Sharma, L. (2011). In situ formation of silver 
nanoparticles in poly (N-isopropyl acrylamide) hydrogel for antibacterial applications. 
Designed Monomers and Polymers, 14(4): 383-394. 
Baumann, L. (2007). Skin ageing and its treatment. The Journal of pathology, 211(2): 
241-251. 
Baumann, L. S. (2007). Less‐known botanical cosmeceuticals. Dermatologic Therapy, 
20(5): 330-342. 
Beguin, A. (2005). A novel micronutrient supplement in skin aging: a randomized 
placebo‐controlled double‐blind study. Journal of cosmetic dermatology, 4(4): 277-
284. 
Bickers, D. R. and Athar, M. (2006). Oxidative stress in the pathogenesis of skin 
disease. Journal of Investigative Dermatology, 126(12): 2565-2575. 
142 
 
 
 
Bikle, D. D. (2004). Vitamin D and skin cancer. The Journal of nutrition, 134(12): 
3472S-3478S. 
Bolzinger, M. A., Briançon, S., Pelletier, J., Fessi, H. and Chevalier, Y. (2008b). 
Percutaneous release of caffeine from microemulsion, emulsion and gel dosage forms. 
European Journal of Pharmaceutics and Biopharmaceutics, 68(2): 446-451. 
Bolzinger, M. A., Carduner, T. C. and Poelman, M. C. (1998a). Bicontinuous sucrose 
ester microemulsion: a new vehicle for topical delivery of niflumic acid. International 
journal of pharmaceutics, 176(1): 39-45. 
Boonme, P. (2007). Applications of microemulsions in cosmetics. Journal of 
Cosmetic Dermatology, 6(4): 223-228. 
Bunghez, I. R., Raduly, M., Doncea, S., Aksahin, I. and Ion, R. M. (2011).  Lycopene 
determination in tomatoes by different spectral techniques (UV-VIS, FTIR and 
HPLC). Digest Journal of Nanomaterials and Biostructures (DJNB), 6(3). 
Chan, I. P., Wangu, C. and Seong, J. L. (2003). Emulsion stability of cosmetic creams 
based on water-in-oil high internal phase emulsions, Korea-Australia Rheo. J., 15: 
125-130. 
Chan, J. L., Ehrlich, A., Lawrence, R. C., Moshell, A. N., Turner, M. L. and Kimball, 
A. B. (2005). Assessing the role of race in quantitative measures of skin pigmentation 
and clinical assessments of photosensitivity. J. Am. Acad. Dermatol, 52(4): 609-615. 
Chandrika, U. G., Jansz, E. R., Wickramasinghe, S. M. D. N., and Warnasuriya, N. D. 
(2003). Bioconversion of pro-vitamin A carotenoids and antioxidant activity of Carica 
papaya fruits. Journal of the National Science Foundation of Sri Lanka, 31(3-4): 437-
444. 
Chen, H., Chang, X., Du, D., Li, J., Xu, H. and Yang, X. (2006b). Microemulsion-
based hydrogel formulation of ibuprofen for topical delivery. International journal of 
pharmaceutics, 315(1): 52-58. 
143 
 
 
 
Chen, H., Chang, X., Du, D., Li, J., Xu, H., and Yang, X. (2006b). Microemulsion-
based hydrogel formulation of ibuprofen for topical delivery. International journal of 
pharmaceutics, 315(1): 52-58. 
Chen, H., Chang, X., Weng, T., Zhao, X., Gao, Z., Yang, Y., Xu, H., and Yang, X. 
(2004a). A study of microemulsion systems for transdermal delivery of triptolide. 
Journal of Controlled Release, 98(3): 427-436. 
Chen, H., Mou, D., Du, D., Chang, X., Zhu, D., Liu, J., Xu, H. and Yang, X. (2007a). 
Hydrogel-thickened microemulsion for topical administration of drug molecule at an 
extremely low concentration. International journal of pharmaceutics, 341(1): 78-84. 
Chiu, A. and Kimball, A. B. (2003). Topical vitamins, minerals and botanical 
ingredients as modulators of environmental and chronological skin damage. British 
Journal of Dermatology, 149(4): 681-691. 
Choksi, P. M. and Joshi, V. Y. (2007). A review on lycopene extraction, purification, 
stability and applications. International Journal of Food Properties, 10(2): 289-298. 
Chung, J. H., Seo, J. Y., Choi, H. R., Lee, M. K., Youn, C. S., Rhie, G. E., Cho, K.H., 
Kim, K. H., Park,  K. C. and  Eun, H. C. (2001). Modulation of skin collagen 
metabolism in aged and photoaged human skin in vivo. Journal of Investigative 
Dermatology, 117(5): 1218-1224. 
Clark, R. K. (2005). Anatomy and physiology: Understanding the human body. Jones 
and Bartlett Learning. 
Courage and Khazaka (2000). Information and operating instructions for Visioscan 
VC 98 and SELS. Available at http://www.courage-kazaka.de. 
Courage and Khazaka (2005). Information and operating instructions for Elastometer 
EM 25. Available at http://www.courage-kazaka.de. 
Courage, K. and Khazaka, G. (2004). Information and operating instructions for the 
multi probe adapter MPA and its probes. Available at http://www.courage-kazaka.de. 
144 
 
 
 
Cui, Y., Li, L., Gu, J., Zhang, T. and Zhang, L. (2011). Investigation of 
microemulsion system for transdermal delivery of ligustrazine phosphate. Afr. J. 
Pharm. Pharmacol, 5(14): 1674-1681. 
Danielsson, I. and Lindman, B. (1981). The definition of microemulsion. Colloids and 
Surfaces, 3(4): 391-392. 
Darvin, M., Zastrow, L., Sterry, W.  and Lademann, J. (2006). Effect of supplemented 
and topically applied antioxidant substances on human tissue. Skin pharmacology and 
physiology, 19(5): 238-247. 
Dawkins, G., Hewitt, H., Wint, Y., Obiefuna, P. C.and Wint, B. (2003). Antibacterial 
effects of Carica papaya fruit on common wound organisms. The West Indian 
Medical Journal, 52(4): 290-292. 
Devitt, L. C., Fanning, K., Dietzgen, R. G. and Holton, T. A. (2009). Isolation and 
functional characterization of a lycopene β-cyclase gene that controls fruit colour of 
papaya (Carica papaya L.). Journal of Experimental Botany, 284. 
Dhamankar, A. K., Manwar, J. V. and Kumbhar, D. D. (2009). The novel formulation 
design of O/W microemulsion of ketoprofen for improving transdermal absorption. 
Int J Pharm Tech Res, 1(4): 1449-1457. 
Djordjevic, L., Primorac, M. and Stupar, M. (2005). In vitro release of diclofenac 
diethylamine from caprylocaproyl macrogolglycerides based microemulsions. 
International journal of pharmaceutics, 296(1): 73-79. 
Draelos, Z. D. (2001). Botanicals as topical agents. Clinics in dermatology, 19(4): 
474-477. 
Dumay, O., Karam, A., Vian, L., Moyal, D., Hourseau, C., Stoebner, P., Peyron, J. L., 
Meynadier, J., Cano, J. P. and Meunier, L. (2001). Ultraviolet AI exposure of human 
skin results in Langerhans cell depletion and reduction of epidermal 
antigen‐presenting cell function: partial protection by a broad‐spectrum sunscreen. 
British Journal of Dermatology, 144(6): 1161-1168. 
145 
 
 
 
Dureja, H., Kaushik, D., Gupta, M., Kumar, V. and Lather, V. (2005). 
Cosmeceuticals: An emerging concept. Indian Journal of Pharmacology, 37(3): 155. 
El Maghraby, G. M. (2008). Transdermal delivery of hydrocortisone from eucalyptus 
oil microemulsion: effects of cosurfactants. International journal of pharmaceutics, 
355(1): 285-292. 
Elias, P. M. and Ghadially, R. (2002). The aged epidermal permeability barrier: basis 
for functional abnormalities. Clinics in geriatric medicine, 18(1): 103-20. 
Essawi, T. and Srour, M. (2000). Screening of some Palestinian medicinal plants for 
antibacterial activity. Journal of Ethnopharmacology, 70(3): 343-349. 
Farage, M. A., Miller, K. W., Elsner, P. and Maibach, H. I. (2008). Intrinsic and 
extrinsic factors in skin ageing: A Review. International journal of cosmetic science, 
30(2): 87-95. 
Fisher, G. J., Wang, Z., Datta, S. C., Varani, J., Kang, S. and Voorhees, J. J. (1997). 
Pathophysiology of premature skin aging induced by ultraviolet light. New England 
Journal of Medicine, 337(20): 1419-1429. 
Gaonkar, A. G. and Bagwe, R. P. (2003). Microemulsions in foods: Challenges and 
applications. Surfactant Science Series, 109: 407-430. 
Gasco, M. R., Pattarino, F. and Lattanzi, F. (1990). Long-acting delivery systems for 
peptides: reduced plasma testosterone levels in male rats after a single injection. 
International Journal of Pharmaceutics, 62(2): 119-123. 
Ghosh, P. K., Majithiya, R. J., Umrethia, M. L. and Murthy, R. S. (2006). Design and 
development of microemulsion drug delivery system of acyclovir for improvement of 
oral bioavailability. AAPS pharmscitech, 7(3): E172-E177. 
Ghosh, P. K., Majithiya, R. J., Umrethia, M. L. and Murthy, R. S. (2006). Design and 
Development of Microemulsion Drug Delivery System of Acyclovir for Improvement 
of Oral Bioavailability. AAPS pharmscitech, 7(3): 72-77.  
146 
 
 
 
Grabe, N. and Neuber, K. (2005). A multicellular systems biology model predicts 
epidermal morphology, kinetics and Ca2+ flow. Bioinformatics, 21(17): 3541-3547. 
Gray, J. (2000). The world of skin care, Ed.1, Macmillan Press, London. 12-16. 
Gurung, S. and Skalko-Basnet, N. (2009). Wound healing properties of Carica papaya 
latex: In vivo evaluation in mice burn model. Journal of Ethnopharmacology, 121(2): 
338-341. 
Hashem, F. M., Shaker D. S., Ghorab, M.  K., Nasr, M. and Ismail, A. (2011). 
Formulation, Characterization, and Clinical Evaluation of Microemulsion Containing 
Clotrimazole for Topical Delivery. AAPS PharmSciTech. 12: 879 
Hendriks, F. M. (2005). Mechanical behaviour of human epidermal and dermal layers 
in vivo. Ph.D Dissertation. Technische Universiteit Eindhoven, The Netherlands. 1-5. 
Hester, S. L., Rees, C. A., Kennis, R. A., Zoran, D. L., Bigley, K. E., Wright, A. S., 
Kirby N. A. and Bauer, J. E. (2004). Evaluation of corneometry (skin hydration) and 
transepidermal water-loss measurements in two canine breeds. The Journal of 
nutrition, 134(8): 2110S-2113S. 
Hire, N. N., Gudsoorkar, V. R., Bhise, K. S., Upasani, C. D., Nandgude, T. D. and 
Dalvi, H. (2007). Microparticulate drug delivery system for topical administration of 
ITR. Asian J Pharmaceu, 1: 83-8. 
Hoar, T. P. and Schulman, J. H. (1943). Transparent water-in-oil dispersions: the 
oleopathic hydro-micelle. Nature, 152: 102-103. 
Holtkotter, O., Schlotmann, K., Hofheinz, H., Olbrisch, R. R. and Petersohn, D. 
(2005). Unveiling the molecular basis of intrinsic skin aging1. International journal of 
cosmetic science, 27(5): 263-269. 
Hua, L., Weisan, P., Jiayu, L. and Hongfei, L. (2004). Preparation and evaluation of 
microemulsion of vinpocetine for transdermal delivery. Die Pharmazie-An 
International Journal of Pharmaceutical Sciences, 59(4): 274-278. 
147 
 
 
 
Hua, L., Weisan, P., Jiayu, L. and Ying, Z. (2004). Preparation, evaluation, and NMR 
characterization of vinpocetine microemulsion for transdermal delivery. Drug 
development and industrial pharmacy, 30(6): 657-666. 
Jablonski, N. G. (2006). Skin: A natural history. Univ. of California Press. 9-20. 
Jablonski, N. G. (2013). Skin: A natural history. Univ. of California Press. , USA 
Jadhav, K. R., Shetye, S. L. and Kadam, V. J. (2010). Design and evaluation of 
microemulsion based drug delivery system. International journal of Advances in 
pharmaceutical Sciences, 1: 156-166. 
Jaspers, S., Hopermann, H., Sauermann, G., Hoppe, U., Lunderstädt, R. and Ennen, J. 
(1999). Rapid in vivo measurement of the topography of human skin by active image 
triangulation using a digital micromirror device. Skin Research and Technology, 5(3): 
195-207. 
Jenkins, G. (2002). Molecular mechanisms of skin ageing. Mechanisms of ageing and 
development, 123(7): 801-810. 
Junqueira, L. C., Carneiro, J. and Kelley, R. O. (2006). Basic Histology: Text and 
Atlas. 360-372. 
Junqueira, V. B., Barros, S., Chan, S. S., Rodrigues, L., Giavarotti, L., Abud, R. L. 
and Deucher, G. P. (2004). Aging and oxidative stress. Molecular aspects of 
medicine, 25(1): 5-16. 
Kalra, R., Mulik, R. S., Badgujar, L., Paradkar, A. R., Mahadik, K. R., Bodhankar, S. 
L. and Sharma, S. (2010). Development and characterization of microemulsion 
formulations for transdermal delivery of aceclofenac: a research. International Journal 
of Drug Formulation and Research, 1(1): 359-386. 
Kasai, K., Yoshimura, M., Koga, T., Arii, M. and Kawasaki, S. (2006). Effects of oral 
administration of ellagic acid-rich pomegranate extract on ultraviolet-induced 
pigmentation in the human skin. J. Nutrition Science and Vitaminol. 52(5): 383-388. 
148 
 
 
 
Katakam, P. and Narendra, C. (2011). Aceclofenac Nanoemulsions for Transdermal 
Delivery: Stability and In-vitro Evaluation. Asian Journal of Pharmacy and Life 
Science. 1(4): 354-69. 
Katie, M. D. and Rebecca, S. M. (2008). Molecules in focus: Vitamin D, The 
International Journal of Biochemistry and Cell Biology, Elsevier Ltd. 
Khalil, E., Al-Sotari, S. T. and Taha, M. O. (2012). Formulation and Characterization 
of IPM/Water/Nonionic-lonic Surfactant Microemulsions. Journal of Chemistry and 
Chemical Engineering, 6(2): 187-198. 
Korac, R. R. and Khambholja, K. M. (2011). Potential of herbs in skin protection 
from ultraviolet radiation. Pharmacognosy Reviews, 5(10): 164-73. 
Kreilgaard, M., Pedersen, E. J. and Jaroszewski, J. W. (2000). NMR characterisation 
and transdermal drug delivery potential of microemulsion systems. Journal of 
controlled release, 69(3): 421-433. 
Kronevi, T. and Ljungberg, S. (1983). Sequelae following intra-arterially injected 
diazepam formulations. Acta pharmaceutica suecica, 20(5): 389-396. 
Kulkarni, A. P. and Aradhya, S. M. (2005). Chemical changes and antioxidant activity 
in pomegranate arils during fruit development. Food Chemistry, 93(2): 319-324. 
Lambers, H., Piessens, S., Bloem, A., Pronk, H. and Finkel, P. (2006). Natural skin 
surface pH is on average below 5, which is beneficial for its resident flora. 
International journal of cosmetic science, 28(5): 359-370. 
Lansky, E. P. and Newman, R. A. (2007). Punica granatum (pomegranate) and its 
potential for prevention and treatment of inflammation and cancer. Journal of 
ethnopharmacology, 109(2): 177-206. 
Larson, E. (1999). Skin hygiene and infection prevention: more of the same or 
different approaches? Clinical Infectious Diseases, 29(5): 1287-1294. 
Lawrence, M. J. and Rees, G. D. (2000). Microemulsion-based media as novel drug 
delivery systems. Advanced Drug Delivery Reviews, 45(1): 89-121. 
149 
 
 
 
Leveque, J. L. and Goubanova, E. (2004). Influence of age on the lips and perioral 
skin. Dermatology, 208(4): 307-313. 
Lin, J. Y., Selim, M. A., Shea, C. R., Grichnik, J. M., Omar, M. M., Monteiro-Riviere, 
N. A. and Pinnell, S. R. (2003). UV photoprotection by combination topical 
antioxidants vitamin C and vitamin E. Journal of the American Academy of 
Dermatology, 48(6): 866-874. 
Lonsdale, K. (1968). Human Stones Limited studies give some details of composition, 
rates of growth, distribution, and possible causes. Science, 159(3820): 1199-1207. 
Lopes, L. B. and Reed, R. (2010). A simple and rapid method to assess lycopene in 
multiple layers of skin samples. Biomedical Chromatography, 24(2): 154-159. 
Lopes, L. B., Vandewall, H., Li, H. T., Venugopal, V., Li, H. K., Naydin, S., Hosmer, 
J., Levendusky, M., Zheng, H., Bentley, M. V. L. B., Levin, R. and Hass, M. A. 
(2010). Topical delivery of lycopene using microemulsions: enhanced skin 
penetration and tissue antioxidant activity. Journal of pharmaceutical sciences, 99(3): 
1346-1357. 
Mader, S. S. (2005). Understanding human anatomy and physiology. McGraw-Hill 
Boston Company. 70-79. 
Malvy, D. J. M., Guinot, C., Preziosi, P., Galan, P., Chapuy, M. C., Maamer, M., 
Arnaud, S., Meunier, S. H. and Tschachler, E. (2000). Relationship between vitamin 
D status and skin phototype in general adult population. Photochemistry and 
photobiology, 71(4): 466-469. 
Mantena, S. K. and Katiyar, S. K. (2006). Grape seed proanthocyanidins inhibit UV-
radiation-induced oxidative stress and activation of MAPK and NF-κB signaling in 
human epidermal keratinocytes. Free Radical Biology and Medicine, 40(9): 1603-
1614. 
Maria, P., Arij W., Johanna, K., Aat, M., Geert, S. G., Joke, B. and A. Mieke M. 
(1997). The Formation Of Component Barrier Lipids In Reconstructed Human 
150 
 
 
 
Epidermis Requires The Presence Of Vitamin C. Journal Of Investigation Dermatol. 
109: 348-355. 
Maskan, M. (2006). Production of pomegranate (Punica granatum L.) juice 
concentrate by various heating methods: colour degradation and kinetics. Journal of 
Food Engineering, 72(3): 218-224. 
Matousek, J. L., Campbell, K. L., Kakoma, I., Solter, P. F. and Schaeffer, D. J. 
(2003). Evaluation of the effect of pH on in vitro growth of Malassezia 
pachydermatis. Canadian journal of veterinary research, 67(1): 56-59 
Meeran, S. M., Katiyar, S., Elmets, C. A. and Katiyar, S. K. (2006). Silymarin inhibits 
UV radiation-induced immunosuppression through augmentation of interleukin-12 in 
mice. Molecular cancer therapeutics, 5(7): 1660-1668. 
Mehta, S. K., Kaur, G. and Bhasin, K. K. (2010). Tween-embedded 
microemulsions—physicochemical and spectroscopic analysis for antitubercular 
drugs. AAPS PharmSciTech, 11(1): 143-153. 
Menaa, F. (2014). Emulsions Systems for Skin Care: From Macro to Nano-
Formulations. J. Pharma Care Health Sys, 1, e104. 
 
Michael, H. R., Gordon, I. K. and Wojciech, P., Histology (2003). A Text and Atlas, 
with cell and molecular biology, (Ed. 4th), Lippincott Williams and Wilkins, USA, p. 
400-417. 
Mizushima, Y., Hamano, T. and Yokoyama, K. (1982). Use of a lipid emulsion as a 
novel carrier for corticosteroids. Journal of Pharmacy and Pharmacology, 34(1): 49-
50. 
Moghimipour, E., Salimi, A., and Eftekhari, S. (2013). Design and Characterization of 
Microemulsion Systems for Naproxen. Advanced pharmaceutical bulletin, 3(1): 63-
71. 
Montagna, W. (1974). An introduction to sebaceous glands. Journal of Investigative 
Dermatology, 62(3): 120-123. 
151 
 
 
 
Moon, J. S. and Oh, C. H. (2001). Solar damage in skin tumors: quantification of 
elastotic material. Dermatology, 202(4): 289-292. 
Mortazavi, S. A., Pishrochi, S. and Azar, Z. J., (2013). Formulation and In-vitro 
Evaluation of Tretinoin Microemulsion as a Potential Carrier for Dermal Drug 
Delivery. Iranian journal of pharmaceutical research: IJPR, 12(4): 599. 
Mortazavi, S. A., Pishrochi, S., and Azar, Z. J., (2013). Formulation and In-vitro 
Evaluation of Tretinoin Microemulsion as a Potential Carrier for Dermal Drug 
Delivery. Iranian journal of pharmaceutical research: IJPR, 12(4): 599. 
Moulik, S. P. and Pakshit, N. K., (2006). Physicochemistry and applications of 
microemulsions. J. surface. Sci. technol. 22: 159-199. 
Nagariya, K., Jadon, P. S., Naruka, P. S. and Chauhan, C. S. (2010). Formulation 
development and characterization of aceclofenac gel using poloxamer 407. J. Chem. 
Pharm. Res, 2(4): 357-363. 
Nandi, I., Bari, M. and Joshi, H. (2003). Study of isopropyl myristate microemulsion 
systems containing cyclodextrins to improve the solubility of 2 model hydrophobic 
drugs. AAPS PharmSciTech, 4(1): 71-79. 
Nishigori, C., Hattori, Y. and Toyokuni, S. (2004). Role of reactive oxygen species in 
skin carcinogenesis. Antioxidants and Redox Signaling, 6(3): 561-570. 
Nusgens, B. V., Humbert, P., Rougier, A., Colige, A. C., Haftek, M., Lambert, C. A. 
and Lapiere, C. M. (2001). Topically Applied Vitamin C Enhances the mRNA Level 
of Collagens I and III, Their Processing Enzymes and Tissue Inhibitor of Matrix 
Metalloproteinase 1 in the Human Dermis1. Journal of Investigative Dermatology, 
116(6): 853-859. 
Ohnishi, Y., Tajima, S., Akiyama, M., Ishibashi, A., Kobayashi, R. and Horii, I. 
(2000). Expression of elastin-related proteins and matrix metalloproteinases in actinic 
elastosis of sun-damaged skin. Archives of dermatological research, 292(1): 27-31. 
 
152 
 
 
 
Omodamiro, O. D. and Amechi, U. (2013). The phytochemical content, antioxidant, 
antimicrobial and antiinflammatory activities of Lycopersicon esculentum (Tomato). 
Asian Journal of Plant Science and Research, 3(5): 70-81. 
Ortonne, J. P. and Bissett, D. L. (2008). Latest insights into skin hyperpigmentation. 
In: Journal of Investigative Dermatology Symposium Proceedings, 13: 10-14.  
Ozguney, I. S., Karasulu, H. Y., Kantarci, G., Sozer, S., Goneri, T. and Ertan, G. 
(2006). Transdermal delivery of diclofenac sodium through rat skin from various 
formulations. AAPS PharmSciTech, 7(4): E39-E45. 
Pande, S. Y. and Misri, R. (2005). Sebumeter. Indian Journal of Dermatology, 
Venereology and Leprology, 71(6): 444-446. 
Parikh, D. K. and Ghosh, T. K. (2005). Feasibility of transdermal delivery of 
fluoxetine. AAPS PharmSciTech, 6(2): E144-E149. 
Park, C. I., Cho, W. G. and Lee, S. J. (2003). Emulsion stability of cosmetic creams 
based on water-in-oil high internal phase emulsions. Korea-Australia Rheology 
Journal, 15(3): 125-130. 
Park, K. M. and Kim, C. K. (1999). Preparation and evaluation of flurbiprofen-loaded 
microemulsion for parenteral delivery. International journal of pharmaceutics, 181(2): 
173-179. 
Parvez, S., Kang, M., Chung, H. S., Cho, C., Hong, M. C., Shin, M. K. and Bae, H. 
(2006). Survey and mechanism of skin depigmenting and lightening agents. 
Phytotherapy Research, 20(11): 921-934. 
Patel, D., Dasgupta, S., Dey, S., Ramani, Y. R., Ray, S. and Mazumder, B. (2012). 
Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: 
preparation, characterization, and in vivo evaluation. Scientia pharmaceutica, 80(3): 
749. 
153 
 
 
 
Pays, K., Giermanska-Kahn, J., Pouligny, B., Bibette, J. and Leal-Calderon, F. (2002). 
Double emulsions: how does release occur? Journal of controlled release, 79(1): 193-
205. 
Pena Ferreira, M. R., Costa, P. C. and Bahia, F. M. (2010). Efficacy of anti‐wrinkle 
products in skin surface appearance: a comparative study using non‐invasive methods. 
Skin Research and Technology, 16(4): 444-449. 
Periago, M. J., Rincon, F., Aguera, M. D. and Ros, G. (2004). Mixture approach for 
optimizing lycopene extraction from tomato and tomato products. J. Agric. Food 
Chem. 52 (19): 5796-5802. 
Piepkorn, M., Predd, H., Underwood, R. and Cook, P. (2003). Proliferation–
differentiation relationships in the expression of heparin-binding epidermal growth 
factor-related factors and erbB receptors by normal and psoriatic human 
keratinocytes. Archives of dermatological research, 295(3): 93-101. 
Pieroni, A., Quave, C. L., Villanelli, M. L., Mangino, P., Sabbatini, G., Santini, L., 
and Tomasi, M. (2004). Ethnopharmacognostic survey on the natural ingredients used 
in folk cosmetics, cosmeceuticals and remedies for healing skin diseases in the inland 
Marches, Central-Eastern Italy. Journal of Ethnopharmacology, 91(2): 331-344. 
Plasencia, I., Norlen, L. and Bagatolli, L. A. (2007). Direct visualization of lipid 
domains in human skin Stratum corneum's lipid membranes: effect of pH and 
temperature. Biophysical journal, 93(9): 3142-3155. 
Priyanka, C., Kadam, D. A., Kadam, A. S., Ghule, Y. A. and Aparadh, V. T. (2013). 
Free Radical Scavenging (DPPH) and Ferric Reducing Ability (FRAP) of Some 
Gymnosperm species. Int J Res Bot, 3(2): 34-36. 
Quevedo, W. C., Fitzpatrick, T. B., Pathak, M. A. and Jimbow, K. (1975). Role of 
light in human skin color variation. Am. J. Phys. Anthropol. 43(3): 393-408. 
Rabe, J. H., Mamelak, A. J., McElgunn, P. J., Morison, W. L. and Sauder, D. N. 
(2006). Photoaging: mechanisms and repair. Journal of the American Academy of 
Dermatology, 55(1): 1-19. 
154 
 
 
 
Rebecca, C. M., den Worm, E., Weelden, H. and Piet, L. B. (2006). Pathophysiology 
of photoaging of human skin: focus on neutrophils. Photochemical & Photobiological 
Sciences, 5(2): 184-189. 
Redo, M. C., Rios, J. L. and Villar, A. (1989). A review of some antimicrobial 
compounds isolated from medicinal plants reported in the literature 1978–1988. 
Phytotherapy Research, 3(4): 117-125. 
Reichrath, J. (2007). Vitamin D and the skin: an ancient friend, revisited. 
Experimental dermatology, 16(7): 618-625. 
Rhee, Y. S., Choi, J. G., Park, E. S. and Chi, S. C. (2001).Transdermal delivery of 
ketoprofen using microemulsions. International journal of pharmaceutics, 228(1): 
161-170. 
Robert, W. D., Herdt, T. H., Credille, K., Maier, R. L., Tucker, K. A. and Davenport, 
G. M. ((2000). Current research in canine dermatology. The Iams Company, Dayton, 
USA. 10-15. 
Ross, F. P. and Christiano, A. M. (2006). Nothing but skin and bone. The Journal of 
Clinical Investigation, 116(5): 1140-1149. 
Ross, M. H., Kaye, G. I. and Pawlina, W. (2003). Histology: a text and atlas with cell 
and molecular biology. (Ed. 4th), Lippincott Williams and Wilkins, USA, p. 400-417. 
Rozzi, N. L., Singh, R. K., Vierling, R. A. and Watkins, B. A. (2002). Supercritical 
fluid extraction of lycopene from tomato processing byproducts. J. Agric. Food 
Chem. 50(9): 2638-2643. 
Ruckenstein, E. and Chi, J. C. (1975). Stability of microemulsions. J. Chem. Soc. 
Faraday Transactions 2: Molecular and Chemical Physics, 71: 1690-1707. 
Sadler, G., Davis, J. and Dezman, D. (1990). Rapid Extraction of Lycopene and 
β‐Carotene from Reconstituted Tomato Paste and Pink Grapefruit Homogenates. J. 
Food Sci, 55(5): 1460-1461. 
155 
 
 
 
Salavkar, S. M., Tamanekar, R. A. and Athawale, R. B. (2011). Antioxidants in skin 
ageing-Future of dermatology. International Journal of Green Pharmacy, 5(3): 161-
168. 
Sander, C. S., Chang, H., Hamm, F., Elsner, P. and Thiele, J. J. (2004). Role of 
oxidative stress and the antioxidant network incutaneous carcinogenesis. International 
Journal of Dermatology, 43(5): 326-335. 
Schwarz, K., Bertelsen, G., Nissen, L. R., Gardner, P. T., Heinonen, M. I., Hopia, A. 
and Tijburg, L. (2001). Investigation of plant extracts for the protection of processed 
foods against lipid oxidation. Comparison of antioxidant assays based on radical 
scavenging, lipid oxidation and analysis of the principal antioxidant compounds. 
European Food Research and Technology, 212(3): 319-328. 
Schweikert, K., Kalhofer, V. and Gabard, B. (2005). Improving the properties of 
Hyaluronic acid on dry skin. Personal Care. 35-39. 
Seeram, N. P., Henning, S. M., Zhang, Y., Suchard, M., Li, Z. and Heber, D. (2006). 
Pomegranate juice ellagitannin metabolites are present in human plasma and some 
persist in urine for up to 48 hours. The Journal of Nutrition, 136(10): 2481-2485. 
Shafiq, S., Shakeel, F., Baboota, S., Ahuja, A., Ali, J. and Aqil, M. (2007b) 
Nanoemulsions as Vehicles for Transdermal Delivery of Aceclofenac. AAPS 
PharmSciTech; 8(4): 104. 
Shafiq-un-Nabi, S., Shakeel, F., Talegaonkar, S., Ali, J., Baboota, S., Ahuja, A., 
Roop, K. and Ali, M. (2007). Formulation development and optimization using 
nanoemulsion technique: a technical note. AAPS pharmscitech, 8(2): E12-E17. 
Shah, R. R., Magdum, C. S., Patil, S. S. and Niakwade, N. S. (2010). Preparation and 
evaluation of aceclofenac topical microemulsion. IJPR. 9(1): 5. 
Shakeel, F., Baboota, S., Ahuja, A., Ali, J., Aqil, M. and Shafiq, S. (2007). 
Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS 
PharmSciTech, 8(4): 191-199. 
156 
 
 
 
Sharif, A., Akhtar, N., Khan, M. S., Menaa, B., Khan, B.A. and Menaa, F. (2014). 
Development and Optimization of Dimethicone-based Cream Containing Muscat 
Hamburg Grape Extract: In-vitro Evaluation. J Pharma Care Health Sys 1:107. doi: 
10.4172/jpchs.1000107  
 
Sharif, A., Akhtar, N., Khan, M. S., Menaa, A., Menaa, B., Khan, B. A and Menaa, F. 
(2014). Formulation and evaluation on human skin of a water‐in‐oil emulsion 
containing Muscat hamburg black grape seed extract. Int J Cosmet Sci., 1-6 
Sharma, P. K. and Bajpai, M. (2011). Enhancement of solubility and stability of 
Celecoxib using microemulsion based topical formulation. Journal of Pharmacy 
Research, 4(7): 2216-2220 
Shephard, R. J., Jones, G., Ishii, K., Kaneko, M. and Olbrecht, A. J. (1969). Factors 
affecting body density and thickness of subcutaneous fat data on 518 Canadian city 
dwellers. The American journal of clinical nutrition, 22(9): 1175-1189. 
Silver, F. H., Freeman, J. W. and DeVore, D. (2001). Viscoelastic properties of 
human skin and processed dermis. Skin Research and Technology, 7(1): 18-23. 
Sintov, A. C. and Botner, S. (2006). Transdermal drug delivery using microemulsion 
and aqueous systems: influence of skin storage conditions on the in vitro permeability 
of diclofenac from aqueous vehicle systems. International journal of pharmaceutics, 
311(1): 55-62. 
Song, J. H., Bae, E. Y., Choi, G., Hyun, J. W., Lee, M. Y., Lee, H. W.and Chae, S. 
(2013). Protective effect of mango (Mangifera indica L.) against UVB‐induced skin 
aging in hairless mice. Photodermatology, photoimmunology and photomedicine, 
29(2): 84-89. 
Souza, L. M. D., Ferreira, K. S., Chaves, J. B. P. and Teixeira, S. L. (2008). L-
ascorbic acid, β-carotene and lycopene content in papaya fruits (Carica papaya) with 
or without physiological skin freckles. Scientia Agricola, 65(3): 246-250. 
157 
 
 
 
Stahl, W., Heinrich, U., Wiseman, S., Eichler, O., Sies, H. and Tronnier, H. (2001). 
Dietary tomato paste protects against ultraviolet light–induced erythema in humans. 
The Journal of nutrition, 131(5): 1449-1451. 
Stevens, A. and Lowe, J. S. (1997). Human histology, 117-258. London: Mosby. 
Stone, W. L. and Smith, M. (2004). Therapeutic uses of antioxidant liposomes. 
Molecular biotechnology, 27(3), 217-230. 
Syed, D. N., Afaq, F. and Mukhtar, H. (2007). Pomegranate derived products for 
cancer chemoprevention. In Seminars in cancer biology, 17: 377-385. 
Tadros, T. F. (1992). Future developments in cosmetic formulations. International 
Journal of Cosmetic Science, 14(3): 93-111. 
Tenjarla, S. (1999). Microemulsions: an overview and pharmaceutical applications. 
Critical Reviews™ in Therapeutic Drug Carrier Systems, 16(5). 
Toor, R. K., Lister, C. E. and Savage, G. P. (2005a). Antioxidant activities of New 
Zealand-grown tomatoes. International journal of food sciences and nutrition, 56(8): 
597-605. 
Toor, R. K., Savage, G. P. and Lister, C. E. (2008b). Release of antioxidant 
components from tomatoes determined by an in vitro digestion method. International 
Journal of Food Sciences and Nutrition, 60(2): 119-129. 
Tronnier, H., Wiebusch, M. and Heinrich, U. (2003). Frictiometry on human skin. In: 
14th Congress of the International society for Bioengineering and Skin (ISBS), p. 21-
24. 
Tronnier, H., Wiebusch, M., Heinrich, U. and Stute, R. (1997). Surface evaluation of 
living skin-SELS. Journal of the European Academy of Dermatology and 
Venereology, 9(1001): 199-199. 
Varani, J., Warner, R. L., Gharaee-Kermani, M., Phan, S. H., Kang, S., Chung, J., 
Wang, Z., Datta, S. C., Fisher, G. J. and Voorhees, J. J. (2000). Vitamin A 
Antagonizes Decreased Cell Growth and Elevated Collagen-Degrading Matrix 
158 
 
 
 
Metalloproteinases and Stimulates Collagen Accumulation in Naturally Aged Human 
Skin1. Journal of Investigative Dermatology, 114(3): 480-486. 
Vayalil, P. K., Elmets, C. A. and Katiyar, S. K. (2003). Treatment of green tea 
polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and 
proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in 
SKH-1 hairless mouse skin. Carcinogenesis, 24(5): 927-936. 
Veena, B. (2005). Text Book of Histology, (Ed. 2nd). AITBS Publishers and 
Distributors, Delhi, India. 245. 
Vyas, S. P. and Khar R. K. (2002). Targeted and controlled Drug delivery novel 
carrier system, Submicron emulsions. CBS publishers and distributors. 280-303. 
Waghmare, N., Waghmare, P., Wani, S. and Yerawar, A. (2011). Development of 
isotretinoin gel for treatment of acne vulgaris. Research Journal of Pharmaceutical, 
Biological and Chemical Sciences, 2(1): 220-230. 
Waller, J. M. and Maibach, H. I. (2006). Age and skin structure and function, a 
quantitative approach (II): protein, glycosaminoglycan, water, and lipid content and 
structure. Skin Research and Technology, 12(3): 145-154. 
Waqas, M., Akhtar, N., Ahmad, M., Murtaza, G., Khan, H., Iqbal, M. (2010). 
Formulation and characterization of a cream containing extract of fenugreek seeds. 
Acta. Pol. Pharm. Drug Res. 67: 173-178. 
Wen, L. and Papadopoulos, K. D. (2001). Effects of Osmotic Pressure on Water 
Transport in w1/o/w2 Emulsions. Journal of colloid and interface science, 235(2): 
398-404. 
Werner, Y. L. V. A. (1985). The water content of the stratum corneum in patients 
with atopic dermatitis measurement with the Corneometer CM 420. Acta. Derm. 
Venereol, 66(4): 281-284. 
159 
 
 
 
Wlaschek, M., Tantcheva-Poór, I., Naderi, L., Ma, W., Schneider, L. A., Razi-Wolf, 
Z., Schulle, J. and Scharffetter-Kochanek, K. (2001). Solar UV irradiation and dermal 
photoaging. Journal of Photochemistry and Photobiology B: Biology, 63(1): 41-51. 
Yong, C. S., Oh, Y. K., Lee, K. H., Park, S. M., Park, Y. J., Gil, Y. S. and Choi, H. G. 
(2005). Trials of clear aceclofenac-loaded soft capsules with accelerated oral 
absorption in human subjects. International journal of pharmaceutics, 302(1): 78-83. 
Yoshimura, M., Watanabe, Y., Kasai, K., Yamakoshi, J. and Koga, T. (2005). 
Inhibitory effect of an ellagic acid-rich pomegranate extract on tyrosinase activity and 
ultraviolet-induced pigmentation. Bioscience, biotechnology, and biochemistry, 
69(12): 2368-2373. 
Youn, S. W., Na, J. I., Choi, S. Y., Huh, C. H. and Park, K. C. (2005). Regional and 
seasonal variations in facial sebum secretions: a proposal for the definition of 
combination skin type. Skin Research and Technology, 11(3): 189-195. 
Young, B., Woodford, P., and O'Dowd, G. (2013). Wheater's functional histology: a 
text and colour atlas. Elsevier Health Sciences. 
Zhang, Q., Jiang, X., Jiang, W., Lu, W., Su, L. and Shi, Z. (2004). Preparation of 
nimodipine-loaded microemulsion for intranasal delivery and evaluation on the 
targeting efficiency to the brain. International journal of pharmaceutics, 275(1): 85-
96. 
Zhu, W. and Gao, J. (2008). The use of botanical extracts as topical skin-lightening 
agents for the improvement of skin pigmentation disorders. In: Journal of 
Investigative Dermatology Symposium Proceedings, 1(13): 20-24. 
Zhu, W., Yu, A., Wang, W., Dong, R., Wu, J. and Zhai, G. (2008). Formulation 
design of microemulsion for dermal delivery of penciclovir. International journal of 
pharmaceutics, 360(1): 184-190. 
 
 
